>pdb|1B97|D Chain D, ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP
AAAGATATCTT
>pdb|1B97|C Chain C, ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP
AAAGATATCTT
>pdb|1B96|D Chain D, ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP
AAAGATATCTT
>pdb|1B96|C Chain C, ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP
AAAGATATCTT
>pdb|1BSS|D Chain D, ECORV-T93A/DNA/CA2+
AAAGATATCTT
>pdb|1BSS|C Chain C, ECORV-T93A/DNA/CA2+
AAAGATATCTT
>MQ262301.1 Sequence 161 from Patent WO2021209813
ANCNCTAAANT
>MQ261255.1 Sequence 71 from Patent WO2021211963
AACATTGCCAA
>pdb|1SX8|D Chain D, EcoRV bound to cognate DNA and Mn2+
CAAGATATCTT
>pdb|1SX8|C Chain C, EcoRV bound to cognate DNA and Mn2+
CAAGATATCTT
>pdb|1SUZ|D Chain D, The structure of K92A EcoRV bound to cognate DNA and Mg2+
CAAGATATCTT
>pdb|1SUZ|C Chain C, The structure of K92A EcoRV bound to cognate DNA and Mg2+
CAAGATATCTT
>pdb|1MW8|Y Chain Y, Crystal Structure of a Complex between H365R mutant of 67 kDA N-terminal fragment of E. coli DNA Topoisomerase I and 5'-ACTTCGGGATG-3'
ACTTCGGGATG
>pdb|1P5W|B Chain B, The structures of host range controlling regions of the capsids of canine and feline parvoviruses and mutants
NTACCTCTTGC
>pdb|1O3S|B Chain B, PROTEIN-DNA RECOGNITION AND DNA DEFORMATION REVEALED IN CRYSTAL STRUCTURES OF CAP-DNA COMPLEXES
AAAAATGCGAT
>pdb|1KU7|C Chain C, Crystal Structure of Thermus aquatics RNA Polymerase SigmaA Subunit Region 4 Bound to-35 Element DNA
CCTTTGTCAAG
>pdb|1KU7|B Chain B, Crystal Structure of Thermus aquatics RNA Polymerase SigmaA Subunit Region 4 Bound to-35 Element DNA
CCTTGACAAAG
>pdb|1JK2|C Chain C, Zif268 D20A mutant bound to the GCT DNA site
TCAGCCCACGC
>pdb|1JK2|B Chain B, Zif268 D20A mutant bound to the GCT DNA site
AGCGTGGGCTG
>pdb|1JK1|C Chain C, Zif268 D20A Mutant Bound to WT DNA Site
TCCGCCCACGC
>pdb|1JK1|B Chain B, Zif268 D20A Mutant Bound to WT DNA Site
AGCGTGGGCGG
>PA270430.1 WO 2021141121-A/1: Novel TLR9 Agonists
TCGCAACGTTT
>PA269627.1 WO 2021132589-A/78: POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION
CAGCCACCATG
>PA269003.1 WO 2021132661-A/2: Production method for library, cyclic peptide, binding agents for FXIIa and IFNGR1
AGGGGNCCCCT
>PA268693.1 WO 2021132528-A/71: OLIGODEOXYNUCLEOTIDE CONTAINING SHORT CPG ODN LINKED WITH POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE THEREOF
GATCGTCGTTC
>PA268635.1 WO 2021132528-A/13: OLIGODEOXYNUCLEOTIDE CONTAINING SHORT CPG ODN LINKED WITH POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE THEREOF
TCGAGCGTTCT
>PA268196.1 JP 2021100390-A/5: Method of obtaining the digestion efficiency of nucleases
CCANNNNNTGG
>MQ247799.1 Sequence 12 from Patent WO2021204479
GACAGCACTTC
>MQ212733.1 Sequence 6 from Patent EP3886887
TTTTTTTTTTT
>MQ234950.1 Sequence 36 from Patent WO2021202425
GCGGTTTGCGG
>MQ234934.1 Sequence 20 from Patent WO2021202425
GGTGGTGGTGG
>MQ230729.1 Sequence 4 from Patent WO2021198424
CGGAACAGCGG
>pdb|3G0Q|C Chain C, Crystal Structure of MutY bound to its inhibitor DNA
GTCCCNGTCTT
>pdb|3G0Q|B Chain B, Crystal Structure of MutY bound to its inhibitor DNA
AAGACNGGGAC
>pdb|3G9C|H Chain H, Crystal structure of the product Bacillus anthracis glmS ribozyme
GCGCCAGAACT
>pdb|3G9C|G Chain G, Crystal structure of the product Bacillus anthracis glmS ribozyme
GCGCCAGAACT
>pdb|3G9C|F Chain F, Crystal structure of the product Bacillus anthracis glmS ribozyme
GCGCCAGAACT
>pdb|3G9C|E Chain E, Crystal structure of the product Bacillus anthracis glmS ribozyme
GCGCCAGAACT
>pdb|3BM3|D Chain D, Restriction endonuclease PspGI-substrate DNA complex
GGTACCTGGAT
>pdb|3BM3|C Chain C, Restriction endonuclease PspGI-substrate DNA complex
CATCCAGGTAC
>pdb|3C5F|U Chain U, Structure of a binary complex of the R517A Pol lambda mutant
CGGCCGTACTG
>pdb|3C5F|T Chain T, Structure of a binary complex of the R517A Pol lambda mutant
CGGCCGTACTG
>pdb|3C5G|U Chain U, Structure of a ternary complex of the R517K Pol lambda mutant
CGGCAATACTG
>pdb|3C5G|T Chain T, Structure of a ternary complex of the R517K Pol lambda mutant
CGGCAATACTG
>pdb|2NQ9|D Chain D, High resolution crystal structure of Escherichia coli endonuclease IV (Endo IV) Y72A mutant bound to damaged DNA
ATCTGAAGTAT
>pdb|2PYL|X Chain X, Phi29 DNA polymerase complexed with primer-template DNA and incoming nucleotide substrates (ternary complex)
GACTGCTTACN
>pdb|2PFQ|T Chain T, Manganese promotes catalysis in a DNA polymerase lambda-DNA crystal
CGGCGGTACTG
>pdb|2PFP|T Chain T, DNA Polymerase lambda in complex with DNA and dCTP
CGGCGGTACTG
>pdb|2PFO|T Chain T, DNA Polymerase lambda in complex with DNA and dUPNPP
CGGCAGTACTG
>pdb|2PFN|T Chain T, Na in the active site of DNA Polymerase lambda
CGGCAGTACTG
>pdb|2H8C|X Chain X, Structure of RusA D70N in complex with DNA
CCGGTACCGGT
>pdb|2H8C|W Chain W, Structure of RusA D70N in complex with DNA
CCGGTACCGGT
>pdb|2H8C|Z Chain Z, Structure of RusA D70N in complex with DNA
CCGGTACCGGT
>pdb|2H8C|Y Chain Y, Structure of RusA D70N in complex with DNA
CCGGTACCGGT
>pdb|2H7F|Y Chain Y, Structure of variola topoisomerase covalently bound to DNA
TTGTCGCCCTT
>pdb|1YQK|B Chain B, Human 8-oxoguanine glycosylase crosslinked with guanine containing DNA
GGTAGACCTGG
>pdb|1XSP|T Chain T, Crystal Structure of human DNA polymerase lambda in complex with nicked DNA and pyrophosphate
CGGCCGTACTG
>pdb|1XSN|T Chain T, Crystal Structure of human DNA polymerase lambda in complex with a one nucleotide DNA gap and ddTTP
CGGCAATACTG
>pdb|4X66|b Chain b, Crystal Structure of 30S ribosomal subunit from Thermus thermophilus
NACTNTTNANC
>pdb|4X65|b Chain b, Crystal Structure of 30S ribosomal subunit from Thermus thermophilus
NACTNTTNANC
>pdb|6FWS|C Chain C, Structure of DinG in complex with ssDNA and ADPBeF
TTTTTTTTTTT
>MY420146.1 Sequence 75 from patent US 11111492
GGTATACAGGA
>MY420145.1 Sequence 74 from patent US 11111492
GGTATACACGA
>MY420144.1 Sequence 73 from patent US 11111492
GGTATACAGCA
>MY420143.1 Sequence 72 from patent US 11111492
GGTATACATTA
>MY420142.1 Sequence 71 from patent US 11111492
GGTATACACTA
>MY420141.1 Sequence 70 from patent US 11111492
GGTATACATCA
>MY420140.1 Sequence 69 from patent US 11111492
GGTATACACCA
>MY415722.1 Sequence 357 from patent US 11110166
GGGTTTTTGGG
>MY415712.1 Sequence 346 from patent US 11110166
GGTTTTTTTGG
>MY415311.1 Sequence 23 from patent US 11110114
CTCANATNGCT
>MY414044.1 Sequence 6 from patent US 11104955
CAGAAGCAGAA
>MY414042.1 Sequence 4 from patent US 11104955
TACCCAGAAGC
>MY413907.1 Sequence 191 from patent US 11104943
ACACTCTTTCC
>MY413879.1 Sequence 100 from patent US 11104943
ACACTCTTTCC
>MY413774.1 Sequence 6 from patent US 11104940
CTAATCGGATC
>MY413773.1 Sequence 5 from patent US 11104940
GTCAGTCAATG
>MY413772.1 Sequence 4 from patent US 11104940
ACGTAGGGTCA
>MY413771.1 Sequence 3 from patent US 11104940
TAGCCTAGTAA
>MY413770.1 Sequence 2 from patent US 11104940
ACTGTCAGTAG
>MY413768.1 Sequence 6 from patent US 11104939
CTAATCGGATC
>MY413767.1 Sequence 5 from patent US 11104939
GTCAGTCAATG
>MY413766.1 Sequence 4 from patent US 11104939
ACGTAGGGTCA
>MY413765.1 Sequence 3 from patent US 11104939
TAGCCTAGTAA
>MY413764.1 Sequence 2 from patent US 11104939
ACTGTCAGTAG
>MY413146.1 Sequence 4 from patent US 11104934
GGGATCCTACC
>MY412556.1 Sequence 36 from patent US 11104911
CATCCACCATT
>MY410024.1 Sequence 4 from patent US 11104676
CTTTCTCTCTG
>MY409960.1 Sequence 24 from patent US 11103578
GGGATCCTACC
>MY409185.1 Sequence 8 from patent US 11100404
CGTCNTNGCTT
>MY408282.1 Sequence 20 from patent US 11098356
CCTTCCCCGGN
>MY408280.1 Sequence 18 from patent US 11098356
GGGGGAGGCCN
>MY407385.1 Sequence 334 from patent US 11098326
GAAGCTGGAGG
>MY407384.1 Sequence 333 from patent US 11098326
GAAGCTGGAGG
>MY407365.1 Sequence 314 from patent US 11098326
TCAACCGGTGG
>MY391442.1 Sequence 3 from patent US 11092606
CTAACTAATTA
>MY367774.1 Sequence 16 from patent US 11091524
CTGGGGATTTA
>MY367772.1 Sequence 14 from patent US 11091524
AGGGGGATCTG
>MY367771.1 Sequence 13 from patent US 11091524
GGGGACTTTCC
>MY367770.1 Sequence 12 from patent US 11091524
GGGGAATCCCC
>MY367765.1 Sequence 7 from patent US 11091524
RGGRNNHHYYB
>MY367505.1 Sequence 116 from patent US 11091475
GGAGTAAGTCT
>MY367504.1 Sequence 115 from patent US 11091475
ATACTTACCTG
>MY367463.1 Sequence 74 from patent US 11091475
GAGGTGGGTTT
>MY367440.1 Sequence 51 from patent US 11091475
GAGGTGGGTTT
>MY367438.1 Sequence 49 from patent US 11091475
CTGGTGAGTTC
>MY367432.1 Sequence 43 from patent US 11091475
CAGGTGAGTGG
>MY367427.1 Sequence 38 from patent US 11091475
CAGGTAGGTGA
>MY367426.1 Sequence 37 from patent US 11091475
CAGGTAGGAGG
>MY367420.1 Sequence 31 from patent US 11091475
CAGGTAACCTC
>MY367415.1 Sequence 26 from patent US 11091475
AGTGTGAGTAC
>MY367406.1 Sequence 17 from patent US 11091475
AAGGTGACCTT
>MY367402.1 Sequence 13 from patent US 11091475
AAGGTAATGTA
>MY367397.1 Sequence 8 from patent US 11091475
AAGGTAACATG
>MY365742.1 Sequence 24 from patent US 11085077
CTTTGGATGCT
>MY365738.1 Sequence 20 from patent US 11085077
CTTTGGATGTC
>MY365737.1 Sequence 19 from patent US 11085077
CTTTGGATGTA
>MY365736.1 Sequence 18 from patent US 11085077
CTTTGGATGTT
>MY365735.1 Sequence 17 from patent US 11085077
CTTTGGATGAG
>MY363738.1 Sequence 32 from patent US 11084864
GGCCTCCCTAA
>MY363737.1 Sequence 31 from patent US 11084864
CCGGTTAGGGA
>MY230357.1 Sequence 7 from patent US 11079388
TTATACATCTA
>MY222800.1 Sequence 197 from patent US 11078490
TAAKNNNNGTC
>MY222783.1 Sequence 180 from patent US 11078490
ACANNNNNGTG
>MY222781.1 Sequence 178 from patent US 11078490
GAYNNNNNRTC
>MY222770.1 Sequence 167 from patent US 11078490
GAGNNNNRTAA
>MY222768.1 Sequence 165 from patent US 11078490
CAGNNNNNGAT
>MY222765.1 Sequence 162 from patent US 11078490
AAGNNNNNCTT
>MY222762.1 Sequence 159 from patent US 11078490
CCANNNNNNTC
>MY222758.1 Sequence 155 from patent US 11078490
GACNNNNNGGT
>MY222757.1 Sequence 154 from patent US 11078490
GATGNNNNTGT
>MY222747.1 Sequence 144 from patent US 11078490
CCCNNNNNCTC
>MY222744.1 Sequence 141 from patent US 11078490
ATTCNNNNCTG
>MY222717.1 Sequence 114 from patent US 11078490
CACNNNNNTAC
>MY222716.1 Sequence 113 from patent US 11078490
GAGNNNNNRTG
>MY222715.1 Sequence 112 from patent US 11078490
GATGNNNNTGT
>MY222707.1 Sequence 104 from patent US 11078490
GATNNNNRTAC
>MY222703.1 Sequence 100 from patent US 11078490
AGGNNNNNGAT
>MY222686.1 Sequence 83 from patent US 11078490
GACNNNNNTGA
>MY222684.1 Sequence 81 from patent US 11078490
GAGNNNNNTAC
>MY222682.1 Sequence 71 from patent US 11078490
CCTNNNNNAGG
>MY222666.1 Sequence 18 from patent US 11078490
GAGNNNNNTCC
>MY222652.1 Sequence 4 from patent US 11078490
AACNNNNCTTT
>MY222651.1 Sequence 3 from patent US 11078490
CACNNNNGTAY
>MY218745.1 Sequence 52 from patent US 11078469
AAATSGGGGAA
>MY217867.1 Sequence 27 from patent US 11078236
GCCNNNNNGGC
>MY216148.1 Sequence 20 from patent US 11072823
CCTNNNNNAGG
>MY208777.1 Sequence 461 from patent US 11071756
GRTVDGTVVSD
>MY206677.1 Sequence 31 from patent US 11066700
AAAAATTTGAG
>MY206638.1 Sequence 19 from patent US 11066698
AAAAAAAAAAA
>MY206636.1 Sequence 17 from patent US 11066698
AAAAWAAAAAA
>MY198995.1 Sequence 479 from patent US 11066667
TCTCAGTGCTT
>MY198765.1 Sequence 244 from patent US 11066667
TCGTGACTCTT
>MY198632.1 Sequence 111 from patent US 11066667
TCTCAGTGCTT
>MY198200.1 Sequence 97 from patent US 11066655
GCAAGGAGACA
>MY181408.1 Sequence 545 from patent US 11066464
GCCAGTCTATC
>MY180643.1 Sequence 46 from patent US 11065311
GGAAAGTCCCC
>MY177383.1 Sequence 16 from patent US 11060111
GTGTGCTGTCC
>pdb|3IGC|B Chain B, Smallpox virus topoisomerase-DNA transition state
GTGTCGCCCTT
>pdb|3MFI|P Chain P, DNA Polymerase Eta in Complex With a cis-syn Thymidine Dimer
GTCCTCCCCTN
>pdb|3MFH|P Chain P, DNA Polymerase Eta in Complex With Undamaged DNA
GTCCTCCCCTN
>MQ209541.1 Sequence 211 from Patent EP3814505
AAGAGGAAAGG
>MQ205106.1 Sequence 49 from Patent WO2021181108
ATGTCAAAATT
>MQ205105.1 Sequence 48 from Patent WO2021181108
AATTTTGACTA
>MQ205088.1 Sequence 31 from Patent WO2021181108
ATCGCCACTGC
>MQ204995.1 Sequence 15 from Patent EP3877551
CCGTTGCCGCC
>MQ204994.1 Sequence 14 from Patent EP3877551
CCGCCGTTGCC
>MQ198260.1 Sequence 48 from Patent WO2021176330
CTTTCTCTCTG
>PA265684.1 WO 2021100833-A/4: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
NNGGNNNCCNT
>PA265682.1 WO 2021100833-A/2: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
GCGGGNCCCGT
>PA265681.1 WO 2021100833-A/1: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
AGGGGNCCCCT
>PA265026.1 WO 2021111641-A/45: GUIDE RNA FOR CONDITIONAL AND POST-TRANSCRIPTIONAL CONTROL OF CRISPR-CAS PROTEIN
ATAAGTAGGAG
>PA264417.1 WO 2021085509-A/2: Nucleoside Derivatives and the Use thereof
AAGAAGAAGAA
>PA264416.1 WO 2021085509-A/1: Nucleoside Derivatives and the Use thereof
TTCTTCTTCTT
>PA263508.1 JP 2021078428-A/4: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
NNGGNNNCCNT
>PA263506.1 JP 2021078428-A/2: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
GCGGGNCCCGT
>PA263505.1 JP 2021078428-A/1: Logical engineering of T-stem of tRNA that enhances D-amino acid incorporation
AGGGGNCCCCT
>MQ183413.1 Sequence 2 from Patent EP3875586
GGGGGGGGGGG
>pdb|3KET|C Chain C, Crystal structure of a Rex-family transcriptional regulatory protein from Streptococcus agalactiae bound to a palindromic operator
NTTTCACAATT
>pdb|3KET|B Chain B, Crystal structure of a Rex-family transcriptional regulatory protein from Streptococcus agalactiae bound to a palindromic operator
AATTGTGAAAT
>MQ165617.1 Sequence 19 from Patent WO2021156370
TTTTTTTTTTT
>MQ165603.1 Sequence 5 from Patent WO2021156370
TTTTTTTTTTT
>MQ161898.1 Sequence 109 from Patent WO2021156478
CCTCGTGTCTC
>MQ161897.1 Sequence 108 from Patent WO2021156478
TAAGAGCCGCC
>MQ159739.1 Sequence 10 from Patent WO2021159130
GGGATCCTACC
>MQ159365.1 Sequence 129 from Patent WO2021159040
GGGATCCTACC
>MQ151286.1 Sequence 23 from Patent EP3864658
AGACTCCGACT
>MQ151223.1 Sequence 2 from Patent EP3863683
ACCATTCCTTC
>MQ151222.1 Sequence 1 from Patent EP3863683
TGATATCACAG
>pdb|7K9Y|E Chain E, GsI-IIC RT Template-Switching Complex (twinned)
CTCCAGGCAAC
>pdb|7K9Y|B Chain B, GsI-IIC RT Template-Switching Complex (twinned)
CTCCAGGCAAC
>MQ146050.1 Sequence 406 from Patent WO2021154738
AACACACAGAG
>MQ146047.1 Sequence 403 from Patent WO2021154738
ATTCAACACAC
>MQ146041.1 Sequence 397 from Patent WO2021154738
AACACACAGAG
>MQ146040.1 Sequence 396 from Patent WO2021154738
TCAACACACAG
>MQ146035.1 Sequence 391 from Patent WO2021154738
AACACACAGAG
>MQ144984.1 Sequence 26 from Patent WO2021152587
GGGGGCGGGGY
>MQ144962.1 Sequence 4 from Patent WO2021152587
RAAANNGAAAS
>MQ144776.1 Sequence 33 from Patent WO2021154745
TCGAGCGTTCT
>MQ144770.1 Sequence 27 from Patent WO2021154745
TCGAGCGTTCT
>MQ143343.1 Sequence 70 from Patent EP3861357
TGCATTCCTTA
>MQ143314.1 Sequence 41 from Patent EP3861357
TGCATTCCTTA
>MQ142870.1 Sequence 70 from Patent EP3860452
TGCATTCCTTA
>MQ142841.1 Sequence 41 from Patent EP3860452
TGCATTCCTTA
>MQ142820.1 Sequence 20 from Patent EP3860452
CCCGTAGGAGT
>MQ143293.1 Sequence 20 from Patent EP3861357
CCCGTAGGAGT
>MQ143076.1 Sequence 70 from Patent EP3860629
TGCATTCCTTA
>MQ143047.1 Sequence 41 from Patent EP3860629
TGCATTCCTTA
>MQ143026.1 Sequence 20 from Patent EP3860629
CCCGTAGGAGT
>MQ142157.1 Sequence 74 from Patent EP3841209
AATTTTTGGAG
>MQ141870.1 Sequence 19 from Patent EP3860634
CGCGATGACGG
>MQ141869.1 Sequence 18 from Patent EP3860634
CACGATGACGG
>MQ141868.1 Sequence 17 from Patent EP3860634
CGCCATGACGG
>MQ141867.1 Sequence 16 from Patent EP3860634
CGCGATGGCGG
>MQ141866.1 Sequence 15 from Patent EP3860634
CACCATGACGG
>MQ141865.1 Sequence 14 from Patent EP3860634
CACGATGGCGG
>MQ141864.1 Sequence 13 from Patent EP3860634
CGCCATGGCGG
>MQ141863.1 Sequence 12 from Patent EP3860634
CACCATGGCGG
>MQ141715.1 Sequence 70 from Patent EP3861345
TGCATTCCTTA
>MQ141686.1 Sequence 41 from Patent EP3861345
TGCATTCCTTA
>MQ141665.1 Sequence 20 from Patent EP3861345
CCCGTAGGAGT
>MQ130083.1 Sequence 10 from Patent EP3856227
AGGAGAGGACT
>MQ130082.1 Sequence 9 from Patent EP3856227
AGGAGGGGACT
>MY151457.1 Sequence 16 from patent US 11049587
GAACGTTGCTA
>MY151451.1 Sequence 10 from patent US 11049587
TTGGATATGGG
>MY147365.1 Sequence 425 from patent US 11046956
GCCGAGTTCAC
>MY143192.1 Sequence 5 from patent US 11045489
TCCCTGATCCA
>MY061917.1 Sequence 6 from patent US 11041205
CCCCCCCTGGC
>MY061916.1 Sequence 5 from patent US 11041205
TTACCCCCATA
>MY061915.1 Sequence 4 from patent US 11041205
TAGTCCCTTTT
>MY061914.1 Sequence 3 from patent US 11041205
CACCCCCATAG
>MY060892.1 Sequence 389 from patent US 11041173
CCNNNNNNNGG
>MY060118.1 Sequence 75 from patent US 11041162
GGAAATCCATT
>MY060022.1 Sequence 27 from patent US 11041159
TGGAGGAGACA
>MY058441.1 Sequence 7 from patent US 11035854
ATAGTTGACAC
>MY003342.1 Sequence 15 from patent US 11028380
TCAACCGGTGG
>MY003340.1 Sequence 13 from patent US 11028380
TTGGAGCGGGG
>MY002923.1 Sequence 148 from patent US 11028366
ACGCCGTCATT
>MY000749.1 Sequence 14 from patent US 11027008
GGGGGGCCGGG
>MY000560.1 Sequence 108 from patent US 11026979
ACGCCGTCATT
>MX992781.1 Sequence 75 from patent US 11054421
GTGCTGGTGCT
>MX992754.1 Sequence 48 from patent US 11054421
GTGCGCGCGTT
>MX992752.1 Sequence 46 from patent US 11054421
GAAGGTGGTGA
>MX927205.1 Sequence 1 from patent US 11053541
CAGTAAAAATA
>MX917164.1 Sequence 64 from patent US 11053495
CAGGTAAGTAT
>MX916289.1 Sequence 45 from patent US 11053288
GTGCCTGTGCA
>MX912943.1 Sequence 1 from patent US 11021748
CGATCGATCGA
>MX912466.1 Sequence 8 from patent US 11021735
TAGCAGCACGT
>MX912461.1 Sequence 3 from patent US 11021735
GCATCAGCGAC
>MX912456.1 Sequence 1 from patent US 11021734
CGGTAAAAAAT
>MX911730.1 Sequence 116 from patent US 11021708
GGAGTAAGTCT
>MX911729.1 Sequence 115 from patent US 11021708
ATACTTACCTG
>MX911688.1 Sequence 74 from patent US 11021708
GAGGTGGGTTT
>MX911665.1 Sequence 51 from patent US 11021708
GAGGTGGGTTT
>MX911663.1 Sequence 49 from patent US 11021708
CTGGTGAGTTC
>MX911657.1 Sequence 43 from patent US 11021708
CAGGTGAGTGG
>MX911652.1 Sequence 38 from patent US 11021708
CAGGTAGGTGA
>MX911651.1 Sequence 37 from patent US 11021708
CAGGTAGGAGG
>MX911645.1 Sequence 31 from patent US 11021708
CAGGTAACCTC
>MX911640.1 Sequence 26 from patent US 11021708
AGTGTGAGTAC
>MX911631.1 Sequence 17 from patent US 11021708
AAGGTGACCTT
>MX911627.1 Sequence 13 from patent US 11021708
AAGGTAATGTA
>MX911622.1 Sequence 8 from patent US 11021708
AAGGTAACATG
>MX910952.1 Sequence 37 from patent US 11021706
AGTTCAGCGAC
>MX910951.1 Sequence 36 from patent US 11021706
ACACGTTGTTC
>MX910950.1 Sequence 35 from patent US 11021706
CCTCCGAGGGA
>MX910949.1 Sequence 34 from patent US 11021706
TTTACAAGTGC
>MX910948.1 Sequence 33 from patent US 11021706
ATGTTGTCCAT
>MX910947.1 Sequence 32 from patent US 11021706
TGTTGTCCATT
>MX910946.1 Sequence 31 from patent US 11021706
GTTGTCCATTA
>MX910945.1 Sequence 30 from patent US 11021706
TTGTCCATTAC
>MX910944.1 Sequence 29 from patent US 11021706
TGTCCATTACC
>MX910943.1 Sequence 28 from patent US 11021706
TCCATTACCCC
>MX910942.1 Sequence 27 from patent US 11021706
CCATTACCCCT
>MX910941.1 Sequence 26 from patent US 11021706
CATTACCCCTC
>MX910940.1 Sequence 25 from patent US 11021706
GTCCATTACCC
>MX910939.1 Sequence 24 from patent US 11021706
GGATGCATGAG
>MX910938.1 Sequence 23 from patent US 11021706
ATGCATGAGCC
>MX910937.1 Sequence 22 from patent US 11021706
CTTTCGTTCGC
>MX910936.1 Sequence 21 from patent US 11021706
GCCCGAGATCC
>MX910935.1 Sequence 20 from patent US 11021706
CGTGTGGCAAC
>MX910934.1 Sequence 19 from patent US 11021706
CGTGAACGAAG
>MX910933.1 Sequence 18 from patent US 11021706
CATGGATGTCC
>MX910932.1 Sequence 17 from patent US 11021706
TCGGATCTGTG
>MX910931.1 Sequence 16 from patent US 11021706
AAGGTCTGCAT
>MX910930.1 Sequence 15 from patent US 11021706
ATACTGTCCAA
>MX910929.1 Sequence 14 from patent US 11021706
GGCAATTCCAT
>MX910928.1 Sequence 13 from patent US 11021706
CCATCAAGTTT
>MX910927.1 Sequence 12 from patent US 11021706
TCCTTTTATTC
>MX910926.1 Sequence 11 from patent US 11021706
TCAAGTTTTCC
>MX910887.1 Sequence 8 from patent US 11021705
GGGCACTGTAC
>MX910886.1 Sequence 7 from patent US 11021705
GGGCACTGTAC
>MX896545.1 Sequence 37 from patent US 11021502
AAAAAAAAAAA
>MX896543.1 Sequence 34 from patent US 11021502
AAAAAAAACTC
>MX895864.1 Sequence 90 from patent US 11017881
GACTACATTTT
>MX895854.1 Sequence 80 from patent US 11017881
GGACTACATTT
>MX895845.1 Sequence 71 from patent US 11017881
CGGACTACATT
>MX895837.1 Sequence 63 from patent US 11017881
CCGGACTACAT
>MX895830.1 Sequence 56 from patent US 11017881
CCCGGACTACA
>MX895824.1 Sequence 50 from patent US 11017881
CCCCGGACTAC
>MX895819.1 Sequence 45 from patent US 11017881
CCCCCGGACTA
>MX895815.1 Sequence 41 from patent US 11017881
GCCCCCGGACT
>MX895812.1 Sequence 38 from patent US 11017881
TGCCCCCGGAC
>MX895810.1 Sequence 36 from patent US 11017881
GTGCCCCCGGA
>MX895804.1 Sequence 30 from patent US 11017881
GTGGGCCCAGA
>MX895801.1 Sequence 27 from patent US 11017881
TGGGCCCAGAC
>MX895799.1 Sequence 25 from patent US 11017881
GTGGGCCCAGA
>MX895795.1 Sequence 21 from patent US 11017881
GTGGGCCCAGA
>MX895792.1 Sequence 18 from patent US 11017881
TGGGCCCAGAC
>MX895790.1 Sequence 16 from patent US 11017881
GTGGGCCCAGA
>MX895785.1 Sequence 11 from patent US 11017881
TGGGCCCAGAC
>MX895783.1 Sequence 9 from patent US 11017881
GTGGGCCCAGA
>MX895778.1 Sequence 4 from patent US 11017881
TGGGCCCAGAC
>MX895742.1 Sequence 28 from patent US 11016094
GGTGGGGGTGG
>MX895515.1 Sequence 91 from patent US 11015220
TTTTTTGAAAT
>MX895514.1 Sequence 90 from patent US 11015220
CCCCCCGAAAT
>MX895473.1 Sequence 3 from patent US 11015219
TAGCTCGATCG
>MX894758.1 Sequence 97 from patent US 11015206
CCTTATATATC
>MX890024.1 Sequence 1755 from patent US 11013757
TCGCCCTTCAG
>MX890023.1 Sequence 1754 from patent US 11013757
CGTCGCCCTTC
>MX890014.1 Sequence 1745 from patent US 11013757
CGCCCTTCAGC
>MX890012.1 Sequence 1743 from patent US 11013757
TTCAGCACGCA
>MX890007.1 Sequence 1738 from patent US 11013757
CCTTCAGCACG
>MX889996.1 Sequence 1727 from patent US 11013757
GTCGCCCTTCA
>MX889989.1 Sequence 1720 from patent US 11013757
CCGTCGCCCTT
>MX889974.1 Sequence 1705 from patent US 11013757
CTTCAGCACGC
>MX889959.1 Sequence 1690 from patent US 11013757
CGTTTTGTCGT
>MX889945.1 Sequence 1676 from patent US 11013757
TTGTCGTTTTG
>MX889939.1 Sequence 1670 from patent US 11013757
GTCGTTTTGTC
>MX889934.1 Sequence 1665 from patent US 11013757
TCGTCGTTTTG
>MX889933.1 Sequence 1664 from patent US 11013757
TCGTTTTGTCG
>MX889911.1 Sequence 1642 from patent US 11013757
TGTCGTTTTGT
>MX889890.1 Sequence 1621 from patent US 11013757
GTTTTGTCGTT
>MX889885.1 Sequence 1616 from patent US 11013757
TTTGTCGTTTT
>MX889875.1 Sequence 1606 from patent US 11013757
TTTTGTCGTTT
>MX889874.1 Sequence 1605 from patent US 11013757
CGTCGTTTTGT
>MX889852.1 Sequence 1583 from patent US 11013757
CTCCCCGCAGC
>MX889851.1 Sequence 1582 from patent US 11013757
CCTTCTCCCCG
>MX889838.1 Sequence 1569 from patent US 11013757
TCGCCCCTTCT
>MX889828.1 Sequence 1559 from patent US 11013757
CTTCTCCCCGC
>MX889823.1 Sequence 1554 from patent US 11013757
TTCTCCCCGCA
>MX889820.1 Sequence 1551 from patent US 11013757
CGCCCCTTCTC
>MX889816.1 Sequence 1547 from patent US 11013757
TCTCCCCGCAG
>MX889808.1 Sequence 1539 from patent US 11013757
GTCGCCCCTTC
>MX889790.1 Sequence 1521 from patent US 11013757
TTCCTGATGCT
>MX889788.1 Sequence 1519 from patent US 11013757
TTTTTTTTTGT
>MX883550.1 Sequence 375 from patent US 11008588
CCNNNNNNNGG
>MX881459.1 Sequence 116 from patent US 11008572
GGAGTAAGTCT
>MX881458.1 Sequence 115 from patent US 11008572
ATACTTACCTG
>MX881417.1 Sequence 74 from patent US 11008572
GAGGTGGGTTT
>MX881394.1 Sequence 51 from patent US 11008572
GAGGTGGGTTT
>MX881392.1 Sequence 49 from patent US 11008572
CTGGTGAGTTC
>MX881386.1 Sequence 43 from patent US 11008572
CAGGTGAGTGG
>MX881381.1 Sequence 38 from patent US 11008572
CAGGTAGGTGA
>MX881380.1 Sequence 37 from patent US 11008572
CAGGTAGGAGG
>MX881374.1 Sequence 31 from patent US 11008572
CAGGTAACCTC
>MX881369.1 Sequence 26 from patent US 11008572
AGTGTGAGTAC
>MX881360.1 Sequence 17 from patent US 11008572
AAGGTGACCTT
>MX881356.1 Sequence 13 from patent US 11008572
AAGGTAATGTA
>MX881351.1 Sequence 8 from patent US 11008572
AAGGTAACATG
>MX881162.1 Sequence 1290 from patent US 11008568
CTAACTGGGGA
>MX881160.1 Sequence 1283 from patent US 11008568
ATACAGGGGGG
>MX881155.1 Sequence 1261 from patent US 11008568
ATAACTACGGC
>MX881151.1 Sequence 1242 from patent US 11008568
CTAACTGGGAG
>MX881084.1 Sequence 906 from patent US 11008568
GAGTACCTACC
>MX881083.1 Sequence 904 from patent US 11008568
GACTACCTACC
>MX881082.1 Sequence 901 from patent US 11008568
GAATACCTACC
>MX881081.1 Sequence 899 from patent US 11008568
CTAACTGGGAC
>MX881062.1 Sequence 516 from patent US 11008568
CTAACTGGGGA
>MX880884.1 Sequence 11 from patent US 11008567
CTGTCTCTTAT
>MX880146.1 Sequence 4 from patent US 11008548
TGCCTACTGCC
>MX880144.1 Sequence 2 from patent US 11008548
GACAGTGAGCG
>MX879886.1 Sequence 516 from patent US 11008383
CTAACTGGGGA
>MX879481.1 Sequence 1 from patent US 11008340
AAAGTAGGTCA
>MX879048.1 Sequence 85 from patent US 11007280
GCGGCCGTACC
>MX878721.1 Sequence 23 from patent US 11007233
CAGCCCTGGTG
>MX738177.1 Sequence 13 from patent US 11002731
TTTTTTTTTTT
>MX738176.1 Sequence 12 from patent US 11002731
AAAAAAAAAAA
>MX648847.1 Sequence 127 from patent US 11001834
AGATGCACAAG
>MX647973.1 Sequence 1 from patent US 11001583
AAAGTAGGTCA
>MX643104.1 Sequence 34 from patent US 10995373
CAAGTACGTGA
>MX627371.1 Sequence 22 from patent US 10993971
GACNNNNNGTC
>MX627367.1 Sequence 15 from patent US 10993971
CCTNNNNNAGG
>MX627366.1 Sequence 14 from patent US 10993971
GACNNNNNGTC
>OF066204.1 KR 1020200091499-A/39: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
GTTTTTGTACT
>OF066190.1 KR 1020200091499-A/25: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
AATCATTTGAG
>OF066189.1 KR 1020200091499-A/24: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
TTTCATTTGAG
>OF066117.1 KR 1020200104347-A/19: GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE
TTTACCTGGTT
>OF066083.1 KR 1020200104345-A/19: OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE
TTTACCTGGTT
>OF065784.1 KR 1020200093066-A/14: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY
ATAATTCCCCC
>OF065639.1 KR 1020200099564-A/96: NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES
ACTCATCGATA
>OF065638.1 KR 1020200099564-A/94: NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES
ACTCATCGATT
>OF065637.1 KR 1020200099564-A/93: NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES
ACTCATCGATC
>OF065636.1 KR 1020200099564-A/87: NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES
ACTCATCGATA
>OF065634.1 KR 1020200099564-A/85: NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES
ACTCCTCGGTA
>OF097234.1 KR 1020200120675-A/161: OLIGONUCLEOTIDE THERAPY FOR WILSON DISEASE
GACTTAGATGA
>OF096922.1 KR 1020200119276-A/70: TREATMENT OF AMD USING AAV SFLT-1
GGTTCGAACAG
>OF014594.1 KR 1020200133476-A/4: COMPOSITION FOR DETECTING HIGH RISK VIRUS AND USE THEREOF
AGTGGGGGCAA
>OF096220.1 KR 1020200112957-A/8: VIRUS-RESISTANT PLANT AND METHOD FOR PRODUCTION THEREOF
AGTGTAACAGC
>OF096218.1 KR 1020200112957-A/6: VIRUS-RESISTANT PLANT AND METHOD FOR PRODUCTION THEREOF
AGGGTAACAGC
>OF089800.1 KR 1020200108319-A/66: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089799.1 KR 1020200108319-A/65: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089798.1 KR 1020200108319-A/64: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089797.1 KR 1020200108319-A/63: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089796.1 KR 1020200108319-A/62: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089795.1 KR 1020200108319-A/61: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089794.1 KR 1020200108319-A/60: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089793.1 KR 1020200108319-A/59: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089789.1 KR 1020200108319-A/55: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089788.1 KR 1020200108319-A/54: BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS
TCGACNGGATC
>OF089647.1 KR 1020200116933-A/2482: COMPOSITIONS AND METHODS FOR CORRECTING DYSTROPHIN MUTATIONS IN HUMAN CARDIOMYOCYTES
CCCCACAGGTC
>OF125728.1 KR 1020200128438-A/1: ANTIOXIDANT DIETARY SUPPLEMENT AND RELATED METHOD
GTGACTCAGCA
>OF043953.1 KR 1020200136363-A/6: METHOD FOR PRODUCING HAIRPIN SINGLE-STRANDED RNA MOLECULE
ACTCTGCTTCG
>OF042799.1 KR 1020200104302-A/19: NOVEL THIOPHOSPHORAMIDITES
TTTACCTGGTT
>OF120217.1 KR 1020200121926-A/2464: PLASMA KALLIKREIN BINDING PROTEINS
CCTNNNNNAGG
>OF120214.1 KR 1020200121926-A/2461: PLASMA KALLIKREIN BINDING PROTEINS
CGTCTCNNNNN
>OF120211.1 KR 1020200121926-A/2458: PLASMA KALLIKREIN BINDING PROTEINS
CCANNNNNTGG
>OF120209.1 KR 1020200121926-A/2456: PLASMA KALLIKREIN BINDING PROTEINS
GACNNNNNGTC
>OF120208.1 KR 1020200121926-A/2455: PLASMA KALLIKREIN BINDING PROTEINS
GACNNNNNGTC
>OF120207.1 KR 1020200121926-A/2454: PLASMA KALLIKREIN BINDING PROTEINS
NNNNNGAGACC
>OF120206.1 KR 1020200121926-A/2453: PLASMA KALLIKREIN BINDING PROTEINS
GGTCTCNNNNN
>OF120205.1 KR 1020200121926-A/2452: PLASMA KALLIKREIN BINDING PROTEINS
GCCNNNNNGGC
>OF120198.1 KR 1020200121926-A/2445: PLASMA KALLIKREIN BINDING PROTEINS
GCANNNNNTGC
>OF117525.1 KR 1020200130383-A/92: COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
AAAAAAAAAAA
>OF116283.1 KR 1020200116550-A/12: CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY
AATTTTTGGAG
>OF116282.1 KR 1020200116550-A/11: CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY
AATTTGTCTAG
>OF027640.1 KR 1020200079244-A/30: NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS
TAAATATTTTA
>OF108089.1 KR 1020200110480-A/4765: Abtibody libraries
CTAACTGGGGA
>pdb|7LPH|A Chain A, APE1 Mn-bound product complex with abasic ribonucleotide DNA
NCGACGGATCC
>pdb|7LPG|A Chain A, APE1 product complex with abasic ribonucleotide DNA
NCGACGGATCC
>PA261461.1 JP 2021065112-A/6: Channel chip for detecting plant molecule
CTCTTCTGTCA
>PA261458.1 JP 2021065112-A/3: Channel chip for detecting plant molecule
CTCCTTTGGCA
>pdb|7DTA|C Chain C, Solution structure of the C-clamp domain from human HDBP1 in complex with DNA
GTCCCGGCATA
>pdb|7DTA|B Chain B, Solution structure of the C-clamp domain from human HDBP1 in complex with DNA
TATGCCGGGAC
>MQ108003.1 Sequence 16 from Patent WO2021127367
GGCTAATGAAT
>MQ108002.1 Sequence 15 from Patent WO2021127367
TCCTTTACACC
>MQ108001.1 Sequence 14 from Patent WO2021127367
TCCTTTACACC
>MQ107804.1 Sequence 29 from Patent WO2021122982
GGTACGTAAGG
>MQ102051.1 Sequence 109 from Patent EP3844277
AGCCGATAACC
>MQ102050.1 Sequence 108 from Patent EP3844277
GAAGCAGTAAT
>MQ102049.1 Sequence 107 from Patent EP3844277
TTAAGGCACTT
>MQ102048.1 Sequence 106 from Patent EP3844277
GAGCCTACTTC
>MQ102047.1 Sequence 105 from Patent EP3844277
GTGACCTTTTA
>MQ102046.1 Sequence 104 from Patent EP3844277
CACTGTGTGTG
>MQ102045.1 Sequence 103 from Patent EP3844277
TTCCACTCATG
>MQ102044.1 Sequence 102 from Patent EP3844277
TCTGCCCCTCT
>MQ102043.1 Sequence 101 from Patent EP3844277
GTTTAATTCAG
>MQ102041.1 Sequence 99 from Patent EP3844277
TGCCGATAACC
>MQ102040.1 Sequence 98 from Patent EP3844277
GAAGCAGTAAT
>MQ102039.1 Sequence 97 from Patent EP3844277
CTCTCCTGACA
>MQ102038.1 Sequence 96 from Patent EP3844277
GTTGTTAGTTA
>MQ102037.1 Sequence 95 from Patent EP3844277
TTTTACAAAAA
>MQ102036.1 Sequence 94 from Patent EP3844277
TCACAATTATG
>MQ102035.1 Sequence 93 from Patent EP3844277
ATGTATGAACA
>MQ102034.1 Sequence 92 from Patent EP3844277
TTGGGGCTTTC
>MQ102033.1 Sequence 91 from Patent EP3844277
GGAACTTGAAG
>MQ102032.1 Sequence 90 from Patent EP3844277
TTTTTTTTTTT
>MQ102031.1 Sequence 89 from Patent EP3844277
GCCATTGTAAA
>MQ102030.1 Sequence 88 from Patent EP3844277
ACAAACCTAAA
>MQ102029.1 Sequence 87 from Patent EP3844277
GACTTGCCTTT
>MQ102028.1 Sequence 86 from Patent EP3844277
AAATCATACAG
>MQ102027.1 Sequence 85 from Patent EP3844277
TTTGGGGGGGG
>MQ102026.1 Sequence 84 from Patent EP3844277
TCATGAAATAA
>MQ102025.1 Sequence 83 from Patent EP3844277
ATTAACATGCT
>MQ102024.1 Sequence 82 from Patent EP3844277
TTTAAAAAAAT
>MQ102023.1 Sequence 81 from Patent EP3844277
TTTTACAAAAA
>MQ102022.1 Sequence 80 from Patent EP3844277
TCACAATTATG
>MQ102021.1 Sequence 79 from Patent EP3844277
GATAAATCTCT
>MQ102020.1 Sequence 78 from Patent EP3844277
GTTCTGGCGAC
>MQ102018.1 Sequence 76 from Patent EP3844277
AAATTTAGTCT
>MQ102017.1 Sequence 75 from Patent EP3844277
TCAGCATAAAC
>MQ102016.1 Sequence 74 from Patent EP3844277
CTAGAAAATTG
>MQ102015.1 Sequence 73 from Patent EP3844277
ATTTATACTTT
>MQ102014.1 Sequence 72 from Patent EP3844277
CATAATTTTCC
>MQ102012.1 Sequence 70 from Patent EP3844277
GTTCTGGCGAC
>MQ102009.1 Sequence 67 from Patent EP3844277
GCACGAATATA
>MQ102008.1 Sequence 66 from Patent EP3844277
TTTTGATTTTG
>MQ102007.1 Sequence 65 from Patent EP3844277
TTAATGAGAAG
>MQ102006.1 Sequence 64 from Patent EP3844277
CAAATTAAAAA
>MQ102003.1 Sequence 61 from Patent EP3844277
TTCTTACCGAC
>MQ102002.1 Sequence 60 from Patent EP3844277
AATTTTAGGCA
>MQ102001.1 Sequence 59 from Patent EP3844277
CAAAGACATAG
>MQ102000.1 Sequence 58 from Patent EP3844277
GTGCCCTCCAT
>MQ101999.1 Sequence 57 from Patent EP3844277
ATTTGGTTCAC
>MQ101998.1 Sequence 56 from Patent EP3844277
CACATCACAAA
>MQ101997.1 Sequence 55 from Patent EP3844277
TTATGACATAT
>MQ101996.1 Sequence 54 from Patent EP3844277
ACAAATGTAGA
>MQ101995.1 Sequence 53 from Patent EP3844277
AAGTAAGAAAA
>MQ101993.1 Sequence 51 from Patent EP3844277
CAGCTGGTTCC
>MQ101992.1 Sequence 50 from Patent EP3844277
AATTTTAGGCA
>MQ101991.1 Sequence 49 from Patent EP3844277
CAAAGACATAG
>MQ101990.1 Sequence 48 from Patent EP3844277
TTGGAGTGAAA
>MQ101989.1 Sequence 47 from Patent EP3844277
TTTCCAAAGGG
>MQ101988.1 Sequence 46 from Patent EP3844277
GATCTGTCGAT
>MQ101987.1 Sequence 45 from Patent EP3844277
CCTTCTCTTGG
>MQ101986.1 Sequence 44 from Patent EP3844277
TGGAAACTTGG
>MQ101985.1 Sequence 43 from Patent EP3844277
AACACTATGTA
>MQ101984.1 Sequence 42 from Patent EP3844277
AGTGCACTTAA
>MQ101983.1 Sequence 41 from Patent EP3844277
AAACAAAAAGC
>MQ101982.1 Sequence 40 from Patent EP3844277
AGCAAAGAATA
>MQ101981.1 Sequence 39 from Patent EP3844277
TTTTTTAATAC
>MQ101980.1 Sequence 38 from Patent EP3844277
GTCTTGAAAAC
>MQ101979.1 Sequence 37 from Patent EP3844277
TTGCTTTTGAA
>MQ101978.1 Sequence 36 from Patent EP3844277
GTGGACTCATC
>MQ101977.1 Sequence 35 from Patent EP3844277
TTTCTCATGGG
>MQ101976.1 Sequence 34 from Patent EP3844277
GTGATGCATGT
>MQ101975.1 Sequence 33 from Patent EP3844277
TCTGTGAAGGA
>MQ101974.1 Sequence 32 from Patent EP3844277
CATTTTCAATA
>MQ099278.1 Sequence 23 from Patent WO2021138678
CTGAAGTCAGT
>MQ099270.1 Sequence 15 from Patent WO2021138678
CTGAAGTCAGT
>MQ101973.1 Sequence 31 from Patent EP3844277
AAAAGAAAACA
>MQ101972.1 Sequence 30 from Patent EP3844277
TTGTTAAAGAA
>MQ101971.1 Sequence 29 from Patent EP3844277
ACAATTTTGGT
>MQ101970.1 Sequence 28 from Patent EP3844277
CTCAGGCAGAG
>MQ101969.1 Sequence 27 from Patent EP3844277
GAGGTTGAGAC
>MQ101968.1 Sequence 26 from Patent EP3844277
CCCTCAATAAA
>MQ101967.1 Sequence 25 from Patent EP3844277
AAGAAGAAGCC
>MQ101966.1 Sequence 24 from Patent EP3844277
AAGATTGCAAA
>MQ101965.1 Sequence 23 from Patent EP3844277
TTTTTTTTTTA
>MQ101964.1 Sequence 22 from Patent EP3844277
GTCTTGAAAAC
>MQ101963.1 Sequence 21 from Patent EP3844277
TTGCTTTTGAA
>MQ101962.1 Sequence 20 from Patent EP3844277
GCCTGCTCCTT
>MQ101961.1 Sequence 19 from Patent EP3844277
AGGCTTGCAGA
>MQ101960.1 Sequence 18 from Patent EP3844277
GTTTTCTGTGC
>MQ101958.1 Sequence 16 from Patent EP3844277
TTTTGGTTGAT
>MQ101956.1 Sequence 14 from Patent EP3844277
ATTCACATGGG
>MQ101955.1 Sequence 13 from Patent EP3844277
GGGGAAAAAAC
>MQ101954.1 Sequence 12 from Patent EP3844277
GATAAGAACAT
>MQ101952.1 Sequence 10 from Patent EP3844277
TGTGGAGCAAT
>MQ101951.1 Sequence 9 from Patent EP3844277
AATATGTTTTA
>MQ101949.1 Sequence 7 from Patent EP3844277
TAATTTATTGT
>MQ101948.1 Sequence 6 from Patent EP3844277
GTTTTCTGTGC
>MQ101945.1 Sequence 3 from Patent EP3844277
CTCCTGGCACT
>pdb|7M82|T Chain T, Human DNA Pol eta with dA-ended primer and dATP: in crystallo reaction for 300 s
ATTTTGACGCT
>pdb|7M81|T Chain T, Human DNA Pol eta with dA-ended primer and dATP: in crystallo reaction for 100 s
ATTTTGACGCT
>pdb|7M80|T Chain T, Human DNA Pol eta with dA-ended primer and dATP: in crystallo reaction for 100 s
ATTTTGACGCT
>pdb|7M7Z|T Chain T, Human DNA Pol eta with dA-ended primer and dATP: in crystallo reaction for 40 s
ATTTTGACGCT
>pdb|7M7Y|T Chain T, Human DNA Pol eta with dA-ended primer and dATP: in crystallo reaction for 0 s
ATTTTGACGCT
>pdb|6THN|A Chain A, Multiple Genomic RNA-Coat Protein Contacts Play Vital Roles in the Assembly of Infectious Enterovirus-E symmetry expansion+2fold focused classification
AGAGCATGATT
>MX625776.1 Sequence 72 from patent US 10988802
CTGAGTCGGBN
>MX625767.1 Sequence 63 from patent US 10988802
CTGAGTCGGBH
>MX625758.1 Sequence 54 from patent US 10988802
CTGAGTCGGAH
>MX625750.1 Sequence 46 from patent US 10988802
CTGAGTCGGAG
>MX625721.1 Sequence 17 from patent US 10988802
GATCGGAAGBN
>MX625716.1 Sequence 12 from patent US 10988802
GATCGGAAGBH
>MX625711.1 Sequence 7 from patent US 10988802
GATCGGAAGAH
>MX625707.1 Sequence 3 from patent US 10988802
GATCGGAAGAG
>MX624005.1 Sequence 171 from patent US 10988781
AATTTCTACTG
>MX624004.1 Sequence 170 from patent US 10988781
AATTTCTACTG
>MX624003.1 Sequence 169 from patent US 10988781
AATTTCTACTG
>MX624002.1 Sequence 168 from patent US 10988781
AATTTCTACTG
>MX571865.1 Sequence 3051 from patent US 10988754
CRRRRRRRRRR
>MX571851.1 Sequence 3035 from patent US 10988754
CRRRRRRRRRC
>MX571823.1 Sequence 3006 from patent US 10988754
GGGTTTTTGGG
>MX571813.1 Sequence 2995 from patent US 10988754
GGTTTTTTTGG
>MX568113.1 Sequence 110 from patent US 10988513
GCGAAAACTTC
>MX568111.1 Sequence 108 from patent US 10988513
GAAATATTATA
>MX568110.1 Sequence 107 from patent US 10988513
GAAGTTTTCGC
>MX568108.1 Sequence 105 from patent US 10988513
TATAATATTTC
>MX568107.1 Sequence 104 from patent US 10988513
GCGAAAATTTC
>MX568105.1 Sequence 102 from patent US 10988513
GCGAAATTTTC
>MX568104.1 Sequence 101 from patent US 10988513
GAAATATTATC
>MX568103.1 Sequence 100 from patent US 10988513
GAAATTTTCGC
>MX568101.1 Sequence 98 from patent US 10988513
GAAAATTTCGC
>MX568100.1 Sequence 97 from patent US 10988513
GATAATATTTC
>MX566865.1 Sequence 2 from patent US 10975445
GCCACATGGCT
>MX549057.1 Sequence 9 from patent US 10975435
GGGCTTAGCTG
>MX539130.1 Sequence 45 from patent US 10975380
KCACYSAAGAG
>MX537878.1 Sequence 19 from patent US 10975357
TACTTCCCCCT
>MX537631.1 Sequence 62 from patent US 10975158
GGATATCCACC
>MX537625.1 Sequence 49 from patent US 10975158
GGATATCCACC
>MX534409.1 Sequence 27 from patent US 10973899
GATCTCTAGAT
>MX525735.1 Sequence 12 from patent US 10968446
TCCAGCTCTGG
>MX525734.1 Sequence 11 from patent US 10968446
AGGTCGAGACC
>MX525733.1 Sequence 10 from patent US 10968446
CCAGAGCTTAC
>MX525732.1 Sequence 9 from patent US 10968446
GGTCTCGAATG
>MX525731.1 Sequence 8 from patent US 10968446
ATGAGCTCTGG
>MX525730.1 Sequence 7 from patent US 10968446
TACTCGAGACC
>MX525729.1 Sequence 6 from patent US 10968446
CCAGAGCCCTC
>MX525728.1 Sequence 5 from patent US 10968446
GGTCTCGGGAG
>MX525702.1 Sequence 11 from patent US 10968443
TCGAAGTATTC
>MX519932.1 Sequence 28 from patent US 10962540
ACTGGTGTAGG
>MX519930.1 Sequence 26 from patent US 10962540
ACTGGTGTAGG
>MX519929.1 Sequence 25 from patent US 10962540
ATAGCGTATCG
>MX519924.1 Sequence 20 from patent US 10962540
ATACCACAACA
>MX519923.1 Sequence 19 from patent US 10962540
TTCGCATTCTG
>MX519921.1 Sequence 17 from patent US 10962540
TTCGCATTCTG
>MX519920.1 Sequence 16 from patent US 10962540
CATCTGGACAA
>MX519841.1 Sequence 48 from patent US 10961594
GGTCAGGAGTT
>MX516960.1 Sequence 95 from patent US 10961579
TCCCACCGCTG
>MX509879.1 Sequence 5686 from patent US 10960063
GAGCTAATAAA
>MX509853.1 Sequence 5660 from patent US 10960063
TTTACTTCCTC
>MX509684.1 Sequence 5484 from patent US 10960063
TTATAACACCT
>MX509559.1 Sequence 5352 from patent US 10960063
TAGGATAAGAA
>MX509393.1 Sequence 5174 from patent US 10960063
GAATAGCTATC
>MX509306.1 Sequence 5084 from patent US 10960063
TATATCTACTC
>MX509176.1 Sequence 4949 from patent US 10960063
ATTATTTGAGC
>MX509008.1 Sequence 4772 from patent US 10960063
ATTTTCACAAC
>MX508929.1 Sequence 4692 from patent US 10960063
GATTATCACCT
>MX508836.1 Sequence 4596 from patent US 10960063
AAAATTCCTCC
>MX508770.1 Sequence 4526 from patent US 10960063
AATATTCCTCC
>MX508646.1 Sequence 4398 from patent US 10960063
CCGTGATTAAT
>MX508473.1 Sequence 4221 from patent US 10960063
GGTGATTAACT
>MX508435.1 Sequence 4182 from patent US 10960063
GCGGTGGTATC
>MX508434.1 Sequence 4181 from patent US 10960063
GAGGAATTGAC
>MX508233.1 Sequence 3969 from patent US 10960063
GAGGATGAATT
>MX508215.1 Sequence 3950 from patent US 10960063
AATTGGAAGAT
>MX508118.1 Sequence 3848 from patent US 10960063
AATTAATTAAA
>MX508048.1 Sequence 3775 from patent US 10960063
AGGGTGAAAAT
>MX508013.1 Sequence 3738 from patent US 10960063
AAGCTTGTAGC
>MX507972.1 Sequence 3696 from patent US 10960063
CTTATTTTCAC
>MX507886.1 Sequence 3606 from patent US 10960063
ATTTATTATTT
>MX507881.1 Sequence 3601 from patent US 10960063
GAGTGTTTAGT
>MX507849.1 Sequence 3567 from patent US 10960063
TTTTGATTTGT
>MX507838.1 Sequence 3556 from patent US 10960063
TTTTGATTTGT
>MX507793.1 Sequence 3508 from patent US 10960063
AAAATTAGAAC
>MX507786.1 Sequence 3499 from patent US 10960063
GAGTTGAATAT
>MX507784.1 Sequence 3495 from patent US 10960063
GGAGAATTTTT
>MX507773.1 Sequence 3483 from patent US 10960063
AAGGTGAGAAT
>MX507697.1 Sequence 3395 from patent US 10960063
AATAAAATTTT
>MX507641.1 Sequence 3338 from patent US 10960063
TTGTGAATCAG
>MX507585.1 Sequence 3280 from patent US 10960063
TTCGACCAATT
>MX507389.1 Sequence 3078 from patent US 10960063
GATTTTTAATC
>MX507192.1 Sequence 2881 from patent US 10960063
TAGTGAAACTA
>MX507162.1 Sequence 2851 from patent US 10960063
CTCTTTTAGAG
>MX507050.1 Sequence 2739 from patent US 10960063
TTTTATAAAAA
>MX506916.1 Sequence 2605 from patent US 10960063
TTAAAATTTAA
>MX506768.1 Sequence 2457 from patent US 10960063
TTTATCATAAA
>MX506552.1 Sequence 2241 from patent US 10960063
TTTATTTTAAA
>MX506467.1 Sequence 2156 from patent US 10960063
CTTTTAAAAAG
>MX506313.1 Sequence 2002 from patent US 10960063
TATTTTTAATA
>MX506303.1 Sequence 1992 from patent US 10960063
CTATGGAATAG
>MX506299.1 Sequence 1988 from patent US 10960063
TCCTTAAAGGG
>MX506183.1 Sequence 1872 from patent US 10960063
TAGTTTTACTA
>MX506143.1 Sequence 1832 from patent US 10960063
GATTTACAATC
>MX503561.1 Sequence 119 from patent US 10959415
ATGAACACTCC
>MX502077.1 Sequence 9 from patent US 10954569
ACTACRGTCAA
>MX502076.1 Sequence 8 from patent US 10954569
CGTACKAAGAG
>MX501517.1 Sequence 3 from patent US 10954562
TTTTTTTTTTT
>MX501516.1 Sequence 2 from patent US 10954562
AAAAAAAAAAA
>MX501493.1 Sequence 252 from patent US 10954558
ACACTCTTTCC
>MX501490.1 Sequence 191 from patent US 10954558
ACACTCTTTCC
>MX501462.1 Sequence 100 from patent US 10954558
ACACTCTTTCC
>MX501421.1 Sequence 252 from patent US 10954557
ACACTCTTTCC
>MX501418.1 Sequence 191 from patent US 10954557
ACACTCTTTCC
>MX501390.1 Sequence 100 from patent US 10954557
ACACTCTTTCC
>MX501147.1 Sequence 217 from patent US 10954548
ACATCACAGGG
>MX472296.1 Sequence 3 from patent US 10947589
CCCCCCCCCCC
>MX444777.1 Sequence 17 from patent US 10947538
GGTCCCCAAGT
>MX436575.1 Sequence 465 from patent US 10946108
CCNNNNNNNGG
>MX435627.1 Sequence 306 from patent US 10946090
GCCACCATGGA
>MX435369.1 Sequence 168 from patent US 10946035
TTTTGCTTTAA
>MX435368.1 Sequence 167 from patent US 10946035
TTTTGCTTAAT
>MX435367.1 Sequence 166 from patent US 10946035
TTTTGCAATTT
>MX435366.1 Sequence 165 from patent US 10946035
TTTTAATTTTT
>MX435365.1 Sequence 164 from patent US 10946035
TTAAGCTTTTT
>MX435364.1 Sequence 163 from patent US 10946035
AATTGCTTTTT
>MX435363.1 Sequence 162 from patent US 10946035
TTTAAAAATTT
>MX435362.1 Sequence 161 from patent US 10946035
TTTTGCTTTTT
>MX435271.1 Sequence 70 from patent US 10946035
AAAAAGCAAAA
>MX407663.1 Sequence 12 from patent US 10940201
AACGTCAGGAA
>MX426637.1 Sequence 164 from patent US 10941416
GTATTGAGTGG
>MX406780.1 Sequence 83 from patent US 10934598
TACCCGGTACT
>MX405877.1 Sequence 4 from patent US 10934581
CCCCCCCCCCC
>MX405876.1 Sequence 3 from patent US 10934581
GGGGGGGGGGG
>MX405051.1 Sequence 8 from patent US 10934553
AAGATCGACAG
>MX403911.1 Sequence 68 from patent US 10934546
CTCCTTCCTCC
>MQ083735.1 Sequence 6 from Patent WO2021110855
TTCAGCTTGGG
>MQ081280.1 Sequence 264 from Patent EP3833780
ACCAGTAATGT
>MQ081279.1 Sequence 263 from Patent EP3833780
ACCAGGAATGT
>MQ081278.1 Sequence 262 from Patent EP3833780
ACCAGGAATGT
>MQ081277.1 Sequence 261 from Patent EP3833780
CCAAGTGGACT
>MQ081276.1 Sequence 260 from Patent EP3833780
CCAAGTGGACT
>MQ081275.1 Sequence 259 from Patent EP3833780
CCAAGCGGACT
>MQ065221.1 Sequence 10 from Patent EP3827847
AAAGAGTTTGC
>MQ065219.1 Sequence 8 from Patent EP3827847
AAATTTCTACT
>MQ063957.1 Sequence 59 from Patent EP3827084
TGTKTGTKTGT
>MQ063437.1 Sequence 14 from Patent EP3827824
TGGGCGTGTCT
>MQ063436.1 Sequence 13 from Patent EP3827824
GCTGCGTGTGG
>MQ063435.1 Sequence 12 from Patent EP3827824
TGTCACTCAAG
>MQ052919.1 Sequence 5 from Patent WO2021094251
GAGTTAAAACT
>MQ052574.1 Sequence 153 from Patent WO2021096605
GANNNNNNAAA
>MQ052474.1 Sequence 53 from Patent WO2021096605
GTACAGGGATG
>MQ051786.1 Sequence 152 from Patent WO2021094752
KAGCCGAGATG
>MQ051668.1 Sequence 34 from Patent WO2021094752
KAGCCGAGATG
>MQ049114.1 Sequence 32 from Patent WO2021097255
GACAATTGTCG
>MQ049113.1 Sequence 31 from Patent WO2021097255
CAACTTTAGCG
>MQ049112.1 Sequence 30 from Patent WO2021097255
GAGGATTGCGC
>MQ049090.1 Sequence 8 from Patent WO2021097255
AAAAAAAAAAA
>MQ048334.1 Sequence 14 from Patent WO2021089721
TGGGCGTGTCT
>MQ048333.1 Sequence 13 from Patent WO2021089721
GCTGCGTGTGG
>MQ048332.1 Sequence 12 from Patent WO2021089721
TGTCACTCAAG
>MQ047519.1 Sequence 32 from Patent WO2021092299
GGGGGGGGGGG
>pdb|7B5K|6 Chain 6, E. coli 70S containing suppressor tRNA in the A-site stabilized by a Negamycin analogue and P-site tRNA-nascent chain.
NTAATCTGAAC
>OG170245.1 WO 2021025104-A/26: Plant RNA
TTCTTCTTCTT
>OG170235.1 WO 2021025104-A/16: Plant RNA
TCTTCTTCTTC
>OG170225.1 WO 2021025104-A/6: Plant RNA
CTTCTTCTTCT
>OG168245.1 JP 2021023222-A/26: Plant RNA
TTCTTCTTCTT
>OG168235.1 JP 2021023222-A/16: Plant RNA
TCTTCTTCTTC
>OG168225.1 JP 2021023222-A/6: Plant RNA
CTTCTTCTTCT
>OG167360.1 JP 2021024792-A/12: agent and method for promoting muscle differentiation, and oligodeoxynucleotide for promoting muscle differentiation
TTGGGTGGGAA
>OG167351.1 JP 2021024792-A/3: agent and method for promoting muscle differentiation, and oligodeoxynucleotide for promoting muscle differentiation
GGGTTAGGGTT
>OG167350.1 JP 2021024792-A/2: agent and method for promoting muscle differentiation, and oligodeoxynucleotide for promoting muscle differentiation
GTTAGGGTTAG
>pdb|7LHZ|E Chain E, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25)
TTACGTTGTAT
>pdb|7LHZ|H Chain H, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25)
TTACGTTGTAT
>pdb|7LHZ|J Chain J, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25)
TTACGTTGTAT
>pdb|7LHZ|P Chain P, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and (3S)-10-[(3R)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-9-fluoro-3-methyl-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (compound 25)
TTACGTTGTAT
>pdb|7K5T|P Chain P, Bst DNA polymerase I time-resolved structure, 25.5 hr post dATP and dCTP addition
GCGATCACGTA
>pdb|7K5S|P Chain P, Bst DNA polymerase I time-resolved structure, 4 hr post dATP and dCTP addition
GCGATCACGTA
>pdb|7K5R|P Chain P, Bst DNA polymerase I time-resolved structure, 120 min post dATP addition
NCGATCACGTA
>MQ032324.1 Sequence 767 from Patent EP3814510
CAACAAGTTCA
>MQ032323.1 Sequence 766 from Patent EP3814510
ACATCTGGGTG
>MQ032322.1 Sequence 765 from Patent EP3814510
CTTTAATTTGT
>MQ032321.1 Sequence 764 from Patent EP3814510
AGCTGCAGCAT
>MQ032320.1 Sequence 763 from Patent EP3814510
AAAGAGATTCC
>MQ031661.1 Sequence 104 from Patent EP3814510
GCAGATCCTCC
>MQ031621.1 Sequence 64 from Patent EP3814510
GCCACATGGCT
>MQ031620.1 Sequence 63 from Patent EP3814510
CTTCCAGGTTA
>MQ031607.1 Sequence 50 from Patent EP3814510
AAAGGAGGATC
>MQ031606.1 Sequence 49 from Patent EP3814510
TGGCTGCGCTG
>MQ031577.1 Sequence 20 from Patent EP3814510
TTCACAGAGTA
>MQ031570.1 Sequence 13 from Patent EP3814510
GGGCCGGGCCC
>MQ031565.1 Sequence 8 from Patent EP3814510
TGGTGGCATGA
>MQ026996.1 Sequence 18 from Patent WO2021072288
AGACGGGATCA
>MQ026995.1 Sequence 17 from Patent WO2021072288
ACGGGATCATA
>MQ026992.1 Sequence 14 from Patent WO2021072288
ACGGGATCATA
>MQ021871.1 Sequence 1 from Patent WO2021079196
TCTGGACTAAA
>MQ012582.1 Sequence 26 from Patent EP3760727
GACAACATTCA
>MQ012567.1 Sequence 11 from Patent EP3760727
TGATTACCCCA
>MQ012566.1 Sequence 10 from Patent EP3760727
TGATTACCTCA
>MQ012565.1 Sequence 9 from Patent EP3760727
TGATTACCTCA
>MQ011509.1 Sequence 29 from Patent EP3802557
GTTAGGGTTAG
>MQ010962.1 Sequence 20 from Patent EP3802572
TGTGCGAAAGA
>MP997972.1 Sequence 10 from Patent WO2021067483
TATGGCCCGGA
>MP997971.1 Sequence 9 from Patent WO2021067483
CATTGCTCGGA
>MP997970.1 Sequence 8 from Patent WO2021067483
GTAACGAGCCT
>MP992435.1 Sequence 36 from Patent WO2021050779
GCGGTTTGCGG
>MP992419.1 Sequence 20 from Patent WO2021050779
GGTGGTGGTGG
>MP980520.1 Sequence 56 from Patent EP3793590
AACCGTAAAAT
>MX394701.1 Sequence 1 from patent US 10930369
GTGGCCCATAT
>MX394663.1 Sequence 1039 from patent US 10930367
GAAGAAAAGAG
>MX394662.1 Sequence 1038 from patent US 10930367
GAAGAGAAGAG
>MX394658.1 Sequence 1034 from patent US 10930367
GGAGAAAAGAG
>MX394657.1 Sequence 1033 from patent US 10930367
GGAGAGAAGAG
>MX394650.1 Sequence 1026 from patent US 10930367
GAAGAAGACGG
>MX394648.1 Sequence 1024 from patent US 10930367
GAAGAAAAGGG
>MX394647.1 Sequence 1023 from patent US 10930367
GAAGAGAAGGG
>MX394604.1 Sequence 980 from patent US 10930367
TGACTGGGAAG
>MX394601.1 Sequence 977 from patent US 10930367
TGACTGGGTGG
>MX393640.1 Sequence 8 from patent US 10929039
GHGDBRADCKG
>MX393639.1 Sequence 7 from patent US 10929039
GAGTTGATCTG
>MX393638.1 Sequence 6 from patent US 10929039
GCGATAAACGG
>MX393637.1 Sequence 5 from patent US 10929039
GTGAGGAGCTG
>MX393636.1 Sequence 4 from patent US 10929039
GTGGCAATCGG
>MX393635.1 Sequence 3 from patent US 10929039
GCGTCGAGCGG
>MX393634.1 Sequence 2 from patent US 10929039
GAGGGAAACTG
>MX393503.1 Sequence 13 from patent US 10928386
TTTTTTTTTTT
>MX393502.1 Sequence 12 from patent US 10928386
AAAAAAAAAAA
>MX386529.1 Sequence 21 from patent US 10925958
GGGATCCTACC
>MX381138.1 Sequence 4 from patent US 10925935
AAAAAGCAAAA
>MX381136.1 Sequence 2 from patent US 10925935
TTTTGCTTTTT
>MX378575.1 Sequence 19 from patent US 10920270
CTAGCCTCGTA
>MX377911.1 Sequence 119 from patent US 10920242
ATGAACACTCC
>MX374034.1 Sequence 26 from patent US 10919934
ACGCCAGGATC
>MX374031.1 Sequence 22 from patent US 10919934
ATGTGCCCGGT
>MX374030.1 Sequence 21 from patent US 10919934
GAGTCGTACAC
>MX374029.1 Sequence 20 from patent US 10919934
GCCTGCACCTC
>MX374028.1 Sequence 17 from patent US 10919934
TGCACTGCGCG
>MX374025.1 Sequence 12 from patent US 10919934
ACACGGGCACA
>MX373870.1 Sequence 17 from patent US 10918971
GGGTACCCTGC
>MX365450.1 Sequence 366 from patent US 10918740
GGGTTTTTGGG
>MX365440.1 Sequence 355 from patent US 10918740
GGTTTTTTTGG
>MX357759.1 Sequence 169 from patent US 10913946
ATCCTGTAGGA
>MX357758.1 Sequence 168 from patent US 10913946
AGCATCCTGTA
>MX357756.1 Sequence 166 from patent US 10913946
AGTTTCTTCCA
>MX357735.1 Sequence 145 from patent US 10913946
ATTCTCAGGAA
>MX357679.1 Sequence 89 from patent US 10913946
NNNNNGNNGGN
>MX357678.1 Sequence 88 from patent US 10913946
NGNNNNNNGNN
>MX357676.1 Sequence 86 from patent US 10913946
NGNNNNNNNNN
>MX357656.1 Sequence 65 from patent US 10913946
NNNNNNNGGNN
>MX357280.1 Sequence 2 from patent US 10913934
CTAAATACCCC
>MX355440.1 Sequence 4 from patent US 10913767
CAGGTAAGTAT
>MX355414.1 Sequence 1 from patent US 10912863
GCTGTCGGAAG
>MX355238.1 Sequence 58 from patent US 10912826
TGGAGAAAGGT
>MX348526.1 Sequence 84 from patent US 10907164
GCTCTTCTGGT
>MX348525.1 Sequence 83 from patent US 10907164
ACCAGAAGAGC
>MX348520.1 Sequence 78 from patent US 10907164
GCTCTTCCATC
>MX348519.1 Sequence 77 from patent US 10907164
GATGGAAGAGC
>MX348518.1 Sequence 76 from patent US 10907164
GGTGGAAGAGC
>MX348517.1 Sequence 75 from patent US 10907164
GCTCTTCCACC
>MX348385.1 Sequence 84 from patent US 10907161
CGATCGATCCC
>MX348354.1 Sequence 53 from patent US 10907161
GGGATCGATCG
>MX348244.1 Sequence 50 from patent US 10907158
GGCAANNCCAN
>MX348243.1 Sequence 38 from patent US 10907158
AGNAACNCCAC
>MX348242.1 Sequence 37 from patent US 10907158
NCANCNNNGCN
>MX348241.1 Sequence 36 from patent US 10907158
NNCGGNCANGN
>MX348240.1 Sequence 35 from patent US 10907158
NNACNCCNGAA
>MX348239.1 Sequence 34 from patent US 10907158
AGGCCANAGCG
>MX348238.1 Sequence 33 from patent US 10907158
AAAGCNCCNCN
>MX348237.1 Sequence 32 from patent US 10907158
NAGGCANCGAC
>MX348236.1 Sequence 31 from patent US 10907158
NNAAAANCCAN
>MX348235.1 Sequence 30 from patent US 10907158
CANNACCCAAG
>MX348234.1 Sequence 29 from patent US 10907158
NNGCCAACANG
>MX348233.1 Sequence 28 from patent US 10907158
NNNCCNGNCAA
>MX348232.1 Sequence 27 from patent US 10907158
NCANGGCAAAG
>MX348230.1 Sequence 25 from patent US 10907158
NCCNNNNANNC
>MX348229.1 Sequence 24 from patent US 10907158
NCAAGNNNNCC
>MX348228.1 Sequence 23 from patent US 10907158
AACGANANNCC
>MX348227.1 Sequence 22 from patent US 10907158
GANACAGNGAC
>MX348226.1 Sequence 21 from patent US 10907158
NNNGCANNCCN
>MX348225.1 Sequence 20 from patent US 10907158
ANNCCNNGNGG
>MX348224.1 Sequence 19 from patent US 10907158
NNCANNNGCAN
>MX348223.1 Sequence 18 from patent US 10907158
NANGNNCGNGA
>MX348222.1 Sequence 17 from patent US 10907158
NAGGCANGNCN
>MX348221.1 Sequence 16 from patent US 10907158
AGGCANGNCNN
>MX348220.1 Sequence 15 from patent US 10907158
GNCNNAACGGC
>MX348219.1 Sequence 14 from patent US 10907158
NGNNCANANGN
>MX348218.1 Sequence 13 from patent US 10907158
AACCCNCNGNN
>MX348217.1 Sequence 12 from patent US 10907158
GNNCANANGNA
>MX348216.1 Sequence 11 from patent US 10907158
ANGNAAACCNC
>MX348215.1 Sequence 10 from patent US 10907158
CANGGANANCC
>MX346340.1 Sequence 59 from patent US 10906957
TAAAAAAAAAT
>MX343557.1 Sequence 63 from patent US 10905109
CTAACTGGGGA
>MX343496.1 Sequence 63 from patent US 10905108
CTAACTGGGGA
>MX343375.1 Sequence 12 from patent US 10902939
CGTCNTNGCTT
>MX342392.1 Sequence 275 from patent US 10900974
AACGAACAGAG
>MX342391.1 Sequence 274 from patent US 10900974
AAGGCCTCACC
>MX342390.1 Sequence 273 from patent US 10900974
AATTGTCTGTA
>MX342389.1 Sequence 272 from patent US 10900974
ACAGACTCAGT
>MX342388.1 Sequence 271 from patent US 10900974
ACCATTATTGG
>MX342387.1 Sequence 270 from patent US 10900974
ACTCTTCTTCC
>MX342386.1 Sequence 269 from patent US 10900974
AGATGAGCGTA
>MX342385.1 Sequence 268 from patent US 10900974
AGGCCCTTTGT
>MX342384.1 Sequence 267 from patent US 10900974
AGTTGAAATAG
>MX342383.1 Sequence 266 from patent US 10900974
ATTACACGCCC
>MX342382.1 Sequence 265 from patent US 10900974
ATCCTATCCAA
>MX342381.1 Sequence 264 from patent US 10900974
ATTAGTATGTT
>MX342380.1 Sequence 263 from patent US 10900974
TAATGTGGATG
>MX342379.1 Sequence 262 from patent US 10900974
TAGACCAGGGC
>MX342378.1 Sequence 261 from patent US 10900974
TATCGACGTCA
>MX342377.1 Sequence 260 from patent US 10900974
TCATACTACAT
>MX342376.1 Sequence 259 from patent US 10900974
TCGAACATATG
>MX342375.1 Sequence 258 from patent US 10900974
TCTCATATTGG
>MX342374.1 Sequence 257 from patent US 10900974
TGAGTAATTAA
>MX342373.1 Sequence 256 from patent US 10900974
TGGATGCTCCT
>MX342372.1 Sequence 255 from patent US 10900974
TGTGACCAGTG
>MX342371.1 Sequence 254 from patent US 10900974
TTATCCCCCAC
>MX342370.1 Sequence 253 from patent US 10900974
TTGACATCACA
>MX342369.1 Sequence 252 from patent US 10900974
TTTATATGTGT
>MX341611.1 Sequence 43 from patent US 10900094
CAGAAGAAGAA
>MX341609.1 Sequence 41 from patent US 10900094
CTTCAGCAGGT
>MX340498.1 Sequence 6 from patent US 10900073
CTAATCGGATC
>MX340497.1 Sequence 5 from patent US 10900073
GTCAGTCAATG
>MX340496.1 Sequence 4 from patent US 10900073
ACGTAGGGTCA
>MX340495.1 Sequence 3 from patent US 10900073
TAGCCTAGTAA
>MX340494.1 Sequence 2 from patent US 10900073
ACTGTCAGTAG
>MX337624.1 Sequence 24 from patent US 10900046
ATCTTGATAGC
>MX337622.1 Sequence 22 from patent US 10900046
GTAATTAAAAA
>MX337469.1 Sequence 10 from patent US 10900043
GAGNNNNNTAC
>MX300693.1 Sequence 109 from patent US 10900035
WWWWWWWWNWW
>MX300690.1 Sequence 106 from patent US 10900035
WWWWWNCCCCC
>MX300687.1 Sequence 103 from patent US 10900035
CCCCCNCCCCC
>MX300685.1 Sequence 101 from patent US 10900035
GCAATACTATA
>MX300684.1 Sequence 100 from patent US 10900035
TGACAGGTTGT
>MX300682.1 Sequence 98 from patent US 10900035
CAGCAGGGAGC
>MX300681.1 Sequence 97 from patent US 10900035
ATGTATGTGTG
>MX300651.1 Sequence 64 from patent US 10900035
CCCTCTTACTA
>MX300650.1 Sequence 63 from patent US 10900035
ATGTCACGGGG
>MX300626.1 Sequence 39 from patent US 10900035
CATACTGTTGA
>MX300624.1 Sequence 37 from patent US 10900035
GTCAATCATGG
>MX300623.1 Sequence 36 from patent US 10900035
GTCAATCATGG
>MX295570.1 Sequence 117 from patent US 10894983
TCTTCCGATCT
>MX295538.1 Sequence 85 from patent US 10894983
TCTTCCGATCT
>MX206383.1 Sequence 106 from patent US 10888569
TGCTGASTCAY
>MX178286.1 Sequence 461 from patent US 10881690
GRTVDGTVVSD
>MX288005.1 Sequence 214 from patent US 10894975
GGAGCTGTGAT
>MX287981.1 Sequence 190 from patent US 10894975
GGAGCTAGTGG
>MX287800.1 Sequence 5 from patent US 10894975
GGAGCTGTTGG
>MX287799.1 Sequence 4 from patent US 10894975
GGAGCTGATGG
>MX286313.1 Sequence 5 from patent US 10894151
TTCTGGGAATT
>MX285763.1 Sequence 119 from patent US 10893667
ATGAACACTCC
>MX282638.1 Sequence 6 from patent US 10892034
ACTNNNNGATT
>MX282636.1 Sequence 4 from patent US 10892034
TCGNNNNGATT
>MX282634.1 Sequence 2 from patent US 10892034
CGCNNNNGATT
>MX273205.1 Sequence 18 from patent US 10889825
TGATATGTGCA
>MX269504.1 Sequence 495 from patent US 10889812
TTNNTTTNNTT
>MX269497.1 Sequence 487 from patent US 10889812
NNTTNNTTTNN
>MX268212.1 Sequence 4765 from patent US 10889811
CTAACTGGGGA
>MX263801.1 Sequence 16 from patent US 10888830
GCCCACTACAG
>MX263800.1 Sequence 15 from patent US 10888830
CGCCCACTACA
>MX263287.1 Sequence 461 from patent US 10888587
GRTVDGTVVSD
>pdb|7CUK|B Chain B, Structure of a GG mismatch-containing duplex formed by G4C2 repeats
CTAGGGCCTAG
>pdb|7CUK|A Chain A, Structure of a GG mismatch-containing duplex formed by G4C2 repeats
CTAGGGCCTAG
>OG163023.1 WO 2020241876-A/3: Methods for Efficiently Producing PPR Proteins and Use thereof
GTGGTGAGACC
>OG163022.1 WO 2020241876-A/2: Methods for Efficiently Producing PPR Proteins and Use thereof
GGTCTCAATAC
>OG161545.1 JP 2020198784-A/3: Nucleic Acid Molecule Modulating Immunity Function and Use Thereof
TAATTTTTTGG
>MP733828.1 Sequence 24 from Patent EP3689331
GTTAGGGTTAG
>MP838429.1 Sequence 28 from Patent EP3595676
GGGATCCTACC
>MP939880.1 Sequence 1042 from Patent WO2021040736
ATCGGGCTAGC
>MP730434.1 Sequence 4 from Patent WO2020141470
CTTTCTCTCTG
>MP934654.1 Sequence 2 from Patent EP3789490
TGTGAGCCAAG
>MP933383.1 Sequence 25 from Patent EP3784790
GAAAACTGAGT
>MP830105.1 Sequence 16 from Patent WO2020227618
AATATCTGCAA
>MP830411.1 Sequence 66 from Patent EP3737748
TCGACNGGATC
>MP830410.1 Sequence 65 from Patent EP3737748
TCGACNGGATC
>MP830409.1 Sequence 64 from Patent EP3737748
TCGACNGGATC
>MP830408.1 Sequence 63 from Patent EP3737748
TCGACNGGATC
>MP830407.1 Sequence 62 from Patent EP3737748
TCGACNGGATC
>MP830406.1 Sequence 61 from Patent EP3737748
TCGACNGGATC
>MP830405.1 Sequence 60 from Patent EP3737748
TCGACNGGATC
>MP830404.1 Sequence 59 from Patent EP3737748
TCGACNGGATC
>MP830400.1 Sequence 55 from Patent EP3737748
TCGACNGGATC
>MP830399.1 Sequence 54 from Patent EP3737748
TCGACNGGATC
>MP721708.1 Sequence 171 from Patent WO2020132408
CTTGATTAATG
>MP721704.1 Sequence 167 from Patent WO2020132408
TTAATAGGAGT
>MP714937.1 Sequence 8 from Patent WO2020128421
TGGTCTTTAGA
>MP923052.1 Sequence 33 from Patent WO2021023896
CAACCGATTCC
>MP923045.1 Sequence 26 from Patent WO2021023896
ACTCCTATCTA
>MP822366.1 Sequence 22 from Patent WO2020216637
AATTGCACAAT
>MP822365.1 Sequence 21 from Patent WO2020216637
ARTTGCACART
>MP818518.1 Sequence 404 from Patent WO2020214784
AACGGAANNGA
>MP918919.1 Sequence 10 from Patent EP3781695
TAAAAAAAAAT
>MP918916.1 Sequence 7 from Patent EP3781695
ATCCCCCCTAA
>MP708709.1 Sequence 10 from Patent EP3680347
TTGGATATGGG
>MP914217.1 Sequence 2 from Patent EP3775264
CGCGCTGTTAT
>MP914017.1 Sequence 235 from Patent EP3781686
ATATTTAAGGA
>MP914016.1 Sequence 234 from Patent EP3781686
TCCTTAAATAT
>MP914015.1 Sequence 233 from Patent EP3781686
AATATTTCCAT
>MP914014.1 Sequence 232 from Patent EP3781686
ATGGAAATATT
>MP914011.1 Sequence 229 from Patent EP3781686
CTCTCCCTGCC
>MP914010.1 Sequence 228 from Patent EP3781686
GGCAGGGAGAG
>MP914009.1 Sequence 227 from Patent EP3781686
CAGCAGCAGCT
>MP914008.1 Sequence 226 from Patent EP3781686
AGCTGCTGCTG
>MP913966.1 Sequence 184 from Patent EP3781686
CCCTCCCCAGC
>MP913965.1 Sequence 183 from Patent EP3781686
GCTGGGGAGGG
>MP913782.1 Sequence 5 from Patent EP3781711
TGAGTCACTTG
>MP910782.1 Sequence 3 from Patent WO2021009336
GGAGATNGGTA
>MP910781.1 Sequence 2 from Patent WO2021009336
GGAGATGGGTA
>MP697371.1 Sequence 1 from Patent EP3670666
TTTCTTCATTA
>MP696994.1 Sequence 18 from Patent EP3673065
CNCACCNGGAG
>MP696983.1 Sequence 7 from Patent EP3673065
CACCNGGAGCA
>MP696982.1 Sequence 6 from Patent EP3673065
CACCNGGAGCA
>MP692473.1 Sequence 8 from Patent WO2020123305
AAAAAAAAAAA
>MP900898.1 Sequence 145 from Patent EP3775217
CCGGCCCCCCG
>MP900894.1 Sequence 141 from Patent EP3775217
CGGGGGGCCGG
>MP900883.1 Sequence 130 from Patent EP3775217
TTACGGTTTGA
>MP900882.1 Sequence 129 from Patent EP3775217
TCATGCTGTGG
>MP900874.1 Sequence 121 from Patent EP3775217
CCCACTCTGTG
>MP900873.1 Sequence 120 from Patent EP3775217
AACACAGTGGG
>MP900838.1 Sequence 85 from Patent EP3775217
CTTTTTTGGCG
>MP900821.1 Sequence 68 from Patent EP3775217
CCTGGCGCTGA
>MP900817.1 Sequence 64 from Patent EP3775217
TGAGGGAACAC
>MP900779.1 Sequence 26 from Patent EP3775217
GGGCAGGAAGC
>MP900775.1 Sequence 22 from Patent EP3775217
CAGTTGGGAGT
>MP798448.1 Sequence 4 from Patent WO2020206248
TGCCTACTGCC
>MP798446.1 Sequence 2 from Patent WO2020206248
GACAGTGAGCG
>MP690835.1 Sequence 479 from Patent WO2020123716
ATCGGGCTAGC
>MP794641.1 Sequence 11 from Patent WO2020193977
TTATACATCTA
>MP894705.1 Sequence 12 from Patent EP3773649
TAAAAAAAAAT
>MP894231.1 Sequence 1 from Patent EP3775259
TCAGTACGAGC
>MP681404.1 Sequence 59 from Patent WO2020109792
ATTCTCCTCAT
>MP681553.1 Sequence 21 from Patent WO2020109600
CGTGCTCGTGC
>MP681551.1 Sequence 19 from Patent WO2020109600
CCGACCACATC
>MP681549.1 Sequence 17 from Patent WO2020109600
TGCGTACCGCG
>MP681535.1 Sequence 3 from Patent WO2020109600
CCACCGCCAGC
>MP681533.1 Sequence 1 from Patent WO2020109600
CAATTCATGGA
>MP681514.1 Sequence 169 from Patent WO2020109792
GTCGAACCAAT
>MP681513.1 Sequence 168 from Patent WO2020109792
GCAAAGTCCTC
>MP681512.1 Sequence 167 from Patent WO2020109792
ATGTCCATCAT
>MP681511.1 Sequence 166 from Patent WO2020109792
CTAGCACTCCC
>MP681510.1 Sequence 165 from Patent WO2020109792
AGGCTCATAGG
>MP681509.1 Sequence 164 from Patent WO2020109792
CAGTCGCCCCT
>MP681508.1 Sequence 163 from Patent WO2020109792
GTACGGTTCAT
>MP681507.1 Sequence 162 from Patent WO2020109792
GCCAGGGTCAT
>MP681506.1 Sequence 161 from Patent WO2020109792
ATCAAACTCAT
>MP681505.1 Sequence 160 from Patent WO2020109792
CCACCTCCAGG
>MP681504.1 Sequence 159 from Patent WO2020109792
TGACTCTCCTC
>MP681503.1 Sequence 158 from Patent WO2020109792
AGCACCCTCAT
>MP681502.1 Sequence 157 from Patent WO2020109792
CTCTAGACATG
>MP681501.1 Sequence 156 from Patent WO2020109792
TTCTCTCCTTT
>MP681499.1 Sequence 154 from Patent WO2020109792
GACATGTCTAT
>MP681498.1 Sequence 153 from Patent WO2020109792
GTCTATTCTCC
>MP681494.1 Sequence 149 from Patent WO2020109792
TCCTTCTGATT
>MP681493.1 Sequence 148 from Patent WO2020109792
CTCTTCCTTTT
>MP681492.1 Sequence 147 from Patent WO2020109792
ATACTGTAAAA
>MP681491.1 Sequence 146 from Patent WO2020109792
GGTGCTCAAAC
>MP681490.1 Sequence 145 from Patent WO2020109792
TAATCCGTCAG
>MP681489.1 Sequence 144 from Patent WO2020109792
GGTTTGCCAAG
>MP681488.1 Sequence 143 from Patent WO2020109792
TGTTTCATACG
>MP681485.1 Sequence 140 from Patent WO2020109792
ATATACCTCAT
>MP681484.1 Sequence 139 from Patent WO2020109792
TCCTGCATCAT
>MP681483.1 Sequence 138 from Patent WO2020109792
GTATATGCCAT
>MP681482.1 Sequence 137 from Patent WO2020109792
TTCTGATTCAT
>MP681481.1 Sequence 136 from Patent WO2020109792
ACATCTGTCAT
>MP681480.1 Sequence 135 from Patent WO2020109792
CATTGAGATTT
>MP681479.1 Sequence 134 from Patent WO2020109792
CTACTGGTCAT
>MP681478.1 Sequence 133 from Patent WO2020109792
GACTTAATCAA
>MP681477.1 Sequence 132 from Patent WO2020109792
AGAGTTCAAGG
>MP681476.1 Sequence 131 from Patent WO2020109792
GGTGCAGTCAT
>MP681473.1 Sequence 128 from Patent WO2020109792
ATCCACCACAG
>MP681472.1 Sequence 127 from Patent WO2020109792
CTCTTAATGAT
>MP681471.1 Sequence 126 from Patent WO2020109792
TGTTTAAGAGC
>MP681470.1 Sequence 125 from Patent WO2020109792
AATTCGAGCAT
>MP681469.1 Sequence 124 from Patent WO2020109792
ACCTCCCAGGC
>MP681468.1 Sequence 123 from Patent WO2020109792
ACGCTAATCAT
>MP681467.1 Sequence 122 from Patent WO2020109792
TTCCCTGCCAT
>MP681466.1 Sequence 121 from Patent WO2020109792
TTTCCAGCCAT
>MP681465.1 Sequence 120 from Patent WO2020109792
TCTTTGGCCAT
>MP681463.1 Sequence 118 from Patent WO2020109792
ATGATACGCAT
>MP681462.1 Sequence 117 from Patent WO2020109792
CTTAGACATGG
>MP681461.1 Sequence 116 from Patent WO2020109792
GGCAGACTCGG
>MP681460.1 Sequence 115 from Patent WO2020109792
CTATTCTCCAA
>MP681459.1 Sequence 114 from Patent WO2020109792
ACTCGGGACAT
>MP681458.1 Sequence 113 from Patent WO2020109792
AAATTTATCCA
>MP681457.1 Sequence 112 from Patent WO2020109792
AATTTATCCAT
>MP681456.1 Sequence 111 from Patent WO2020109792
CATTTAGTTTG
>MP681455.1 Sequence 110 from Patent WO2020109792
ATCCATTTAGT
>MP681454.1 Sequence 109 from Patent WO2020109792
TTCATGCCTGT
>MP681452.1 Sequence 107 from Patent WO2020109792
GGCTGCTGGCA
>MP681451.1 Sequence 106 from Patent WO2020109792
TTGCGCTCGTT
>MP681450.1 Sequence 105 from Patent WO2020109792
CCATGCAGCAC
>MP681449.1 Sequence 104 from Patent WO2020109792
GCCTGTTATCC
>MP681448.1 Sequence 103 from Patent WO2020109792
AGTGCTCTACC
>MP681447.1 Sequence 102 from Patent WO2020109792
GTTGTTTGATC
>MP681446.1 Sequence 101 from Patent WO2020109792
TGTTTCACCAT
>MP681445.1 Sequence 100 from Patent WO2020109792
TGTTTGATCAT
>MP681444.1 Sequence 99 from Patent WO2020109792
TTTGATCATCG
>MP681443.1 Sequence 98 from Patent WO2020109792
TTCCTGCCATA
>MP681439.1 Sequence 94 from Patent WO2020109792
CGCTCATCTAA
>MP681437.1 Sequence 92 from Patent WO2020109792
AATGAGGCCAT
>MP681436.1 Sequence 91 from Patent WO2020109792
TCAAATGAGGC
>MP681435.1 Sequence 90 from Patent WO2020109792
GTTCAAACATA
>MP681434.1 Sequence 89 from Patent WO2020109792
AGTTTCTCTCC
>MP681433.1 Sequence 88 from Patent WO2020109792
GCATTTGACCT
>MP681432.1 Sequence 87 from Patent WO2020109792
CCTCAGACTCC
>MP681431.1 Sequence 86 from Patent WO2020109792
TGGTTCTGCAT
>MP681430.1 Sequence 85 from Patent WO2020109792
TACCAGTAAAC
>MP681429.1 Sequence 84 from Patent WO2020109792
TAGACATACCA
>MP681428.1 Sequence 83 from Patent WO2020109792
GCATTTGACCT
>MP681427.1 Sequence 82 from Patent WO2020109792
TTTATCCATTG
>MP681426.1 Sequence 81 from Patent WO2020109792
AGTAACTCCAC
>MP681425.1 Sequence 80 from Patent WO2020109792
TTTTGCTCCAT
>MP681424.1 Sequence 79 from Patent WO2020109792
TCATCTTTGCT
>MP681420.1 Sequence 75 from Patent WO2020109792
AGGCTTCCGTC
>MP681419.1 Sequence 74 from Patent WO2020109792
GCTTTTTTCAT
>MP681418.1 Sequence 73 from Patent WO2020109792
TTGATAGTCAT
>MP681413.1 Sequence 68 from Patent WO2020109792
AGAAAACCCAT
>MP681412.1 Sequence 67 from Patent WO2020109792
GCACGTTTCAT
>MP681411.1 Sequence 66 from Patent WO2020109792
CGTTTCATTAA
>MP681410.1 Sequence 65 from Patent WO2020109792
TTATCTACCAT
>MP681408.1 Sequence 63 from Patent WO2020109792
TTGCCATTAGC
>MP681407.1 Sequence 62 from Patent WO2020109792
CATACCTTGTT
>MP681406.1 Sequence 61 from Patent WO2020109792
CATTGCTTGTG
>MP681405.1 Sequence 60 from Patent WO2020109792
CACAGGAATTC
>MP681403.1 Sequence 58 from Patent WO2020109792
ATATCGCTCAC
>MP681402.1 Sequence 57 from Patent WO2020109792
CTTCGATAGTG
>MP681399.1 Sequence 54 from Patent WO2020109792
TGCTCATACTC
>MP681398.1 Sequence 53 from Patent WO2020109792
CTCATACCTTG
>MP681397.1 Sequence 52 from Patent WO2020109792
AGTTCAGCGAC
>MP681396.1 Sequence 51 from Patent WO2020109792
ACACGTTGTTC
>MP681395.1 Sequence 50 from Patent WO2020109792
CCTCCGAGGGA
>MP681394.1 Sequence 49 from Patent WO2020109792
TTTACAAGTGC
>MP681393.1 Sequence 48 from Patent WO2020109792
ATGTTGTCCAT
>MP681392.1 Sequence 47 from Patent WO2020109792
TGTTGTCCATT
>MP681391.1 Sequence 46 from Patent WO2020109792
GTTGTCCATTA
>MP681390.1 Sequence 45 from Patent WO2020109792
TTGTCCATTAC
>MP681389.1 Sequence 44 from Patent WO2020109792
TGTCCATTACC
>MP681388.1 Sequence 43 from Patent WO2020109792
TCCATTACCCC
>MP681387.1 Sequence 42 from Patent WO2020109792
CCATTACCCCT
>MP681386.1 Sequence 41 from Patent WO2020109792
CATTACCCCTC
>MP681385.1 Sequence 40 from Patent WO2020109792
GTCCATTACCC
>MP681384.1 Sequence 39 from Patent WO2020109792
TTCGGTCATGT
>MP681383.1 Sequence 38 from Patent WO2020109792
TTACTCCTGAA
>MP681382.1 Sequence 37 from Patent WO2020109792
AGGCCATAGCG
>MP681381.1 Sequence 36 from Patent WO2020109792
AAAGCTCCTCT
>MP681380.1 Sequence 35 from Patent WO2020109792
TAGGCATCGAC
>MP681379.1 Sequence 34 from Patent WO2020109792
TTAAAATCCAT
>MP681378.1 Sequence 33 from Patent WO2020109792
CATTACCCAAG
>MP681377.1 Sequence 32 from Patent WO2020109792
TTGCCAACATG
>MP681376.1 Sequence 31 from Patent WO2020109792
TTTCCTGTCAA
>MP681375.1 Sequence 30 from Patent WO2020109792
TCATGGCAAAG
>MP681373.1 Sequence 28 from Patent WO2020109792
GGATGCATGAG
>MP681372.1 Sequence 27 from Patent WO2020109792
ATGCATGAGCC
>MP681371.1 Sequence 26 from Patent WO2020109792
CTTTCGTTCGC
>MP681370.1 Sequence 25 from Patent WO2020109792
GCCCGAGATCC
>MP681369.1 Sequence 24 from Patent WO2020109792
CGTGTGGCAAC
>MP681368.1 Sequence 23 from Patent WO2020109792
CGTGAACGAAG
>MP681367.1 Sequence 22 from Patent WO2020109792
CATGGATGTCC
>MP681366.1 Sequence 21 from Patent WO2020109792
TCGGATCTGTG
>MP681365.1 Sequence 20 from Patent WO2020109792
AAGGTCTGCAT
>MP681364.1 Sequence 19 from Patent WO2020109792
AACGATATTCC
>MP681363.1 Sequence 18 from Patent WO2020109792
GATACAGTGAC
>MP681362.1 Sequence 17 from Patent WO2020109792
TTTGCATTCCT
>MP681361.1 Sequence 16 from Patent WO2020109792
ATTCCTTGTGG
>MP681360.1 Sequence 15 from Patent WO2020109792
TTCATTTGCAT
>MP681359.1 Sequence 14 from Patent WO2020109792
TATGTTCGTGA
>MP681358.1 Sequence 13 from Patent WO2020109792
TAGGCATGTCT
>MP681357.1 Sequence 12 from Patent WO2020109792
AGGCATGTCTT
>MP681356.1 Sequence 11 from Patent WO2020109792
GTCTTAACGGC
>MP681355.1 Sequence 10 from Patent WO2020109792
TGTTCATATGT
>MP681354.1 Sequence 9 from Patent WO2020109792
ACCCCTCTGTT
>MP681353.1 Sequence 8 from Patent WO2020109792
GTTCATATGTA
>MP681352.1 Sequence 7 from Patent WO2020109792
ATGTAAACCTC
>MP681351.1 Sequence 6 from Patent WO2020109792
CATGGATATCC
>MP681350.1 Sequence 5 from Patent WO2020109792
ATACTGTCCAA
>MP681349.1 Sequence 4 from Patent WO2020109792
GGCAATTCCAT
>MP681348.1 Sequence 3 from Patent WO2020109792
CCATCAAGTTT
>MP681347.1 Sequence 2 from Patent WO2020109792
TCCTTTTATTC
>MP681346.1 Sequence 1 from Patent WO2020109792
TCAAGTTTTCC
>MP681033.1 Sequence 54 from Patent WO2020109619
CGCCGTGACCC
>MP681032.1 Sequence 53 from Patent WO2020109619
TCGACTAGGTA
>MP681031.1 Sequence 52 from Patent WO2020109619
AGGAATAGCAA
>MP681030.1 Sequence 51 from Patent WO2020109619
TGCGCTCATTG
>MP680431.1 Sequence 56 from Patent EP3661553
CCGCCRCCAGG
>MP785953.1 Sequence 3 from Patent WO2020187889
TAAATATTTTA
>MP784360.1 Sequence 9 from Patent EP3717645
TTGCCACAGTA
>MP784359.1 Sequence 8 from Patent EP3717645
TTGCCACAGTA
>MP784358.1 Sequence 7 from Patent EP3717645
AACGGTGTCAT
>MP889260.1 Sequence 8 from Patent EP3760037
AGTGTAACAGC
>MP889258.1 Sequence 6 from Patent EP3760037
AGGGTAACAGC
>MP669535.1 Sequence 54 from Patent EP3660164
CGCCGTGACCC
>MP669534.1 Sequence 53 from Patent EP3660164
TCGACTAGGTA
>MP669533.1 Sequence 52 from Patent EP3660164
AGGAATAGCAA
>MP669532.1 Sequence 51 from Patent EP3660164
TGCGCTCATTG
>MP777933.1 Sequence 122 from Patent EP3713601
GGGATCCTACC
>MP667508.1 Sequence 116 from Patent EP3660154
CGCCGCCATTT
>MP667507.1 Sequence 115 from Patent EP3660154
TCTGTTAGCCA
>MP882902.1 Sequence 18 from Patent WO2020243644
CCGACATACCG
>MP664213.1 Sequence 22 from Patent WO2020099451
GAGTTAAAACT
>MP759363.1 Sequence 2 from Patent EP3712160
TTCTTCTTCTT
>MP662642.1 Sequence 92 from Patent WO2020104782
TGTGACCTTTG
>MP662632.1 Sequence 82 from Patent WO2020104782
AGCAAATATTT
>MP662631.1 Sequence 81 from Patent WO2020104782
GTTATTTACAA
>MP662626.1 Sequence 76 from Patent WO2020104782
TGTTTGCCCAT
>MP662624.1 Sequence 74 from Patent WO2020104782
GGTTGCTTAAT
>MP662597.1 Sequence 47 from Patent WO2020104782
GTGGCCCTTGG
>MP662593.1 Sequence 43 from Patent WO2020104782
CTAATACTCTG
>MP662592.1 Sequence 42 from Patent WO2020104782
GTTCAAACATG
>MP662587.1 Sequence 37 from Patent WO2020104782
TGTAAACAATA
>MP662584.1 Sequence 34 from Patent WO2020104782
CTTTCACTTTC
>MP878734.1 Sequence 5 from Patent WO2020243411
GTGACTCAGCA
>MP661362.1 Sequence 75 from Patent WO2020104783
GTGGCCCTTGG
>MP661336.1 Sequence 49 from Patent WO2020104783
AGCAAATATTT
>MP660975.1 Sequence 13 from Patent WO2020098981
TCTATGCATCA
>MP660964.1 Sequence 2 from Patent WO2020098981
TCTATGCATCA
>MP875545.1 Sequence 6 from Patent WO2020250502
TGGCGTCGGTC
>MP756794.1 Sequence 232 from Patent EP3704239
TTTTTTTTTTT
>MP865425.1 Sequence 82 from Patent WO2020163655
AGCNNNNNCAT
>MP865424.1 Sequence 81 from Patent WO2020163655
AGCNNNNNGAT
>MP865414.1 Sequence 71 from Patent WO2020163655
TCCNNNNNCTA
>MP865410.1 Sequence 67 from Patent WO2020163655
CAGNNNNNTTG
>MP865350.1 Sequence 7 from Patent WO2020163655
ATCNNNNNCCT
>MP865347.1 Sequence 4 from Patent WO2020163655
AGGNNNNNGAT
>MP750681.1 Sequence 20 from Patent EP3682903
CTAACCCTAAC
>MP750674.1 Sequence 13 from Patent EP3682903
GTTAGGGTTAG
>MP750667.1 Sequence 6 from Patent EP3682903
GTGGAAGGCGG
>MP644589.1 Sequence 61 from Patent EP3650096
ACACTATGTCR
>MP858471.1 Sequence 161 from Patent EP3752614
GACTTAGATGA
>MP643786.1 Sequence 17 from Patent EP3650548
AGCCACCATGG
>MP748410.1 Sequence 121 from Patent EP3688167
AATGTGAGACC
>MP748409.1 Sequence 120 from Patent EP3688167
GGTCTCGGGAG
>MP744942.1 Sequence 231 from Patent EP3690045
AAAGAGTTTGC
>MP744940.1 Sequence 229 from Patent EP3690045
AAATTTCTACT
>MP950707.1 Sequence 2 from Patent WO2021045830
AGTAGCGTCGA
>MP950243.1 Sequence 193 from Patent WO2021044378
CAGTGGGTAAG
>MP950211.1 Sequence 161 from Patent WO2021044378
CACACGACTTC
>MP948975.1 Sequence 52 from Patent WO2021044061
TACAAAAAGCA
>MP948972.1 Sequence 49 from Patent WO2021044061
TACAAAAGCAG
>MP948374.1 Sequence 345 from Patent EP3755801
TACAGATTATC
>MP948342.1 Sequence 313 from Patent EP3755801
CTAATACCAAA
>MP948228.1 Sequence 199 from Patent EP3755801
TTTCAATCCGG
>MP948165.1 Sequence 136 from Patent EP3755801
ATTTGAACGTT
>MP948108.1 Sequence 79 from Patent EP3755801
GTCGTGAATTA
>MP948070.1 Sequence 41 from Patent EP3755801
TTATCGTTCTA
>MP841663.1 Sequence 9 from Patent EP3740577
GGATTTCCGCC
>MP841662.1 Sequence 8 from Patent EP3740577
GGATTTCCACC
>MP841661.1 Sequence 7 from Patent EP3740577
GGATTTCCRCC
>MP841660.1 Sequence 6 from Patent EP3740577
GGAWWTSCNCC
>MP841659.1 Sequence 5 from Patent EP3740577
GGANNTNCNCC
>MP841658.1 Sequence 4 from Patent EP3740577
GGANNNNNNCC
>MP841656.1 Sequence 2 from Patent EP3740577
SSWWWWSSRSS
>MP841655.1 Sequence 1 from Patent EP3740577
RRRNNYYYRYY
>MP841578.1 Sequence 86 from Patent EP3746090
GGGATCCTACC
>MP733840.1 Sequence 36 from Patent EP3689331
GTTAGGGTTAG
>pdb|7L35|B Chain B, Human DNA Ligase 1 - R771W nicked DNA complex
GCTGATGCGTC
>pdb|7L34|B Chain B, Human DNA Ligase 1 - R641L nicked DNA complex
GCTGATGCGTC
>pdb|6YMG|F Chain F, VcaM4I restriction endonuclease in complex with 5mC-modified dsDNA
TCAGCGCATGG
>pdb|6YMG|E Chain E, VcaM4I restriction endonuclease in complex with 5mC-modified dsDNA
CCATGNGCTGA
>pdb|6YMG|D Chain D, VcaM4I restriction endonuclease in complex with 5mC-modified dsDNA
TCAGCGCATGG
>pdb|6YMG|C Chain C, VcaM4I restriction endonuclease in complex with 5mC-modified dsDNA
CCATGNGCTGA
>pdb|6LBW|B Chain B, Crystal structure of Ag-mediated base pairs in uncanonical DNA duplex
CGNGANTCGCG
>pdb|6LBW|A Chain A, Crystal structure of Ag-mediated base pairs in uncanonical DNA duplex
CGNGANTCGCG
>pdb|4V6M|AX Chain AX, Structure of the ribosome-SecYE complex in the membrane environment
NCGCCCCTGAA
>pdb|4V6I|CC Chain CC, Localization of the small subunit ribosomal proteins into a 6.1 A cryo-EM map of Saccharomyces cerevisiae translating 80S ribosome
NAAAGACTTCA
>pdb|4V69|AX Chain AX, Ternary complex-bound E.coli 70S ribosome.
AAAAATGTTCA
>pdb|4V5N|AX Chain AX, tRNA translocation on the 70S ribosome: the post- translocational translocation intermediate TI(POST)
TAAAAATGTTC
>pdb|4V5M|AX Chain AX, tRNA tranlocation on the 70S ribosome: the pre-translocational translocation intermediate TI(PRE)
TAAAAATGTTC
>pdb|4V5H|AX Chain AX, E.Coli 70s Ribosome Stalled During Translation Of Tnac Leader Peptide.
NAAACCCAGTA
>pdb|4V5D|CX Chain CX, Structure of the Thermus thermophilus 70S ribosome in complex with mRNA, paromomycin, acylated A- and P-site tRNAs, and E-site tRNA.
AAAATTCTTCA
>pdb|4V5D|AX Chain AX, Structure of the Thermus thermophilus 70S ribosome in complex with mRNA, paromomycin, acylated A- and P-site tRNAs, and E-site tRNA.
AAAATTCTTCA
>pdb|4V3P|S3 Chain S3, The molecular structure of the left-handed supra-molecular helix of eukaryotic polyribosomes
NAAAGACTTCA
>OG160746.1 JP 2020529391-A/9: Virus Like Particle
GAAAAAAGGAG
>OG160344.1 WO 2020204130-A/1: Method of capping RNA, method of producing modified RNA, and modified RNA
GGGCGAATTAA
>OG159376.1 WO 2020204151-A/36: Aptamer for FGF9 and use thereof
CAAGGHTGCCG
>OG148718.1 JP 2019510518-A/2: Modifying Bacteriophage
GGTCTCAAATG
>OG148717.1 JP 2019510518-A/1: Modifying Bacteriophage
CTCGTGAGACC
>OG148665.1 JP 2019510511-A/109: NOVEL pRNA THREE-WAY JUNCTIONS
WWWWWWWWNWW
>OG148662.1 JP 2019510511-A/106: NOVEL pRNA THREE-WAY JUNCTIONS
WWWWWNCCCCC
>OG148659.1 JP 2019510511-A/103: NOVEL pRNA THREE-WAY JUNCTIONS
CCCCCNCCCCC
>OG148657.1 JP 2019510511-A/101: NOVEL pRNA THREE-WAY JUNCTIONS
GCAATACTATA
>OG148656.1 JP 2019510511-A/100: NOVEL pRNA THREE-WAY JUNCTIONS
TGACAGGTTGT
>OG148654.1 JP 2019510511-A/98: NOVEL pRNA THREE-WAY JUNCTIONS
CAGCAGGGAGC
>OG148653.1 JP 2019510511-A/97: NOVEL pRNA THREE-WAY JUNCTIONS
ATGTATGTGTG
>OG148620.1 JP 2019510511-A/64: NOVEL pRNA THREE-WAY JUNCTIONS
CCCTCTTACTA
>OG148619.1 JP 2019510511-A/63: NOVEL pRNA THREE-WAY JUNCTIONS
ATGTCACGGGG
>OG148595.1 JP 2019510511-A/39: NOVEL pRNA THREE-WAY JUNCTIONS
CATACTGTTGA
>OG148593.1 JP 2019510511-A/37: NOVEL pRNA THREE-WAY JUNCTIONS
GTCAATCATGG
>OG148592.1 JP 2019510511-A/36: NOVEL pRNA THREE-WAY JUNCTIONS
GTCAATCATGG
>OG148446.1 JP 2019508065-A/26: Enhanced Production of Immunoglobulins
GTGCCTGTGCA
>OG147769.1 JP 2019500431-A/176: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
ATCACGGAGTG
>OG147759.1 JP 2019500431-A/166: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
GTGCATGGAAT
>OG147725.1 JP 2019500431-A/132: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
CAGTACGACGG
>OG147715.1 JP 2019500431-A/122: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
CAGAGGCAGCA
>OG147678.1 JP 2019500431-A/85: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
CGGACTTGCCT
>OG147668.1 JP 2019500431-A/75: NUCLEIC ACID OLIGOMERS AND USES THEREFOR
CCAGTGAGCCG
>OG143867.1 JP 2019511471-A/79: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TAGCATACTTA
>OG143866.1 JP 2019511471-A/78: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TGGCCATCAAT
>OG143865.1 JP 2019511471-A/77: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
ACCAAAAGAAT
>OG143857.1 JP 2019511471-A/69: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TAGCATACTTA
>OG143856.1 JP 2019511471-A/68: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TGGCCATCAAT
>OG143855.1 JP 2019511471-A/67: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
ACCAAAAGAAT
>OG143843.1 JP 2019511471-A/55: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TAGCATACTTA
>OG143842.1 JP 2019511471-A/54: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TGGCCATCAAT
>OG143841.1 JP 2019511471-A/53: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
ACCAAAAGAAT
>OG143835.1 JP 2019511471-A/47: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TAGCATACTTA
>OG143834.1 JP 2019511471-A/46: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
TGGCCATCAAT
>OG143833.1 JP 2019511471-A/45: Pan-Genotypic Agents Against Influenza Virus and Methods of Using the Same
ACCAAAAGAAT
>OG142929.1 JP 2019500902-A/20: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
AGNAACNCCAC
>OG142928.1 JP 2019500902-A/19: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NCANCNNNGCN
>OG142927.1 JP 2019500902-A/18: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GGCNGCNGGCA
>OG142926.1 JP 2019500902-A/17: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NNGCGCNCGNN
>OG142925.1 JP 2019500902-A/16: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
CCANGCAGCAC
>OG142924.1 JP 2019500902-A/15: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GCCNGNNANCC
>OG142923.1 JP 2019500902-A/14: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
AGNGCNCNACC
>OG142922.1 JP 2019500902-A/13: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NNNGANCANCG
>OG142921.1 JP 2019500902-A/12: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NNCCNGCCANA
>OG142920.1 JP 2019500902-A/11: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
CGCNCANCNAA
>OG142919.1 JP 2019500902-A/10: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GNNCAAACANA
>OG142918.1 JP 2019500902-A/9: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
AGNNNCNCNCC
>OG142917.1 JP 2019500902-A/8: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NGGNNCNGCAN
>OG142916.1 JP 2019500902-A/7: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GACANGNCNAN
>OG142915.1 JP 2019500902-A/6: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GNCNANNCNCC
>OG142914.1 JP 2019500902-A/5: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
GCANNNGACCN
>OG142913.1 JP 2019500902-A/4: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NNNANCCANNG
>OG142912.1 JP 2019500902-A/3: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
CGNNNCANNAA
>OG142911.1 JP 2019500902-A/2: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
NGCNCANACNC
>OG142910.1 JP 2019500902-A/1: ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
CNCANACCNNG
>OG156490.1 WO 2020171070-A/17: AN RNA APTAMER THAT SPECIFICALLY BINDS HISTAMINE
ACTGGATCGTA
>OG156204.1 WO 2020171192-A/10: Nucleic acid for genome editing of plant cell and the use thereof
TTTCATCTCTA
>OG156203.1 WO 2020171192-A/9: Nucleic acid for genome editing of plant cell and the use thereof
TTTCATCCCTG
>OG156202.1 WO 2020171192-A/8: Nucleic acid for genome editing of plant cell and the use thereof
TTTCATCCCTA
>OG156201.1 WO 2020171192-A/7: Nucleic acid for genome editing of plant cell and the use thereof
TTTCATCTGAG
>OG156200.1 WO 2020171192-A/6: Nucleic acid for genome editing of plant cell and the use thereof
TTTCATCCCTA
>OG156199.1 WO 2020171192-A/5: Nucleic acid for genome editing of plant cell and the use thereof
GAGCTATGAAA
>OG156198.1 WO 2020171192-A/4: Nucleic acid for genome editing of plant cell and the use thereof
TAGAGATGAAA
>OG156197.1 WO 2020171192-A/3: Nucleic acid for genome editing of plant cell and the use thereof
GAGGGATGAAA
>OG156196.1 WO 2020171192-A/2: Nucleic acid for genome editing of plant cell and the use thereof
TAGGGATGAAA
>OG156195.1 WO 2020171192-A/1: Nucleic acid for genome editing of plant cell and the use thereof
CAGGGATGAAA
>OG156151.1 WO 2020171092-A/78: Method of producing complementary modified oligonucleotide
GGAAGCTTTGG
>OG156133.1 WO 2020171092-A/60: Method of producing complementary modified oligonucleotide
CACACGTGGGC
>OG156132.1 WO 2020171092-A/59: Method of producing complementary modified oligonucleotide
GCCCACGTGTG
>OG156123.1 WO 2020171092-A/50: Method of producing complementary modified oligonucleotide
GGGGGTGCCAG
>OG156120.1 WO 2020171092-A/47: Method of producing complementary modified oligonucleotide
GCTAACCGGGG
>OG156107.1 WO 2020171092-A/34: Method of producing complementary modified oligonucleotide
GTAACCAAGAG
>OG156093.1 WO 2020171092-A/20: Method of producing complementary modified oligonucleotide
ATGCTTTGTCA
>OG156087.1 WO 2020171092-A/14: Method of producing complementary modified oligonucleotide
AACACTGTTTT
>OG156084.1 WO 2020171092-A/11: Method of producing complementary modified oligonucleotide
TTATAGAGCAA
>OG156079.1 WO 2020171092-A/6: Method of producing complementary modified oligonucleotide
AACAGTGTTCT
>OG156078.1 WO 2020171092-A/5: Method of producing complementary modified oligonucleotide
TTGCTCTATAA
>OG151879.1 JP 2019510515-A/1: ISOTHERMAL AMPLIFICATION COMPONENTS AND PROCESSES
GGCTTATGGAG
>MX176376.1 Sequence 1 from patent US 10878938
TTGGATATGGG
>MX175133.1 Sequence 2 from patent US 10876149
AAAAAAAAAAA
>MX175132.1 Sequence 1 from patent US 10876149
TTTTTTTTTTT
>MX173795.1 Sequence 104 from patent US 10876128
GTCTAATTATT
>MX164673.1 Sequence 3 from patent US 10876106
CCATCTCATCC
>MX164666.1 Sequence 2 from patent US 10876104
GGGATCCTACC
>MX135831.1 Sequence 3 from patent US 10858702
TTTTTTTTTTT
>MX135830.1 Sequence 2 from patent US 10858702
AAAAAAAAAAA
>MX108649.1 Sequence 26 from patent US 10851411
TTATACATCTA
>MX108646.1 Sequence 23 from patent US 10851411
TTATAGTGATT
>MX108644.1 Sequence 21 from patent US 10851411
TTTTGATGATA
>MX108642.1 Sequence 19 from patent US 10851411
TTATAGAGAAG
>MX108640.1 Sequence 17 from patent US 10851411
TTTAATAAGGT
>MX108638.1 Sequence 15 from patent US 10851411
TTATAATGGAT
>MX108636.1 Sequence 13 from patent US 10851411
TTAATTAGGAT
>MX108634.1 Sequence 11 from patent US 10851411
TTAATTGAGTA
>MX108632.1 Sequence 9 from patent US 10851411
TTTTAGGTAAA
>MX108630.1 Sequence 7 from patent US 10851411
TTATGAATCTA
>MX108628.1 Sequence 5 from patent US 10851411
TTTCTTCATTA
>MX108626.1 Sequence 3 from patent US 10851411
TTATCTACATA
>MX108624.1 Sequence 1 from patent US 10851411
TTATACATCTA
>MX108562.1 Sequence 20 from patent US 10851405
CCGTCCGTCCC
>MX108561.1 Sequence 19 from patent US 10851405
CCGTCCGTCCC
>MX108560.1 Sequence 18 from patent US 10851405
CCCTGCCTGCC
>MX106453.1 Sequence 146 from patent US 10851373
ACAGTTTGCCG
>MX106451.1 Sequence 144 from patent US 10851373
CCTGGAGTTCC
>MX104347.1 Sequence 14 from patent US 10851101
ATAATTCCCCC
>MX156082.1 Sequence 86 from patent US 10870889
CTAACTGGGGA
>MX155478.1 Sequence 2 from patent US 10870881
GNTNCNANCGT
>MX154949.1 Sequence 2 from patent US 10870872
ATACGACTAGC
>MX147977.1 Sequence 4 from patent US 10870099
TCGTTCGCAAT
>MX147976.1 Sequence 3 from patent US 10870099
TTAACTCGCGA
>MX147975.1 Sequence 2 from patent US 10870099
ATTGCGAACGA
>MX147974.1 Sequence 1 from patent US 10870099
TCGCGAGTTAA
>MX139576.1 Sequence 366 from patent US 10869935
GGGTTTTTGGG
>MX139566.1 Sequence 355 from patent US 10869935
GGTTTTTTTGG
>MX137164.1 Sequence 461 from patent US 10869897
GRTVDGTVVSD
>MX137017.1 Sequence 4 from patent US 10869880
AGGAAAGGGGA
>MX111525.1 Sequence 36 from patent US 10857237
GCGGTTTGCGG
>MX111511.1 Sequence 20 from patent US 10857237
GGTGGTGGTGG
>MX103207.1 Sequence 103207 from patent US 10837052
ATTATGGGAGA
>MV998346.1 Sequence 11 from patent US 10867693
TTGGATATGGG
>MV994116.1 Sequence 95 from patent US 10865445
TACTCCTATGA
>MV994114.1 Sequence 93 from patent US 10865445
TAATCCAATCA
>MV994113.1 Sequence 92 from patent US 10865445
TAATTGAATCA
>MV994112.1 Sequence 91 from patent US 10865445
TACTTTTATGA
>MV994111.1 Sequence 90 from patent US 10865445
TAATTTAATCA
>MV994110.1 Sequence 89 from patent US 10865445
TAAYBBAATCA
>MV993786.1 Sequence 6 from patent US 10865434
CTAATCGGATC
>MV993785.1 Sequence 5 from patent US 10865434
GTCAGTCAATG
>MV993784.1 Sequence 4 from patent US 10865434
ACGTAGGGTCA
>MV993783.1 Sequence 3 from patent US 10865434
TAGCCTAGTAA
>MV993782.1 Sequence 2 from patent US 10865434
ACTGTCAGTAG
>MV990136.1 Sequence 31 from patent US 10865409
CGAGTCACGTC
>MV990135.1 Sequence 29 from patent US 10865409
CGAGTCACGTC
>MV990094.1 Sequence 153 from patent US 10865407
GGTCTCGCCTC
>MV990093.1 Sequence 152 from patent US 10865407
GTGCGGAGACC
>MV990092.1 Sequence 151 from patent US 10865407
CCTCGGAGACC
>MV990091.1 Sequence 150 from patent US 10865407
GGTCTCGTAAA
>MV990090.1 Sequence 149 from patent US 10865407
TAAAGGAGACC
>MV990089.1 Sequence 148 from patent US 10865407
GGTCTCGAATG
>MV990088.1 Sequence 147 from patent US 10865407
AATGGGAGACC
>MV990087.1 Sequence 146 from patent US 10865407
GGTCTCGGTGC
>MV985866.1 Sequence 6 from patent US 10844441
GGACAGGTGTG
>MV985865.1 Sequence 5 from patent US 10844441
GGCCAGGTGTG
>MV985864.1 Sequence 4 from patent US 10844441
GGACAGGTGCG
>MV985390.1 Sequence 97 from patent US 10844403
GAAGCTGGAGG
>MV985389.1 Sequence 96 from patent US 10844403
GAAGCTGGAGG
>MV985370.1 Sequence 77 from patent US 10844403
TCAACCGGTGG
>MV973450.1 Sequence 39 from patent US 10837879
ATTGCGGTTCT
>MV958359.1 Sequence 43 from patent US 10837003
AGAGCTCTCTC
>MV956394.1 Sequence 103207 from patent US 10829811
ATTATGGGAGA
>MV853179.1 Sequence 10 from patent US 10832797
TTGGATATGGG
>MV848454.1 Sequence 101 from patent US 10829824
CAGTTGGAAAC
>MV848433.1 Sequence 80 from patent US 10829824
GTTTTTCGGTG
>MV843570.1 Sequence 3 from patent US 10829765
TTTCCCGTAAA
>MV838892.1 Sequence 581 from patent US 10829541
GCANNNNNTGC
>MV838889.1 Sequence 578 from patent US 10829541
CCTNNNNNAGG
>MV838885.1 Sequence 574 from patent US 10829541
CCANNNNNTGG
>MV838884.1 Sequence 573 from patent US 10829541
GACNNNNNGTC
>MV838883.1 Sequence 572 from patent US 10829541
GACNNNNNGTC
>MV838882.1 Sequence 571 from patent US 10829541
GGTCTCNNNNN
>MV838881.1 Sequence 570 from patent US 10829541
GCCNNNNNGGC
>MV838878.1 Sequence 567 from patent US 10829541
CGTCTCNNNNN
>MV838875.1 Sequence 564 from patent US 10829541
NNNNNGAAGAG
>MV838870.1 Sequence 559 from patent US 10829541
ACCTGCNNNNN
>MV838836.1 Sequence 520 from patent US 10829541
CCTNNNNNAGG
>MV838832.1 Sequence 516 from patent US 10829541
CGTCTCNNNNN
>MV838829.1 Sequence 513 from patent US 10829541
ACCTGCNNNNN
>MV838827.1 Sequence 511 from patent US 10829541
CCANNNNNTGG
>MV838825.1 Sequence 509 from patent US 10829541
GACNNNNNGTC
>MV838824.1 Sequence 508 from patent US 10829541
GACNNNNNGTC
>MV838823.1 Sequence 507 from patent US 10829541
GGTCTCNNNNN
>MV838822.1 Sequence 506 from patent US 10829541
GCCNNNNNGGC
>MV838817.1 Sequence 501 from patent US 10829541
GCANNNNNTGC
>MV838771.1 Sequence 447 from patent US 10829541
GCCNNNNNGGC
>MV838770.1 Sequence 446 from patent US 10829541
GGTCTCNNNNN
>MV838769.1 Sequence 445 from patent US 10829541
GACNNNNNGTC
>MV838765.1 Sequence 441 from patent US 10829541
CCANNNNNTGG
>MV838764.1 Sequence 440 from patent US 10829541
GCANNNNNTGC
>MV838757.1 Sequence 433 from patent US 10829541
GGTCTCNNNNN
>MV838753.1 Sequence 429 from patent US 10829541
CCANNNNNTGG
>MV838750.1 Sequence 426 from patent US 10829541
GCANNNNNTGC
>MV838749.1 Sequence 425 from patent US 10829541
GACNNNNNGTC
>MV838747.1 Sequence 423 from patent US 10829541
GCCNNNNNGGC
>MV838705.1 Sequence 381 from patent US 10829541
CCTCNNNNNNN
>MV838697.1 Sequence 373 from patent US 10829541
CCCGCNNNNNN
>MV838691.1 Sequence 367 from patent US 10829541
GCATCNNNNNN
>MV838689.1 Sequence 365 from patent US 10829541
ACTGGGNNNNN
>MV838673.1 Sequence 349 from patent US 10829541
ACCTGCNNNNN
>MV838672.1 Sequence 348 from patent US 10829541
GCNNNNNNNGC
>MV838671.1 Sequence 347 from patent US 10829541
GAGTCNNNNNN
>MV838670.1 Sequence 346 from patent US 10829541
NNNNNNGACTC
>MV838413.1 Sequence 88 from patent US 10829541
NNNNNNGAGAC
>MV838412.1 Sequence 87 from patent US 10829541
GAGTCNNNNNN
>MV838410.1 Sequence 85 from patent US 10829541
GCNNNNNNNGC
>MV838339.1 Sequence 14 from patent US 10829541
NNNNNNGAGAC
>MV838301.1 Sequence 70 from patent US 10829531
ACCACCACCAC
>MV838171.1 Sequence 1 from patent US 10829481
AAAGTAGGTCA
>MV837597.1 Sequence 117 from patent US 10827730
AGCCAGCGTGC
>MV837436.1 Sequence 3 from patent US 10822664
TCAAGTTTTCC
>MV836170.1 Sequence 16 from patent US 10822607
GGGTGGGTGGG
>MV833521.1 Sequence 13 from patent US 10822369
CATTTCGACTC
>MV833507.1 Sequence 5 from patent US 10822368
GGGATCCTACC
>MV832533.1 Sequence 5 from patent US 10818378
TAGCTAGTTAA
>MV832530.1 Sequence 2 from patent US 10818378
TAACTAGCTAA
>MV832306.1 Sequence 13 from patent US 10816543
TTTTTTTTTTT
>MV832305.1 Sequence 12 from patent US 10816543
AAAAAAAAAAA
>MV831520.1 Sequence 3 from patent US 10815525
TTTTTTTTTTT
>MV831519.1 Sequence 2 from patent US 10815525
AAAAAAAAAAA
>MV831029.1 Sequence 28 from patent US 10815497
TATTGACTTAG
>MV831028.1 Sequence 27 from patent US 10815497
TATTTGTGTAG
>MV825984.1 Sequence 84 from patent US 10815490
CTGAAGAAGAA
>MV825977.1 Sequence 40 from patent US 10815490
RGTGACNNNGC
>MV825771.1 Sequence 17 from patent US 10815486
GAACGATCGAA
>MV823824.1 Sequence 87 from patent US 10815476
TCGAGAATTTG
>MV818788.1 Sequence 10 from patent US 10813312
CKGAAGACTAC
>MV818787.1 Sequence 9 from patent US 10813312
GTTCTCRGTTT
>MV818786.1 Sequence 8 from patent US 10813312
GGTGTACTYAT
>MV818784.1 Sequence 6 from patent US 10813312
TAGCAGYGTCG
>OF010309.1 KR 1020200074248-A/31: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CGAGTCACGTC
>OF010307.1 KR 1020200074248-A/29: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CGAGTCACGTC
>OF007918.1 KR 1020200064164-A/53: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTAATAAGCT
>OF007917.1 KR 1020200064164-A/52: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
ATCTAATAAGC
>OF007910.1 KR 1020200064164-A/45: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTAATAAGCTA
>OF007904.1 KR 1020200064164-A/39: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
TCTGATAAGCT
>OF007903.1 KR 1020200064164-A/38: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
GTCTGATAAGC
>OF007888.1 KR 1020200064164-A/23: MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
CTGATAAGCTA
>OF005697.1 KR 1020200067871-A/8: METHODS, APPARATUS AND SYSTEMS FOR AMPLIFICATION-FREE DNA DATA STORAGE
CGTCNTNGCTT
>OF003963.1 KR 1020200047783-A/2452: PLASMA KALLIKREIN BINDING PROTEINS
GCCNNNNNGGC
>OF003956.1 KR 1020200047783-A/2445: PLASMA KALLIKREIN BINDING PROTEINS
GCANNNNNTGC
>OF003975.1 KR 1020200047783-A/2464: PLASMA KALLIKREIN BINDING PROTEINS
CCTNNNNNAGG
>OF003972.1 KR 1020200047783-A/2461: PLASMA KALLIKREIN BINDING PROTEINS
CGTCTCNNNNN
>OF003969.1 KR 1020200047783-A/2458: PLASMA KALLIKREIN BINDING PROTEINS
CCANNNNNTGG
>OF003967.1 KR 1020200047783-A/2456: PLASMA KALLIKREIN BINDING PROTEINS
GACNNNNNGTC
>OF003966.1 KR 1020200047783-A/2455: PLASMA KALLIKREIN BINDING PROTEINS
GACNNNNNGTC
>OF003965.1 KR 1020200047783-A/2454: PLASMA KALLIKREIN BINDING PROTEINS
NNNNNGAGACC
>OF003964.1 KR 1020200047783-A/2453: PLASMA KALLIKREIN BINDING PROTEINS
GGTCTCNNNNN
>OF002368.1 KR 1020200057071-A/10: METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
AAGGTAATGTA
>OF002382.1 KR 1020200057071-A/24: METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
ATACTTACCTG
>OF002377.1 KR 1020200057071-A/19: METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
GGAGTAAGTCT
>OF002376.1 KR 1020200057071-A/18: METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS
ATACTTACCTG
>OF001773.1 KR 1020200057759-A/69: A33 ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME IN RADIOIMMUNOTHERAPY
NNNNGAAGAGC
>OF001772.1 KR 1020200057759-A/68: A33 ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME IN RADIOIMMUNOTHERAPY
GCTCTTCNNNN
>pdb|6T7T|5 Chain 5, Structure of yeast 80S ribosome stalled on poly(A) tract.
NAAAAAAAAAA
>pdb|7KR4|B Chain B, Human DNA Ligase 1(E346A/E592A) Bound to a nicked DNA substrate control duplex
AATGTCTGCCC
>pdb|7K97|P Chain P, Human DNA polymerase beta dGDP product complex with Mn2+
GCTGATGCGCG
>pdb|7CSZ|C Chain C, Crystal structure of the N-terminal tandem RRM domains of RBM45 in complex with single-stranded DNA
CGACGGGACGC
>pdb|7CSZ|B Chain B, Crystal structure of the N-terminal tandem RRM domains of RBM45 in complex with single-stranded DNA
CGACGGGACGC
>pdb|6WMT|X Chain X, F. tularensis RNAPs70-(MglA-SspA)-ppGpp-PigR-iglA DNA complex
NCTGACGCGGC
>pdb|6WMT|J Chain J, F. tularensis RNAPs70-(MglA-SspA)-ppGpp-PigR-iglA DNA complex
NCCGCGTCAGA
>MD439386.1 JP 2019059774-A/65: Vaccination in newborns and infants
GGGTTTTTGGG
>MD439376.1 JP 2019059774-A/55: Vaccination in newborns and infants
GGTTTTTTTGG
>MD434663.1 JP 2019023247-A/3394: ANTIBODY LIBRARIES
CTAACTGGGGA
>MD729648.1 JP 2019053088-A/8: ALLERGEN DETECTION
GGTGGGGGTGG
>MD655905.1 JP 2019059769-A/32: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655904.1 JP 2019059769-A/31: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655903.1 JP 2019059769-A/30: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655902.1 JP 2019059769-A/29: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655901.1 JP 2019059769-A/28: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655900.1 JP 2019059769-A/27: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD655899.1 JP 2019059769-A/26: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
AATGCTGGCAG
>MD732242.1 JP 2019065054-A/5: Phosphorodiamidate Backbone Linkage for Oligonucleotides
CTAACCCTAAC
>MD732239.1 JP 2019065054-A/2: Phosphorodiamidate Backbone Linkage for Oligonucleotides
GTTAGGGTTAG
>pdb|5YZE|B Chain B, Crystal structure of the [Co2+-(chromomycin A3)2]-d(CCG)3 complex
TCCGCCGCCGA
>pdb|5YZE|A Chain A, Crystal structure of the [Co2+-(chromomycin A3)2]-d(CCG)3 complex
TCCGCCGCCGA
>pdb|6WMU|J Chain J, E. coli RNAPs70-SspA-gadA DNA complex
NCCGCGTCAGA
>pdb|6WMU|I Chain I, E. coli RNAPs70-SspA-gadA DNA complex
NCTGACGCGGC
>pdb|6WMR|J Chain J, F. tularensis RNAPs70-(MglA-SspA)-iglA DNA complex
NCCGCGTCAGA
>pdb|6WMR|X Chain X, F. tularensis RNAPs70-(MglA-SspA)-iglA DNA complex
NCTGACGCGGC
>pdb|6ZH8|B Chain B, Cryo-EM structure of DNA-PKcs:DNA
NGTTTTTAGTT
>pdb|4PGY|P Chain P, Structure of human DNA polymerase beta complexed with a nicked DNA containing a GT at N-1 position and GC at N position
GCTGATGCGTC
>pdb|7B0G|T Chain T, TgoT_6G12 binary with 2 hCTPs
NGCTGCCCTCC
>pdb|7B0G|P Chain P, TgoT_6G12 binary with 2 hCTPs
NGAGGGCAGNN
>pdb|6LU0|D Chain D, Crystal structure of Cas12i2 ternary complex with 12 nt spacer
GCCGCTTTCTT
>MD398460.1 WO 2020138047-A/8: TREATMENT OF SPINAL CONDITIONS WITH CHIMERA DECOY
TTCATGGGAAG
>MD398455.1 WO 2020138047-A/3: TREATMENT OF SPINAL CONDITIONS WITH CHIMERA DECOY
TTCCCAGGAAA
>MD395241.1 WO 2020111149-A/54: Solanaceae plant and solanaceae plant cells resistant to Begomovirus causing yellow leaf curling symptoms in tomato and method for producing such solanaceae plant
GAGCTAGTTGA
>MD395204.1 WO 2020111149-A/17: Solanaceae plant and solanaceae plant cells resistant to Begomovirus causing yellow leaf curling symptoms in tomato and method for producing such solanaceae plant
AGTGTAACAGC
>MD395202.1 WO 2020111149-A/15: Solanaceae plant and solanaceae plant cells resistant to Begomovirus causing yellow leaf curling symptoms in tomato and method for producing such solanaceae plant
AGGGTAACAGC
>MV751625.1 Sequence 3 from patent US 10793905
TTTTTTTTTTT
>MV751624.1 Sequence 2 from patent US 10793905
AAAAAAAAAAA
>MV751309.1 Sequence 6 from patent US 10793897
CTGGAACTATG
>MV751308.1 Sequence 5 from patent US 10793897
AGCTTGCAGGC
>MV751307.1 Sequence 4 from patent US 10793897
GCTGATCTGAA
>MV751306.1 Sequence 3 from patent US 10793897
GGAGCTCCTAC
>MV751305.1 Sequence 2 from patent US 10793897
CTGCTAGGAAT
>MV751304.1 Sequence 1 from patent US 10793897
AGCGTTAAGGG
>MV745220.1 Sequence 94 from patent US 10793857
GCCAGTCACAA
>MV742274.1 Sequence 1471 from patent US 10793842
TGGGCTGTCAA
>MV740883.1 Sequence 11 from patent US 10793829
AAACCAACGGT
>MV696384.1 Sequence 3488 from patent US 10774138
TCCCCAGTTAG
>MV695639.1 Sequence 1899 from patent US 10774138
GCCNNNNNGGC
>MV694514.1 Sequence 272 from patent US 10774138
CTAACTGGGGA
>MV670645.1 Sequence 19 from patent US 10770183
GGCGAGCAAAA
>MV670638.1 Sequence 5 from patent US 10770183
GCAGGAGGGGA
>MV668518.1 Sequence 140 from patent US 10767194
GCCCCTTCTTC
>MV643298.1 Sequence 2 from patent US 10766852
GGGATCCTACC
>MV642941.1 Sequence 108 from patent US 10765704
ACGCCGTCATT
>MV641599.1 Sequence 22 from patent US 10760118
TAGGTCGTCAT
>MV620741.1 Sequence 16 from patent US 10752905
CCATGGAGACG
>MV813297.1 Sequence 197 from patent US 10808254
TAAKNNNNGTC
>MV813280.1 Sequence 180 from patent US 10808254
ACANNNNNGTG
>MV813278.1 Sequence 178 from patent US 10808254
GAYNNNNNRTC
>MV813267.1 Sequence 167 from patent US 10808254
GAGNNNNRTAA
>MV813265.1 Sequence 165 from patent US 10808254
CAGNNNNNGAT
>MV813262.1 Sequence 162 from patent US 10808254
AAGNNNNNCTT
>MV813259.1 Sequence 159 from patent US 10808254
CCANNNNNNTC
>MV813255.1 Sequence 155 from patent US 10808254
GACNNNNNGGT
>MV813254.1 Sequence 154 from patent US 10808254
GATGNNNNTGT
>MV813244.1 Sequence 144 from patent US 10808254
CCCNNNNNCTC
>MV813241.1 Sequence 141 from patent US 10808254
ATTCNNNNCTG
>MV813214.1 Sequence 114 from patent US 10808254
CACNNNNNTAC
>MV813213.1 Sequence 113 from patent US 10808254
GAGNNNNNRTG
>MV813212.1 Sequence 112 from patent US 10808254
GATGNNNNTGT
>MV813204.1 Sequence 104 from patent US 10808254
GATNNNNRTAC
>MV813200.1 Sequence 100 from patent US 10808254
AGGNNNNNGAT
>MV813183.1 Sequence 83 from patent US 10808254
GACNNNNNTGA
>MV813181.1 Sequence 81 from patent US 10808254
GAGNNNNNTAC
>MV813179.1 Sequence 71 from patent US 10808254
CCTNNNNNAGG
>MV813163.1 Sequence 18 from patent US 10808254
GAGNNNNNTCC
>MV813149.1 Sequence 4 from patent US 10808254
AACNNNNCTTT
>MV813148.1 Sequence 3 from patent US 10808254
CACNNNNGTAY
>MV808957.1 Sequence 110 from patent US 10808015
GCGAAAACTTC
>MV808955.1 Sequence 108 from patent US 10808015
GAAATATTATA
>MV808954.1 Sequence 107 from patent US 10808015
GAAGTTTTCGC
>MV808952.1 Sequence 105 from patent US 10808015
TATAATATTTC
>MV808951.1 Sequence 104 from patent US 10808015
GCGAAAATTTC
>MV808949.1 Sequence 102 from patent US 10808015
GCGAAATTTTC
>MV808948.1 Sequence 101 from patent US 10808015
GAAATATTATC
>MV808947.1 Sequence 100 from patent US 10808015
GAAATTTTCGC
>MV808945.1 Sequence 98 from patent US 10808015
GAAAATTTCGC
>MV808944.1 Sequence 97 from patent US 10808015
GATAATATTTC
>MV808770.1 Sequence 1 from patent US 10807980
AAAGTAGGTCA
>MV802527.1 Sequence 13 from patent US 10801024
GTAACTCTGGG
>MV802522.1 Sequence 8 from patent US 10801024
CCCAGAGTTAC
>MV802517.1 Sequence 3 from patent US 10801024
CCCAGAGTTAC
>MV798709.1 Sequence 58 from patent US 10799577
TGGAGAAAGGT
>MV736008.1 Sequence 6 from patent US 10788452
CTAATCGGATC
>MV736007.1 Sequence 5 from patent US 10788452
GTCAGTCAATG
>MV736006.1 Sequence 4 from patent US 10788452
ACGTAGGGTCA
>MV736005.1 Sequence 3 from patent US 10788452
TAGCCTAGTAA
>MV736004.1 Sequence 2 from patent US 10788452
ACTGTCAGTAG
>MV735346.1 Sequence 55 from patent US 10787712
TTTTAATAGCT
>MV735345.1 Sequence 54 from patent US 10787712
TTTTAATAGCT
>MV735039.1 Sequence 4 from patent US 10787708
ATGTGTGTGTG
>MV734943.1 Sequence 1 from patent US 10787705
CGATCGATCGA
>MV734906.1 Sequence 5 from patent US 10787703
NNNNGACNNNN
>MV734905.1 Sequence 4 from patent US 10787703
NNNNCGTNNNN
>MV734883.1 Sequence 6 from patent US 10787699
CTGGAACTATG
>MV734882.1 Sequence 5 from patent US 10787699
AGCTTGCAGGC
>MV734881.1 Sequence 4 from patent US 10787699
GCTGATCTGAA
>MV734880.1 Sequence 3 from patent US 10787699
GGAGCTCCTAC
>MV734879.1 Sequence 2 from patent US 10787699
CTGCTAGGAAT
>MV734878.1 Sequence 1 from patent US 10787699
AGCGTTAAGGG
>MV728842.1 Sequence 77 from patent US 10787654
TCAAGCAAAGC
>MV722155.1 Sequence 2 from patent US 10786455
GGGATCCTACC
>MV722039.1 Sequence 23 from patent US 10782299
GAGGTGGCAGT
>MV722038.1 Sequence 22 from patent US 10782299
GAGGTTGCAGT
>MV722034.1 Sequence 14 from patent US 10782299
GACTGTGCATG
>MV720926.1 Sequence 1 from patent US 10781477
ATCTGACTACA
>MV719029.1 Sequence 2 from patent US 10781441
GGTCTCAAATG
>MV719028.1 Sequence 1 from patent US 10781441
CTCGTGAGACC
>MV714761.1 Sequence 55 from patent US 10774382
TATAGCGGGGG
>MV714638.1 Sequence 5 from patent US 10774379
CTGGAACTATG
>MV714637.1 Sequence 4 from patent US 10774379
AGCTTGCAGGC
>MV714636.1 Sequence 3 from patent US 10774379
GGAGCTCCTAC
>MV714635.1 Sequence 2 from patent US 10774379
CTGCTAGGAAT
>MV714634.1 Sequence 1 from patent US 10774379
AGCGTTAAGGG
>MV712851.1 Sequence 457 from patent US 10774364
GCTCGAGCGGA
>MV621186.1 Sequence 345 from patent US 10752907
GTTCGGATAAA
>MV621176.1 Sequence 335 from patent US 10752907
GTCCGGATAAG
>MV621163.1 Sequence 322 from patent US 10752907
TAGCGGAGATT
>MV621138.1 Sequence 295 from patent US 10752907
TTGATTGTTAA
>MV621129.1 Sequence 285 from patent US 10752907
TGTATTGTTAG
>MV621121.1 Sequence 277 from patent US 10752907
GCTCAGTTGTC
>MV620806.1 Sequence 81 from patent US 10752905
GGTCTCCTGTT
>MV620805.1 Sequence 80 from patent US 10752905
AACAGGAGACC
>MV620804.1 Sequence 79 from patent US 10752905
GGTCTCGCCAG
>MV620803.1 Sequence 78 from patent US 10752905
CTGGCGAGACC
>MV620802.1 Sequence 77 from patent US 10752905
GGTCTCAGGAC
>MV620801.1 Sequence 76 from patent US 10752905
GTCCTGAGACC
>MV620800.1 Sequence 75 from patent US 10752905
GGTCTCCAACA
>MV620799.1 Sequence 74 from patent US 10752905
TGTTGGAGACC
>MV620798.1 Sequence 73 from patent US 10752905
CTGGCGAGACC
>MV620797.1 Sequence 72 from patent US 10752905
GGTCTCGCCAG
>MV620796.1 Sequence 71 from patent US 10752905
GGTCTCCCTGG
>MV620795.1 Sequence 70 from patent US 10752905
CCAGGGAGACC
>MV620794.1 Sequence 69 from patent US 10752905
GTCCTGAGACC
>MV620793.1 Sequence 68 from patent US 10752905
GGTCTCAGGAC
>MV620792.1 Sequence 67 from patent US 10752905
GGTCTCGGTCC
>MV620791.1 Sequence 66 from patent US 10752905
GGACCGAGACC
>MV620790.1 Sequence 65 from patent US 10752905
CATGGGAGACC
>MV620789.1 Sequence 64 from patent US 10752905
GGTCTCCCATG
>MV620788.1 Sequence 63 from patent US 10752905
GGTCTCCCATG
>MV620787.1 Sequence 62 from patent US 10752905
CATGGGAGACC
>MV620786.1 Sequence 61 from patent US 10752905
CGCCAGAGACC
>MV620785.1 Sequence 60 from patent US 10752905
CTATCGAGACC
>MV620784.1 Sequence 59 from patent US 10752905
GGTCTCGATAG
>MV620783.1 Sequence 58 from patent US 10752905
GGTCTCCCGCC
>MV620782.1 Sequence 57 from patent US 10752905
GGCGGGAGACC
>MV620781.1 Sequence 56 from patent US 10752905
GAGCCGAGACC
>MV620780.1 Sequence 55 from patent US 10752905
GGTCTCCGCTC
>MV620779.1 Sequence 54 from patent US 10752905
GGTCTCTGAGC
>MV620778.1 Sequence 53 from patent US 10752905
GCTCAGAGACC
>MV620777.1 Sequence 52 from patent US 10752905
CATGCGAGACC
>MV620776.1 Sequence 51 from patent US 10752905
GGTCTCGCATG
>MV620775.1 Sequence 50 from patent US 10752905
GGTCTCTGAGC
>MV620774.1 Sequence 49 from patent US 10752905
GCTCAGAGACC
>MV620773.1 Sequence 48 from patent US 10752905
CATGCGAGACC
>MV620772.1 Sequence 47 from patent US 10752905
GGTCTCGCATG
>MV620771.1 Sequence 46 from patent US 10752905
GGTCTCCCATG
>MV620770.1 Sequence 45 from patent US 10752905
CATGGGAGACC
>MV620769.1 Sequence 44 from patent US 10752905
ATAGCGAGACC
>MV620768.1 Sequence 43 from patent US 10752905
GGTCTCGCTAT
>MV620767.1 Sequence 42 from patent US 10752905
CGTCTCCAACG
>MV620766.1 Sequence 41 from patent US 10752905
CGTTGGAGACG
>MV620765.1 Sequence 40 from patent US 10752905
CCCTGGAGACG
>MV620764.1 Sequence 39 from patent US 10752905
CGTCTCCAGGG
>MV620763.1 Sequence 38 from patent US 10752905
CGTCTCTCGTT
>MV620762.1 Sequence 37 from patent US 10752905
AACGAGAGACG
>MV620761.1 Sequence 36 from patent US 10752905
ATAGCGAGACG
>MV620760.1 Sequence 35 from patent US 10752905
CGTCTCGCTAT
>MV620759.1 Sequence 34 from patent US 10752905
CGTCTCGATAG
>MV620758.1 Sequence 33 from patent US 10752905
GCAGAGCTATC
>MV620757.1 Sequence 32 from patent US 10752905
GCCATGAGACG
>MV620756.1 Sequence 31 from patent US 10752905
CGTCTCATGGC
>MV620755.1 Sequence 30 from patent US 10752905
CGTCTCGATAG
>MV620754.1 Sequence 29 from patent US 10752905
CTATCGAGACG
>MV620753.1 Sequence 28 from patent US 10752905
GCCATGAGACG
>MV620752.1 Sequence 27 from patent US 10752905
CGTCTCATGGC
>MV620751.1 Sequence 26 from patent US 10752905
CGTCTCGATAG
>MV620750.1 Sequence 25 from patent US 10752905
CTATCGAGACG
>MV620749.1 Sequence 24 from patent US 10752905
GCCATGAGACG
>MV620748.1 Sequence 23 from patent US 10752905
CGTCTCATGGC
>MV620747.1 Sequence 22 from patent US 10752905
CGTCTCGGCCA
>MV620746.1 Sequence 21 from patent US 10752905
TGGCCGAGACG
>MV620745.1 Sequence 20 from patent US 10752905
CAGGGGAGACG
>MV620744.1 Sequence 19 from patent US 10752905
CGTCTCCCCTG
>MV620743.1 Sequence 18 from patent US 10752905
CGTCTCGCAGG
>MV620742.1 Sequence 17 from patent US 10752905
CCTGCGAGACG
>MV620740.1 Sequence 15 from patent US 10752905
CGTCTCCATGG
>MV620739.1 Sequence 14 from patent US 10752905
CGTCTCGCCAT
>MV620738.1 Sequence 13 from patent US 10752905
ATGGCGAGACG
>MV620737.1 Sequence 12 from patent US 10752905
TCAGGGAGACG
>MV620736.1 Sequence 11 from patent US 10752905
CGTCTCCCTGA
>MV620735.1 Sequence 10 from patent US 10752905
CGTCTCGTCAG
>MV620734.1 Sequence 9 from patent US 10752905
CTGACGAGACG
>MV620733.1 Sequence 8 from patent US 10752905
AGGGGGAGACG
>MV620732.1 Sequence 7 from patent US 10752905
CGTCTCCCCCT
>MV610571.1 Sequence 1 from patent US 10752666
TATGAAAAAAA
>MV605434.1 Sequence 21 from patent US 10746739
CAGTGGAGCGG
>MV604168.1 Sequence 7 from patent US 10746734
ATAGTTGACAC
>MV603304.1 Sequence 2 from patent US 10745745
GAGCNNNCGTT
>MV603303.1 Sequence 1 from patent US 10745745
AACGNNNGCTC
>MV599889.1 Sequence 23 from patent US 10745687
CTAACCCTAAC
>MV599884.1 Sequence 16 from patent US 10745687
GTTAGGGTTAG
>MV599877.1 Sequence 9 from patent US 10745687
GTGGAAGGCGG
>MV599872.1 Sequence 4 from patent US 10745687
GTTAGGGTTAG
>MV593629.1 Sequence 32 from patent US 10738347
GCGTCGATGAG
>MV593590.1 Sequence 7 from patent US 10738346
MGTTCTGGATM
>MV593589.1 Sequence 6 from patent US 10738346
MGTTCCGGAMM
>MV593587.1 Sequence 4 from patent US 10738346
MGTTCTGGATA
>MV593586.1 Sequence 3 from patent US 10738346
MGTTCCGGAMA
>MV593585.1 Sequence 2 from patent US 10738346
MGTTCTGGATM
>MV593584.1 Sequence 1 from patent US 10738346
MGTTCCGGAMM
>MV593489.1 Sequence 19 from patent US 10738339
GACAAGTGCGG
>MV505143.1 Sequence 26 from patent US 10738079
ACGCCAGGATC
>MV505140.1 Sequence 22 from patent US 10738079
ATGTGCCCGGT
>MV505139.1 Sequence 21 from patent US 10738079
GAGTCGTACAC
>MV505138.1 Sequence 20 from patent US 10738079
GCCTGCACCTC
>MV505137.1 Sequence 17 from patent US 10738079
TGCACTGCGCG
>MV505134.1 Sequence 12 from patent US 10738079
ACACGGGCACA
>MV502353.1 Sequence 31 from patent US 10731228
CTGAAGGACGT
>MV502350.1 Sequence 28 from patent US 10731228
TGACCCTGAAG
>MV502349.1 Sequence 27 from patent US 10731228
GGACCCTGAAG
>MV502334.1 Sequence 6 from patent US 10731228
TGATCCTGCAG
>MV502333.1 Sequence 5 from patent US 10731228
CGATCCTGAAG
>MV502332.1 Sequence 4 from patent US 10731228
TGATCCAGAAG
>MV457201.1 Sequence 97 from patent US 10731212
GCCAGCACCAG
>MV456967.1 Sequence 89 from patent US 10731194
TTTTTTTTTTT
>MV456943.1 Sequence 65 from patent US 10731194
AAAAAAAAAAA
>MV456640.1 Sequence 92 from patent US 10731187
AGCCCTGCAGG
>MV455641.1 Sequence 131 from patent US 10731169
TACACTTGTCA
>MV455638.1 Sequence 125 from patent US 10731169
AAAATTAGTAA
>MV455637.1 Sequence 123 from patent US 10731169
CACATTATTAA
>MV454091.1 Sequence 16 from patent US 10731154
NTNNNNNNNNN
>MV452965.1 Sequence 405 from patent US 10730930
CTAACTGGGGA
>MV452654.1 Sequence 93 from patent US 10730930
CTAACTGGGGA
>MV451831.1 Sequence 21 from patent US 10730906
NGTAACACCTN
>MV451685.1 Sequence 75 from patent US 10729790
TAATGAAATTA
>MV451684.1 Sequence 74 from patent US 10729790
TAATGAAATTG
>MV451515.1 Sequence 357 from patent US 10729761
GGGTTTTTGGG
>MV451505.1 Sequence 346 from patent US 10729761
GGTTTTTTTGG
>MV446782.1 Sequence 13 from patent US 10725027
TTTTTTTTTTT
>MV446781.1 Sequence 12 from patent US 10725027
AAAAAAAAAAA
>MV445614.1 Sequence 32 from patent US 10724091
AAGGACGCGGA
>MV439176.1 Sequence 461 from patent US 10722538
GRTVDGTVVSD
>MV386216.1 Sequence 4 from patent US 10716797
AATTACATTCA
>MV386215.1 Sequence 3 from patent US 10716797
AATTGCATTCA
>MV386214.1 Sequence 2 from patent US 10716797
TAGGATCAGGT
>MV386213.1 Sequence 1 from patent US 10716797
TAGGAGCAGGT
>MV384031.1 Sequence 290 from patent US 10711285
CCNNNNNNNGG
>MV381222.1 Sequence 111 from patent US 10709729
TCAGATACATG
>MV381209.1 Sequence 98 from patent US 10709729
CATGTATCTGA
>MV381141.1 Sequence 30 from patent US 10709729
TGCCCACATAA
>MV381129.1 Sequence 18 from patent US 10709729
TTATGTGGGCA
>MV379508.1 Sequence 26 from patent US 10704101
AAGGGCCCCAA
>MV379128.1 Sequence 125 from patent US 10704084
TGTTAACACGA
>MV379127.1 Sequence 124 from patent US 10704084
ATGCGGAAGAC
>MV379126.1 Sequence 123 from patent US 10704084
TACCGTCATTC
>MV379125.1 Sequence 122 from patent US 10704084
GCGAGCCCATC
>MV379124.1 Sequence 121 from patent US 10704084
TATTTCGTAAG
>MV379123.1 Sequence 120 from patent US 10704084
AAAGGGAATTC
>MV379122.1 Sequence 119 from patent US 10704084
TCTGCAGTTGG
>MV379121.1 Sequence 118 from patent US 10704084
GAAGGGCACCC
>MV379120.1 Sequence 117 from patent US 10704084
TTCAAGAGCTA
>MV379119.1 Sequence 116 from patent US 10704084
TACGCCCTCTC
>MV379118.1 Sequence 115 from patent US 10704084
TTCCAACACTC
>MV379117.1 Sequence 114 from patent US 10704084
CTCTAATACAC
>MV379116.1 Sequence 113 from patent US 10704084
TGGGTACGGGC
>MV379115.1 Sequence 112 from patent US 10704084
GACAGATGATC
>MV379114.1 Sequence 111 from patent US 10704084
TCATACAAGTG
>MV379113.1 Sequence 110 from patent US 10704084
AACGCATAAAC
>MV379112.1 Sequence 109 from patent US 10704084
TCGTCTTTGAA
>MV379111.1 Sequence 108 from patent US 10704084
TGCACGCTCCC
>MV379110.1 Sequence 107 from patent US 10704084
TAACGAATCGA
>MV379109.1 Sequence 106 from patent US 10704084
ATCGATGCTGC
>MV379108.1 Sequence 105 from patent US 10704084
TAACGCCCCGT
>MV379107.1 Sequence 104 from patent US 10704084
ATACTTTCCAC
>MV379106.1 Sequence 103 from patent US 10704084
TTCTGTCGGGC
>MV379105.1 Sequence 102 from patent US 10704084
TGACCGAGAAC
>MV379104.1 Sequence 101 from patent US 10704084
TATCGGTACGG
>MV379103.1 Sequence 100 from patent US 10704084
GTACCTGCTGC
>MV379102.1 Sequence 99 from patent US 10704084
TCTGTTTGACG
>MV379101.1 Sequence 98 from patent US 10704084
ACTGGATTGAC
>MV379100.1 Sequence 97 from patent US 10704084
TATGGCGTAGA
>MV379099.1 Sequence 96 from patent US 10704084
TATGTGTCAAC
>MV379098.1 Sequence 95 from patent US 10704084
TAGCCCTGTTA
>MV379097.1 Sequence 94 from patent US 10704084
CGTCAAATTCC
>MV379096.1 Sequence 93 from patent US 10704084
TTATCGTAGTC
>MV379095.1 Sequence 92 from patent US 10704084
ACATAAGCAAC
>MV379080.1 Sequence 77 from patent US 10704084
GGATCACCGGT
>MV379037.1 Sequence 34 from patent US 10704084
TCCGCTTCGGT
>MV379036.1 Sequence 33 from patent US 10704084
ATTCGCCCCCC
>MV379035.1 Sequence 32 from patent US 10704084
TATGCTGTCGG
>MV379034.1 Sequence 31 from patent US 10704084
AAACCGACAGC
>MV379033.1 Sequence 30 from patent US 10704084
TTCCTAGCTGC
>MV379032.1 Sequence 29 from patent US 10704084
CCCGGCCTCCC
>MV379031.1 Sequence 28 from patent US 10704084
TAGGCGGTTGG
>MV379030.1 Sequence 27 from patent US 10704084
CCAACTGTAGC
>MV379029.1 Sequence 26 from patent US 10704084
TTAGGCCAACA
>MV379028.1 Sequence 25 from patent US 10704084
ATAGAAGGGGC
>MV379027.1 Sequence 24 from patent US 10704084
TAGGTCGTTCA
>MV379026.1 Sequence 23 from patent US 10704084
TTGAACGATCC
>MV379025.1 Sequence 22 from patent US 10704084
TTCATCCGTTC
>MV379024.1 Sequence 21 from patent US 10704084
ACCTAACAGCC
>MV379023.1 Sequence 20 from patent US 10704084
TGGCAGTCGGC
>MV379022.1 Sequence 19 from patent US 10704084
ACGCCGATTGC
>MV379021.1 Sequence 18 from patent US 10704084
TGTATTCGCCA
>MV379020.1 Sequence 17 from patent US 10704084
ATCAACCCTGC
>MV379019.1 Sequence 16 from patent US 10704084
TTACCCAGTGC
>MV379018.1 Sequence 15 from patent US 10704084
TTCAATGGGCC
>MV379017.1 Sequence 14 from patent US 10704084
TCGTCTGCGGC
>MV379016.1 Sequence 13 from patent US 10704084
GGCCCTTCTAC
>MV379015.1 Sequence 12 from patent US 10704084
TTGTGGATGTG
>MV379014.1 Sequence 11 from patent US 10704084
TCACATTCACC
>MV379013.1 Sequence 10 from patent US 10704084
TACCTTCTCCC
>MV379012.1 Sequence 9 from patent US 10704084
ACACCCTCGCC
>MV379011.1 Sequence 8 from patent US 10704084
TCTGCCCAGGC
>MV379010.1 Sequence 7 from patent US 10704084
TCTTTTACGCC
>MV379009.1 Sequence 6 from patent US 10704084
TTCGCGTCCAG
>MV379008.1 Sequence 5 from patent US 10704084
ACGGGCCCGGC
>MV379007.1 Sequence 4 from patent US 10704084
TGCGCACACTC
>MV379006.1 Sequence 3 from patent US 10704084
TGAGTGTGTGC
>MV379005.1 Sequence 2 from patent US 10704084
TTAAAGTGACC
>MV379004.1 Sequence 1 from patent US 10704084
TGGATCTCTGC
>MV360884.1 Sequence 5 from patent US 10702478
GGGATCCTACC
>MV352153.1 Sequence 63 from patent US 10694725
CTAACTGGGGA
>MV350649.1 Sequence 13 from patent US 10689709
GCCCCCTCCGG
>MV350442.1 Sequence 616 from patent US 10689694
GGCCCGCCCAA
>MV350422.1 Sequence 596 from patent US 10689694
CCACCAGCTCC
>MV350406.1 Sequence 580 from patent US 10689694
GGCCCGCCCAA
>MV350278.1 Sequence 452 from patent US 10689694
CCACCAGCTCC
>MV350262.1 Sequence 436 from patent US 10689694
GGCCCGCCCAA
>MV349222.1 Sequence 123 from patent US 10689670
AAAAATTGTTG
>MV345439.1 Sequence 130 from patent US 10689653
TTGGAGGTAAG
>MV341318.1 Sequence 1 from patent US 10689642
AAACAAACAAA
>MV340492.1 Sequence 38 from patent US 10689636
CCGTTAAATTT
>MV340491.1 Sequence 37 from patent US 10689636
GTACTAAAACC
>MV335604.1 Sequence 5 from patent US 10689412
ACTGGGGNNNN
>MV334102.1 Sequence 19 from patent US 10683534
CTACTACCTCA
>MV334101.1 Sequence 18 from patent US 10683534
AACTATACAAC
>MV333623.1 Sequence 6 from patent US 10683507
GGCATTTTGCC
>MV331061.1 Sequence 58 from patent US 10682406
TGGAGAAAGGT
>MV330923.1 Sequence 5 from patent US 10682401
ATAGCCATGGC
>MV330922.1 Sequence 4 from patent US 10682401
RYMRMVATGGC
>MV328749.1 Sequence 10 from patent US 10676789
AAATTCCGGCA
>MV328748.1 Sequence 9 from patent US 10676789
GGATCAAGCTA
>MV328747.1 Sequence 8 from patent US 10676789
ATCCTTTAAGC
>MV328739.1 Sequence 4 from patent US 10676782
CCCTCTCCTCT
>MV328737.1 Sequence 2 from patent US 10676782
AGAGGAGAGGG
>MV316822.1 Sequence 1 from patent US 10669582
ACGTACGACGT
>MV316714.1 Sequence 1 from patent US 10669577
ACGTACGACGT
>MV315689.1 Sequence 6 from patent US 10669558
ACTNNNNGATT
>MV315687.1 Sequence 4 from patent US 10669558
TCGNNNNGATT
>MV315685.1 Sequence 2 from patent US 10669558
CGCNNNNGATT
>MV315661.1 Sequence 62 from patent US 10669557
CTGCTACTCGG
>MV305951.1 Sequence 57 from patent US 10669538
TGCACNGAAGC
>pdb|6JHE|C Chain C, Crystal Structure of Bacillus subtilis SigW domain 4 in complexed with -35 element DNA
AAAGGTTTCAA
>pdb|6JHE|B Chain B, Crystal Structure of Bacillus subtilis SigW domain 4 in complexed with -35 element DNA
NTGAAACCTTT
>pdb|6TZ1|T Chain T, In situ structure of BmCPV RNA-dependent RNA polymerase at early-elongation state
NAAAAAAAAAA
>pdb|6U9X|K Chain K, Structure of T. brucei MERS1-RNA complex
GAGAGGGGGTT
>pdb|6U9X|H Chain H, Structure of T. brucei MERS1-RNA complex
GAGAGGGGGTT
>pdb|6P18|R Chain R, Q21 transcription antitermination complex: loading complex
NGGGAGAGGTA
>pdb|6JNL|C Chain C, REF6 ZnF2-4-NAC004 complex
CAAAACAGAGA
>pdb|6DT1|F Chain F, Crystal structure of the ligase from bacteriophage T4 complexed with DNA intermediate
GCTGATGCGTN
>pdb|6DT1|B Chain B, Crystal structure of the ligase from bacteriophage T4 complexed with DNA intermediate
GCTGATGCGTN
>pdb|6C6K|F Chain F, Structural basis for preferential recognition of cap 0 RNA by a human IFIT1-IFIT3 protein complex
NATAGGCGGCG
>pdb|6C6K|E Chain E, Structural basis for preferential recognition of cap 0 RNA by a human IFIT1-IFIT3 protein complex
NATAGGCGGCG
>pdb|5NNU|Y Chain Y, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
AATGTNATCTT
>pdb|5NNU|W Chain W, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
AATGTNATCTT
>pdb|5NNU|U Chain U, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
AATGTNATCTT
>pdb|5NNU|S Chain S, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
AATGTNATCTT
>pdb|5NNU|Z Chain Z, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
NAGATAACATT
>pdb|5NNU|X Chain X, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
NAGATAACATT
>pdb|5NNU|V Chain V, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
NAGATAACATT
>pdb|5NNU|T Chain T, KSHV uracil-DNA glycosylase, product complex with dsDNA exhibiting duplex nucleotide flipping
NAGATAACATT
>pdb|5WX9|C Chain C, Crystal Structure of AtERF96 with GCC-box
GCTGGCGGCTA
>pdb|5WX9|B Chain B, Crystal Structure of AtERF96 with GCC-box
TAGCCGCCAGC
>pdb|5WZK|B Chain B, Structure of APUM23-deletion-of-insert-region-GGAAUUGACGG
GGAATTGACGG
>pdb|5WZJ|B Chain B, Structure of APUM23-GGAUUUGACGG
GGATTTGACGG
>pdb|5WZI|B Chain B, Structure of APUM23-GGAGUUGACGG
GGAGTTGACGG
>pdb|5WZH|B Chain B, Structure of APUM23-GGAAUUGACGG
GGAATTGACGG
>pdb|5U1C|H Chain H, Structure of tetrameric HIV-1 Strand Transfer Complex Intasome
GTACGCTGACT
>pdb|5U1C|G Chain G, Structure of tetrameric HIV-1 Strand Transfer Complex Intasome
GTACGCTGACT
>pdb|5K78|Y Chain Y, Dbr1 in complex with 16-mer branched RNA
TACTAACAAGT
>pdb|5K78|X Chain X, Dbr1 in complex with 16-mer branched RNA
TACTAACAAGT
>pdb|5G4T|A Chain A, The structure of a quasi-cyclic six k-turn duplex RNA species
NGCGAAGAACT
>pdb|5JVT|I Chain I, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
CACTTCCGGTC
>pdb|5JVT|H Chain H, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
GACCGGAAGTG
>pdb|5JVT|F Chain F, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
CACTTCCGGTC
>pdb|5JVT|E Chain E, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
GACCGGAAGTG
>pdb|5JVT|C Chain C, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
CACTTCCGGTC
>pdb|5JVT|B Chain B, Crystal structure of the DNA binding domain of transcription factor FLI1 in complex with an 11-mer DNA GACCGGAAGTG
GACCGGAAGTG
>pdb|5GIP|T Chain T, Crystal structure of box C/D RNP with 13 nt guide regions and 11 nt substrates
CCATGAGTGTT
>pdb|5GIP|S Chain S, Crystal structure of box C/D RNP with 13 nt guide regions and 11 nt substrates
CCATGAGTGTT
>pdb|5GIP|J Chain J, Crystal structure of box C/D RNP with 13 nt guide regions and 11 nt substrates
CCATGAGTGTT
>pdb|5GIP|I Chain I, Crystal structure of box C/D RNP with 13 nt guide regions and 11 nt substrates
CCATGAGTGTT
>pdb|5CNR|F Chain F, Crystal structure-guided design of self-assembling RNA nano triangles
AGAGGACGGCG
>pdb|5CNR|B Chain B, Crystal structure-guided design of self-assembling RNA nano triangles
AGAGGACGGCG
>pdb|4YGI|B Chain B, Crystal Structure of SUVH5 SRA bound to fully hydroxymethylated CG DNA
ACTANGTAGTT
>pdb|5AOR|D Chain D, Structure of MLE RNA ADP AlF4 complex
NTTTTTTTTTT
>pdb|5AOR|C Chain C, Structure of MLE RNA ADP AlF4 complex
NTTTTTTTTTT
>pdb|5BZU|B Chain B, Crystal structure of the RNA-binding domain of yeast Puf5p bound to AAT2 RNA
TGTAATGATTA
>pdb|5CG9|E Chain E, NgTET1 in complex with 5mC DNA in space group P3221
NATGCGCTGAC
>pdb|5CG9|B Chain B, NgTET1 in complex with 5mC DNA in space group P3221
NATGCGCTGAC
>pdb|5AKN|C Chain C, THE CRYSTAL STRUCTURE OF I-DMOI Q42AK120M IN COMPLEX WITH ITS TARGET DNA NICKED IN THE non-CODING STRAND B AND IN THE PRESENCE OF 2MM MN
NTTCCGGCGCG
>pdb|4RTP|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoMet and with DNA Containing Proximal Pap Regulon Sequence
ACGATCTTTAA
>pdb|4RTP|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoMet and with DNA Containing Proximal Pap Regulon Sequence
TTTAAAGATCG
>pdb|4RTO|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with Sinefungin and with DNA Containing Proximal Pap Regulon Sequence
ACGATCTTTAA
>pdb|4RTO|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with Sinefungin and with DNA Containing Proximal Pap Regulon Sequence
TTTAAAGATCG
>pdb|4RTN|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoHcy and with DNA Containing Proximal Pap Regulon Sequence
ACGATCTTTAA
>pdb|4RTN|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoHcy and with DNA Containing Proximal Pap Regulon Sequence
TTTAAAGATCG
>pdb|4RTM|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoMet and with DNA Containing Distal Pap Regulon Sequence
ACGATCTTTAG
>pdb|4RTM|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with AdoMet and with DNA Containing Distal Pap Regulon Sequence
TCTAAAGATCG
>pdb|4RTL|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with Sinefungin and with DNA Containing Distal Pap Regulon Sequence
ACGATCTTTAG
>pdb|4RTL|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with Sinefungin and with DNA Containing Distal Pap Regulon Sequence
TCTAAAGATCG
>pdb|4RTK|G Chain G, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with SAH and with DNA Containing Distal Pap Regulon Sequence
ACGATCTTTAG
>pdb|4RTK|F Chain F, Complex of Escherichia coli DNA Adenine Methyltransferase (DAM) with SAH and with DNA Containing Distal Pap Regulon Sequence
TCTAAAGATCG
>pdb|4P97|D Chain D, Functional conservation despite structural divergence in ligand-responsive RNA switches
CGAGAGGACGG
>pdb|4P97|B Chain B, Functional conservation despite structural divergence in ligand-responsive RNA switches
CGAGAGGACGG
>pdb|4UT0|M Chain M, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mn (state 7)
NTTCCGGCGCG
>pdb|4UT0|H Chain H, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mn (state 7)
NTTCCGGCGCG
>pdb|4UT0|C Chain C, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mn (state 7)
NTTCCGGCGCG
>pdb|4UNC|N Chain N, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 8 Days Incubation In 5mm Mn (state 6)
NTTCCGGCGCG
>pdb|4UNC|L Chain L, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 8 Days Incubation In 5mm Mn (state 6)
NTTCCGGCGCG
>pdb|4UNC|J Chain J, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 8 Days Incubation In 5mm Mn (state 6)
NTTCCGGCGCG
>pdb|4UNB|N Chain N, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 6 Days Incubation In 5mm Mn (state 5)
NTTCCGGCGCG
>pdb|4UNB|L Chain L, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 6 Days Incubation In 5mm Mn (state 5)
NTTCCGGCGCG
>pdb|4UNB|J Chain J, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 6 Days Incubation In 5mm Mn (state 5)
NTTCCGGCGCG
>pdb|4P4P|B Chain B, Crystal structure of Leishmania infantum polymerase beta: Nick complex
CGGCAGTACTG
>pdb|4P4O|F Chain F, Crystal structure of Leishmania infantum polymerase beta: Ternary gap complex
CGGCAATACTG
>pdb|4K4U|D Chain D, Poliovirus polymerase elongation complex (r5_form)
NGGGGAGATGA
>pdb|4K4U|H Chain H, Poliovirus polymerase elongation complex (r5_form)
NGGGGAGATGA
>pdb|3VYQ|C Chain C, Crystal structure of the methyl CpG Binding Domain of MBD4 in complex with the 5mCG/TG sequence in space group P1
TCACTGGATGT
>pdb|3VYQ|B Chain B, Crystal structure of the methyl CpG Binding Domain of MBD4 in complex with the 5mCG/TG sequence in space group P1
ACATCNGGTGA
>pdb|4GZN|B Chain B, Mouse ZFP57 zinc fingers in complex with methylated DNA
ACTGNGGCAAT
>pdb|4GZN|A Chain A, Mouse ZFP57 zinc fingers in complex with methylated DNA
TATTGCNGCAG
>pdb|4EW0|C Chain C, mouse MBD4 glycosylase domain in complex with a G:5hmU (5-hydroxymethyluracil) mismatch
CCATGNGCTGA
>pdb|4EW0|B Chain B, mouse MBD4 glycosylase domain in complex with a G:5hmU (5-hydroxymethyluracil) mismatch
TCAGCGCATGG
>pdb|4EVV|C Chain C, mouse MBD4 glycosylase domain in complex with a G:T mismatch
CCATGTGCTGA
>pdb|4EVV|B Chain B, mouse MBD4 glycosylase domain in complex with a G:T mismatch
TCAGCGCATGG
>pdb|3RAE|H Chain H, Quinolone(Levofloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NACTATGCACG
>pdb|3RAE|F Chain F, Quinolone(Levofloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NGTCATTCATG
>pdb|3RAF|H Chain H, Quinazolinedione-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NACTATGCACG
>pdb|3RAF|F Chain F, Quinazolinedione-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NGTCATTCATG
>pdb|3VH0|F Chain F, Crystal structure of E. coli YncE complexed with DNA
CGGGTACTCAG
>pdb|3VH0|E Chain E, Crystal structure of E. coli YncE complexed with DNA
CGGGTACTCAG
>pdb|2XY7|C Chain C, Crystal structure of a salicylic aldehyde base in the pre-insertion site of fragment DNA polymerase I from Bacillus stearothermophilus
NCGAGTCAGGC
>pdb|1OVF|A Chain A, NMR Structure of ActD/5'-CCGTTTTGTGG-3' Complex
CCGTTTTGTGG
>pdb|3R7P|C Chain C, The crystal structure of I-LtrI
NGGAGCATTTG
>pdb|2Y35|B Chain B, Crystal structure of Xrn1-substrate complex
NTTTTTTTTTT
>pdb|3Q0F|B Chain B, Crystal structure of SUVH5 SRA- methylated CHH DNA complex
CTGAGGAGTAT
>pdb|3Q0C|B Chain B, Crystal structure of SUVH5 SRA-fully methylated CG DNA complex in space group P6122
ACTANGTAGTT
>pdb|3Q0C|C Chain C, Crystal structure of SUVH5 SRA-fully methylated CG DNA complex in space group P6122
ACTANGTAGTT
>pdb|357D|A Chain A, 3.5 A structure of fragment I from E. coli 5S RRNA
TGCNNGGCGGC
>pdb|3MQY|F Chain F, SgrAI with cleaved DNA and Magnesium bound
NCGGTGGACTC
>pdb|3MQY|D Chain D, SgrAI with cleaved DNA and Magnesium bound
NCGGTGGACTC
>pdb|2XSD|B Chain B, Crystal Structure of the dimeric Oct-6 (Pou3f1) POU domain bound to palindromic MORE DNA
NCTCATGCATA
>pdb|2XSD|A Chain A, Crystal Structure of the dimeric Oct-6 (Pou3f1) POU domain bound to palindromic MORE DNA
ATGCATGAGGA
>pdb|3NM9|O Chain O, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|N Chain N, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|L Chain L, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|K Chain K, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|I Chain I, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|H Chain H, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|F Chain F, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|E Chain E, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|C Chain C, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3NM9|B Chain B, HMGD(M13A)-DNA complex
GGCGATATCGC
>pdb|3OH9|C Chain C, AlkA Undamaged DNA Complex: Interrogation of a T:A base pair
ACANGAANGCC
>pdb|3OH9|B Chain B, AlkA Undamaged DNA Complex: Interrogation of a T:A base pair
GGCATTCATGT
>pdb|3OH6|B Chain B, AlkA Undamaged DNA Complex: Interrogation of a C:G base pair
GCATTCATGTC
>pdb|2XO7|C Chain C, Crystal structure of a dA:O-allylhydroxylamine-dC basepair in complex with fragment DNA polymerase I from Bacillus stearothermophilus
AGGAATGGTCA
>pdb|3M3Y|R Chain R, RNA polymerase II elongation complex C
ATGGAGAGGAC
>pdb|3G0R|K Chain K, Complex of Mth0212 and an 8bp dsDNA with distorted ends
CCCTGNGCAGC
>pdb|3DO7|E Chain E, X-ray structure of a NF-kB p52/RelB/DNA complex
CGGGAATTCCC
>pdb|3DO7|D Chain D, X-ray structure of a NF-kB p52/RelB/DNA complex
CGGGAATTCCC
>pdb|3DO7|C Chain C, X-ray structure of a NF-kB p52/RelB/DNA complex
CGGGAATTCCC
>pdb|2VS8|M Chain M, The crystal structure of I-DmoI in complex with DNA and Mn
NTTCCGGCGCG
>pdb|2VS8|H Chain H, The crystal structure of I-DmoI in complex with DNA and Mn
NTTCCGGCGCG
>pdb|2VS8|C Chain C, The crystal structure of I-DmoI in complex with DNA and Mn
NTTCCGGCGCG
>pdb|1HUZ|C Chain C, Crystal Structure Of Dna Polymerase Complexed With Dna And Cr-Pcp
AATAGGCGTCG
>pdb|1HUZ|T Chain T, Crystal Structure Of Dna Polymerase Complexed With Dna And Cr-Pcp
AATAGGCGTCG
>pdb|1HUO|C Chain C, Crystal Structure Of Dna Polymerase Beta Complexed With Dna And Cr-Tmppcp
AATAGGCGTCG
>pdb|1HUO|T Chain T, Crystal Structure Of Dna Polymerase Beta Complexed With Dna And Cr-Tmppcp
AATAGGCGTCG
>pdb|2Q2T|D Chain D, Structure of Chlorella virus DNA ligase-adenylate bound to a 5' phosphorylated nick
NACTATCGGAA
>pdb|2V2T|D Chain D, X-ray structure of a NF-kB p50-RelB-DNA complex
CGGGAATTCCC
>pdb|2V2T|C Chain C, X-ray structure of a NF-kB p50-RelB-DNA complex
CGGGAATTCCC
>pdb|2GE5|D Chain D, EcoRV Restriction Endonuclease C-terminal deletion mutant/GATATC/Ca2+
AAAGATATCTT
>pdb|2GE5|C Chain C, EcoRV Restriction Endonuclease C-terminal deletion mutant/GATATC/Ca2+
AAAGATATCTT
>pdb|2C9N|B Chain B, Structure of the Epstein-Barr virus ZEBRA protein at approximately 3. 5 Angstrom resolution
CATGAGTCAGT
>pdb|2C9N|A Chain A, Structure of the Epstein-Barr virus ZEBRA protein at approximately 3. 5 Angstrom resolution
CACTGACTCAT
>pdb|1VRL|C Chain C, MutY adenine glycosylase in complex with DNA and soaked adenine free base
TGTCCANGTCT
>pdb|1VRL|B Chain B, MutY adenine glycosylase in complex with DNA and soaked adenine free base
AAGACNTGGAC
>pdb|1U47|B Chain B, cytosine-8-Oxoguanine base pair at the polymerase active site
GCCTGACTCGC
>pdb|1NKE|B Chain B, A Bacillus Dna Polymerase I Product Complex Bound To A Cytosine-Thymine Mismatch After A Single Round Of Primer Extension, Following Incorporation Of Dctp.
GCGATCAGCCC
>pdb|1NK8|B Chain B, A Bacillus Dna Polymerase I Product Complex Bound To A Guanine-Thymine Mismatch After A Single Round Of Primer Extension, Following Incorporation Of Dctp.
GCGATCAGCGC
>pdb|1NK0|B Chain B, Adenine-Guanine Mismatch At The Polymerase Active Site
GCGATCAGCAA
>pdb|1NJX|B Chain B, Thymine-Guanine Mismatch At The Polymerase Active Site
GCATGATGCTT
>pdb|1RRS|C Chain C, MutY adenine glycosylase in complex with DNA containing an abasic site
TGTCCANGTCT
>pdb|1RRS|B Chain B, MutY adenine glycosylase in complex with DNA containing an abasic site
AAGACNTGGAC
>pdb|1RRQ|C Chain C, MutY adenine glycosylase in complex with DNA containing an A:oxoG pair
TGTCCAAGTCT
>pdb|1RRQ|B Chain B, MutY adenine glycosylase in complex with DNA containing an A:oxoG pair
AAGACNTGGAC
>pdb|1ORP|C Chain C, Structure of a Trapped Endonuclease III-DNA Covalent Intermediate: Estranged-Adenine Complex
TGTCCANGTCT
>pdb|1ORP|B Chain B, Structure of a Trapped Endonuclease III-DNA Covalent Intermediate: Estranged-Adenine Complex
AAGACATGGAC
>pdb|1ORN|C Chain C, Structure of a Trapped Endonuclease III-DNA Covalent Intermediate: Estranged-Guanine Complex
TGTCCANGTCT
>pdb|1ORN|B Chain B, Structure of a Trapped Endonuclease III-DNA Covalent Intermediate: Estranged-Guanine Complex
AAGACGTGGAC
>pdb|1O3R|B Chain B, Protein-Dna Recognition And Dna Deformation Revealed In Crystal Structures Of Cap-Dna Complexes
AAAAATGCGAT
>pdb|1O3Q|B Chain B, Protein-Dna Recognition And Dna Deformation Revealed In Crystal Structures Of Cap-Dna Complexes
AAAAATGTGAT
>pdb|1L3U|B Chain B, Crystal Structure of Bacillus DNA Polymerase I Fragment product complex with 11 base pairs of duplex DNA following addition of a dTTP and a dATP residue.
GCGATCACGTA
>pdb|2CGP|B Chain B, Catabolite Gene Activator ProteinDNA COMPLEX, ADENOSINE-3', 5'-Cyclic-Monophosphate
GTCACATTAAT
>pdb|1D0E|F Chain F, Crystal Structures Of The N-Terminal Fragment From Moloney Murine Leukemia Virus Reverse Transcriptase Complexed With Nucleic Acid: Functional Implications For Template-Primer Binding To The Fingers Domain
TTTCATGCATG
>pdb|1D0E|E Chain E, Crystal Structures Of The N-Terminal Fragment From Moloney Murine Leukemia Virus Reverse Transcriptase Complexed With Nucleic Acid: Functional Implications For Template-Primer Binding To The Fingers Domain
TTTCATGCATG
>pdb|1CLQ|E Chain E, Crystal Structure Of A Replication Fork Dna Polymerase Editing Complex At 2.7 A Resolution
GCGGAACTACT
>pdb|1B95|D Chain D, Analysis Of A Mutational Hot-Spot In The Ecorv Restriction Endonuclease: A Catalytic Role For A Main Chain Carbonyl Group
AAAGATATCTT
>pdb|1B95|C Chain C, Analysis Of A Mutational Hot-Spot In The Ecorv Restriction Endonuclease: A Catalytic Role For A Main Chain Carbonyl Group
AAAGATATCTT
>pdb|4BDP|P Chain P, Crystal Structure Of Bacillus Dna Polymerase I Fragment Complexed To 11 Base Pairs Of Duplex Dna After Addition Of Two Datp Residues
GCATCATGCAA
>pdb|1BGB|D Chain D, Ecorv Endonuclease Complex With 5'-Cgggatatccc Dna
CGGGATATCCC
>pdb|1BGB|C Chain C, Ecorv Endonuclease Complex With 5'-Cgggatatccc Dna
CGGGATATCCC
>pdb|1BUA|D Chain D, Structural And Energetic Origins Of Indirect Readout In Site-Specific Dna Cleavage By A Restriction Endonuclease
AAAGACNTCTT
>pdb|1BUA|C Chain C, Structural And Energetic Origins Of Indirect Readout In Site-Specific Dna Cleavage By A Restriction Endonuclease
AAAGACNTCTT
>pdb|1A1L|C Chain C, Zif268 Zinc Finger-Dna Complex (Gcac Site)
TGTGCCCACGC
>pdb|1A1L|B Chain B, Zif268 Zinc Finger-Dna Complex (Gcac Site)
AGCGTGGGCAC
>pdb|1A1K|C Chain C, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gacc Site)
TGGTCCCACGC
>pdb|1A1K|B Chain B, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gacc Site)
AGCGTGGGACC
>pdb|1A1J|C Chain C, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gcgt Site)
TACGCCCACGC
>pdb|1A1J|B Chain B, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gcgt Site)
AGCGTGGGCGT
>pdb|1A1I|C Chain C, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gcac Site)
TGTGCCCACGC
>pdb|1A1I|B Chain B, Radr (Zif268 Variant) Zinc Finger-Dna Complex (Gcac Site)
AGCGTGGGCAC
>pdb|1A1H|C Chain C, Qgsr (Zif268 Variant) Zinc Finger-Dna Complex (Gcac Site)
TGTGCCCACGC
>pdb|1A1H|B Chain B, Qgsr (Zif268 Variant) Zinc Finger-Dna Complex (Gcac Site)
AGCGTGGGCAC
>pdb|1A1G|C Chain C, Dsnr (Zif268 Variant) Zinc Finger-Dna Complex (Gcgt Site)
TACGCCCACGC
>pdb|1A1G|B Chain B, Dsnr (Zif268 Variant) Zinc Finger-Dna Complex (Gcgt Site)
AGCGTGGGCGT
>pdb|1A1F|C Chain C, Dsnr (Zif268 Variant) Zinc Finger-Dna Complex (Gacc Site)
TGGTCCCACGC
>pdb|1A1F|B Chain B, Dsnr (Zif268 Variant) Zinc Finger-Dna Complex (Gacc Site)
AGCGTGGGACC
>pdb|1AZ0|D Chain D, Ecorv EndonucleaseDNA COMPLEX
AAAGATATCTT
>pdb|1AZ0|C Chain C, Ecorv EndonucleaseDNA COMPLEX
AAAGATATCTT
>pdb|1T7P|P Chain P, T7 DNA POLYMERASE COMPLEXED TO DNA PRIMER/TEMPLATE,A NUCLEOSIDE TRIPHOSPHATE, AND ITS PROCESSIVITY FACTOR THIOREDOXIN
NCCAGTGCCAN
>pdb|1AAY|C Chain C, Zif268 Zinc Finger-Dna Complex
TACGCCCACGC
>pdb|1AAY|B Chain B, Zif268 Zinc Finger-Dna Complex
AGCGTGGGCGT
>pdb|1RVB|D Chain D, Mg2+ Binding To The Active Site Of Eco Rv Endonuclease: A Crystallographic Study Of Complexes With Substrate And Product Dna At 2 Angstroms Resolution
AAAGATATCTT
>pdb|1RVB|C Chain C, Mg2+ Binding To The Active Site Of Eco Rv Endonuclease: A Crystallographic Study Of Complexes With Substrate And Product Dna At 2 Angstroms Resolution
AAAGATATCTT
>pdb|1RVA|D Chain D, Mg2+ Binding To The Active Site Of Eco Rv Endonuclease: A Crystallographic Study Of Complexes With Substrate And Product Dna At 2 Angstroms Resolution
AAAGATATCTT
>pdb|1RVA|C Chain C, Mg2+ Binding To The Active Site Of Eco Rv Endonuclease: A Crystallographic Study Of Complexes With Substrate And Product Dna At 2 Angstroms Resolution
AAAGATATCTT
>pdb|1ZAA|B Chain B, Zinc Finger-Dna Recognition: Crystal Structure Of A Zif268- Dna Complex At 2.1 Angstroms
TACGCCCACGC
>pdb|1ZAA|A Chain A, Zinc Finger-Dna Recognition: Crystal Structure Of A Zif268- Dna Complex At 2.1 Angstroms
AGCGTGGGCGT
>pdb|3J5Z|f Chain f, Model of the small subunit RNA based on a 5.5 A cryo-EM map of Triticum aestivum translating 80S ribosome
AAAAGACTTCA
>pdb|4X64|b Chain b, Crystal Structure of 30S ribosomal subunit from Thermus thermophilus
NACTNTTNANC
>pdb|4X62|b Chain b, Crystal Structure of 30S ribosomal subunit from Thermus thermophilus
NACTNTTNANC
>pdb|6OZS|d Chain d, Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after a 90 min soak in 10 mM Mg2+
CGGTAACCCNA
>pdb|6OZS|c Chain c, Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after a 90 min soak in 10 mM Mg2+
CGGTAACCCNA
>pdb|6OZP|d Chain d, Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after a 180 min soak in 10 mM Mn2+
CGGTAACCCNA
>pdb|6OZP|c Chain c, Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after a 180 min soak in 10 mM Mn2+
CGGTAACCCNA
>pdb|4DR6|a Chain a, Crystal structure of the Thermus thermophilus (HB8) 30S ribosomal subunit with codon, near-cognate transfer RNA anticodon stem-loop mismatched at the first codon position and streptomycin bound
NTTGAGGNGGT
>pdb|6TUX|F Chain F, human XPG-DNA, Complex 2
NAACTCTGCAG
>pdb|6TUX|E Chain E, human XPG-DNA, Complex 2
TTGCAGAGTTC
>pdb|6TUX|D Chain D, human XPG-DNA, Complex 2
GAACTCTGCAG
>pdb|6TUX|C Chain C, human XPG-DNA, Complex 2
TTGCAGAGTTC
>pdb|6TUW|C Chain C, human XPG-DNA, Complex 1
NAACTCTGCAG
>pdb|6TUW|B Chain B, human XPG-DNA, Complex 1
TTGCAGAGTTC
>pdb|6W2M|P Chain P, Abortive ternary complex crystal structure of DNA polymerase Beta with 8OG-dC base pair at the primer terminus and flipped out dA
GCTGATGCGAC
>pdb|6WE9|F Chain F, YTH domain of human YTHDC1 with 11mer ssDNA Containing N6mA
CGCGGNCTCTG
>pdb|6WE9|B Chain B, YTH domain of human YTHDC1 with 11mer ssDNA Containing N6mA
CGCGGNCTCTG
>pdb|6WAA|P Chain P, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and compound 34 (7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one)
TTACGTTGTAT
>pdb|6WAA|M Chain M, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and compound 34 (7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one)
NTACGTTGTAT
>pdb|6WAA|L Chain L, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and compound 34 (7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one)
TTACGTTGTAT
>pdb|6WAA|I Chain I, K. pneumoniae Topoisomerase IV (ParE-ParC) in complex with DNA and compound 34 (7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one)
TTACGTTGTAT
>pdb|6W4I|C Chain C, APE1 Y269A product complex with abasic DNA
NCGACGGATCC
>pdb|6W4I|D Chain D, APE1 Y269A product complex with abasic DNA
NCGACGGATCC
>pdb|6W43|D Chain D, APE1 AP-endonuclease product complex R237C
NCGACGGATCC
>pdb|6W3U|C Chain C, APE1 exonuclease substrate complex R237C
NCGACGGATCC
>pdb|6W3Q|C Chain C, APE1 exonuclease substrate complex L104R
NCGACGGATCC
>pdb|6W3N|C Chain C, APE1 exonuclease substrate complex D148E
NCGACGGATCC
>pdb|6W3L|C Chain C, APE1 exonuclease substrate complex wild-type
NCGACGGATCC
>pdb|6W2P|D Chain D, APE1 endonuclease product complex L104R
NCGACGGATCC
>pdb|6W0Q|D Chain D, APE1 endonuclease product complex D148E
NCGACGGATCC
>pdb|6UQ3|R Chain R, RNA polymerase II elongation complex with 5-guanidinohydantoin lesion in state 5
ATCGAGAGGAT
>pdb|6VA2|A Chain A, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MH5
CCGGCAGTGTG
>pdb|6VA1|A Chain A, Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element
CCGGCAGTGTG
>pdb|6S48|C Chain C, AvaII RESTRICTION ENDONUCLEASE IN COMPLEX WITH PARTIALLY CLEAVED dsDNA
GATGGTCCTAC
>pdb|6STY|F Chain F, Human REXO2 exonuclease in complex with RNA.
CCCGGCTCATC
>pdb|6STY|C Chain C, Human REXO2 exonuclease in complex with RNA.
CCCGGCTCATC
>pdb|6T0S|M Chain M, Bat Influenza A polymerase stuttering complex using 44-mer vRNA template with intact oligo(U) sequence
GACGGAAAAAA
>pdb|6UR4|C Chain C, DNA polymerase I Large Fragment from Bacillus stearothermophilus with DNA template and 3'-amino primer
NGCTGATCGCA
>pdb|6LAE|D Chain D, Crystal structure of the DNA-binding domain of human XPA in complex with DNA
NGGCGAGATGC
>pdb|6LAE|C Chain C, Crystal structure of the DNA-binding domain of human XPA in complex with DNA
NCATCTCGCCT
>pdb|6P94|D Chain D, Human APE1 C65A AP-endonuclease product complex
NCGACGGATCC
>pdb|6P93|D Chain D, Human APE1 K98A AP-endonuclease product complex
NCGACGGATCC
>pdb|6Q1V|B Chain B, Human DNA Ligase 1 (E592R) Bound to an Adenylated, hydroxyl terminated DNA nick
GCTGATGCGTC
>pdb|6PH5|P Chain P, Binary product complex crystal structure of DNA polymerase Beta with an extra-helical template base
GCTGATGCGCC
>pdb|6P0E|B Chain B, Human DNA Ligase 1 (E346A,E592A) bound to adenylated DNA containing an 8-oxo guanine:adenine base-pair
GCTGATGCGTN
>pdb|6P0D|B Chain B, Human DNA Ligase 1 (E346A/E592A) Bound to an Adenylated, hydroxyl terminated DNA nick
GCTGATGCGTC
>pdb|6P0C|B Chain B, Human DNA Ligase 1 Bound to an Adenylated, hydroxyl terminated DNA nick in EDTA
GCTGATGCGTC
>pdb|6P0B|B Chain B, Human DNA Ligase 1 (E346A/E592A) Bound to an Adenylated, dideoxy Terminated DNA nick with 200 mM Mg2+
GCTGATGCGTC
>pdb|6P0A|B Chain B, Human DNA Ligase 1 Bound to an Adenylated, dideoxy Terminated DNA nick with 2 mM Mg2+
GCTGATGCGTC
>pdb|6P09|B Chain B, Human DNA Ligase 1 Bound to an Adenylated, dideoxy Terminated DNA nick with 200 mM Mg2+
GCTGATGCGTC
>pdb|6KC8|D Chain D, Crystal structure of WT Nme1Cas9 in complex with sgRNA and target DNA (ATATGATT PAM) in post-cleavage state
ATATGATTTTA
>pdb|6KC7|D Chain D, Crystal structure of Nme1Cas9 in complex with sgRNA and target DNA (ATATGATT PAM) in seed-base paring state
ATATGATTTTA
>pdb|6JFU|D Chain D, Crystal structure of Nme2Cas9 in complex with sgRNA and target DNA (AGGCCC PAM)
AGGCCCAGTTA
>pdb|6JDV|D Chain D, Crystal structure of Nme1Cas9 in complex with sgRNA and target DNA (ATATGATT PAM) in catalytic state
ATATGATTTTA
>pdb|5FQ5|D Chain D, Crystal structure of Cas9-sgRNA-DNA complex solved by native SAD phasing
TTGTGGTATTG
>pdb|5FQ5|C Chain C, Crystal structure of Cas9-sgRNA-DNA complex solved by native SAD phasing
CAATACCACAA
>pdb|6TZS|B Chain B, A DNA i-motif/duplex hybrid
CCAGGCTGNAA
>pdb|6TZS|A Chain A, A DNA i-motif/duplex hybrid
CCAGGCTGNAA
>pdb|6TZR|B Chain B, A DNA G-quadruplex/i-motif hybrid
CCAGGCNGCAA
>pdb|6TZR|A Chain A, A DNA G-quadruplex/i-motif hybrid
CCAGGCNGCAA
>pdb|6TZQ|B Chain B, A DNA G-quadruplex/i-motif hybrid
CCAGGCTGCAA
>pdb|6TZQ|A Chain A, A DNA G-quadruplex/i-motif hybrid
CCAGGCTGCAA
>pdb|6U7T|C Chain C, MutY adenine glycosylase bound to DNA containing a transition state analog (1N) paired with d(8-oxo-G)
TGTCCANGTCT
>pdb|6U7T|B Chain B, MutY adenine glycosylase bound to DNA containing a transition state analog (1N) paired with d(8-oxo-G)
AAGACNTGGAC
>pdb|6Q0C|C Chain C, MutY adenine glycosylase bound to DNA containing a transition state analog (1N) paired with undamaged dG
TGTCCANGTCT
>pdb|6Q0C|B Chain B, MutY adenine glycosylase bound to DNA containing a transition state analog (1N) paired with undamaged dG
AAGACGTGGAC
>pdb|6HMO|B Chain B, Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7 in complex with the SMN-C5 splicing modifier
GGAGTAAGTCT
>pdb|6HMO|A Chain A, Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7 in complex with the SMN-C5 splicing modifier
ATACNNACCTG
>pdb|6HMI|B Chain B, Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7
GGAGTAAGTCT
>pdb|6HMI|A Chain A, Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7
ATACNNACCTG
>pdb|6JRP|L Chain L, Crystal structure of CIC-HMG-ETV5-DNA complex
NTTTCATTCAT
>pdb|6JRP|K Chain K, Crystal structure of CIC-HMG-ETV5-DNA complex
NTGAATGAAAA
>pdb|6JRP|I Chain I, Crystal structure of CIC-HMG-ETV5-DNA complex
TTTTCATTCAT
>pdb|6JRP|H Chain H, Crystal structure of CIC-HMG-ETV5-DNA complex
ATGAATGAAAA
>pdb|6JRP|F Chain F, Crystal structure of CIC-HMG-ETV5-DNA complex
TTTTCATTCAT
>pdb|6JRP|E Chain E, Crystal structure of CIC-HMG-ETV5-DNA complex
ATGAATGAAAA
>pdb|6JRP|C Chain C, Crystal structure of CIC-HMG-ETV5-DNA complex
TTTTCATTCAT
>pdb|6JRP|B Chain B, Crystal structure of CIC-HMG-ETV5-DNA complex
ATGAATGAAAA
>pdb|6RCE|D Chain D, Pmar-Lig_PreS3
NACTATCGGAA
>pdb|6RAS|D Chain D, Pmar-Lig_Pre.
NACTATCGGAA
>pdb|6RAR|D Chain D, Pmar-Lig_PreS3-Mn
NACTATCGGAA
>pdb|6KCQ|A Chain A, Crystal structure of yedK with ssDNA containing an abasic site
AAAAANAAAAA
>pdb|6OD4|W Chain W, Human TCF4 C-terminal bHLH domain in Complex with 11-bp Oligonucleotide Containing E-box Sequence
TTACACGTGTA
>pdb|6OD4|X Chain X, Human TCF4 C-terminal bHLH domain in Complex with 11-bp Oligonucleotide Containing E-box Sequence
TTACACGTGTA
>pdb|6MU4|P Chain P, Bst DNA polymerase I FANA/DNA binary complex
NCGATCACGTT
>pdb|5ZT2|A Chain A, Crystal structure of CCG DNA repeats at 1.66 angstrom resolution
TCCGCCGCCGA
>pdb|6MPF|X Chain X, Structure of the Thermus thermophilus 30S ribosomal subunit complexed with a 2-thiocytidine (s2C32) and inosine (I34) modified anticodon stem loop (ASL) of Escherichia coli transfer RNA Arginine 1 (TRNAARG1) bound to an mRNA with an CGC-codon in the A-site and paromomycin
GGNTNCGAACC
>pdb|6J4R|Y Chain Y, Structural basis for the target DNA recognition and binding by the MYB domain of phosphate starvation response regulator 1
CAGTATATACC
>pdb|6J4R|X Chain X, Structural basis for the target DNA recognition and binding by the MYB domain of phosphate starvation response regulator 1
GGTATATACTG
>pdb|6J4R|E Chain E, Structural basis for the target DNA recognition and binding by the MYB domain of phosphate starvation response regulator 1
GTCATATATGG
>pdb|6J4R|F Chain F, Structural basis for the target DNA recognition and binding by the MYB domain of phosphate starvation response regulator 1
CCATATATGAC
>pdb|6H1V|P Chain P, The crystal structure of Pol2CORE in complex with DNA and an incoming nucleotide, carrying an Fe-S cluster
NAACCGCGTTN
>pdb|6QIB|P Chain P, The crystal structure of Pol2CORE in complex with DNA and an incoming nucleotide, carrying an Fe-S cluster
NAACCGCGTTN
>pdb|6G3B|D Chain D, AvaII restriction endonuclease in complex with an RNA/DNA hybrid
CCATGGTCCTA
>pdb|6G3B|C Chain C, AvaII restriction endonuclease in complex with an RNA/DNA hybrid
GTAGGACCATG
>pdb|6AEG|D Chain D, Crystal structure of xCas9 in complex with sgRNA and target DNA (GAT PAM)
AAAGATTATTG
>pdb|6AEB|H Chain H, Crystal structure of xCas9 in complex with sgRNA and target DNA (AAG PAM)
AAAAAGTATTG
>pdb|6AEB|D Chain D, Crystal structure of xCas9 in complex with sgRNA and target DNA (AAG PAM)
AAAAAGTATTG
>pdb|6QIC|H Chain H, Crystal structure of DEAH-box ATPase Prp22-S837A with bound ssRNA
NTTTTTTTTTT
>pdb|6QIC|G Chain G, Crystal structure of DEAH-box ATPase Prp22-S837A with bound ssRNA
NTTTTTTTTTT
>pdb|6QIC|F Chain F, Crystal structure of DEAH-box ATPase Prp22-S837A with bound ssRNA
NTTTTTTTTTT
>pdb|6QIC|E Chain E, Crystal structure of DEAH-box ATPase Prp22-S837A with bound ssRNA
NTTTTTTTTTT
>pdb|6I8A|C Chain C, The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.
NAACCGCGTTN
>pdb|6I8A|P Chain P, The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.
NAACCGCGTTN
>pdb|6GC5|H Chain H, Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM
ATTTTTATTTT
>pdb|6GC5|G Chain G, Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM
ATTTTTATTTT
>pdb|6GC5|F Chain F, Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM
ATTTTTATTTT
>pdb|6GC5|E Chain E, Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM
NTTTTTATTTT
>pdb|6G0A|P Chain P, The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.
NAACCGCGTTN
>pdb|6FWK|C Chain C, The crystal structure of Pol2CORE-M644G in complex with DNA and an incoming nucleotide
NAACCGCGTTN
>pdb|6FWK|P Chain P, The crystal structure of Pol2CORE-M644G in complex with DNA and an incoming nucleotide
NAACCGCGTTN
>pdb|5OC6|C Chain C, Crystal structure of human tRNA-dihydrouridine(20) synthase dsRBD in complex with a 22 nucleotide dsRNA
NGAACTTCGCG
>pdb|5OC6|B Chain B, Crystal structure of human tRNA-dihydrouridine(20) synthase dsRBD in complex with a 22 nucleotide dsRNA
NGAACTTCGCG
>pdb|6FWR|B Chain B, Structure of DinG in complex with ssDNA
TTTTTTTTTTT
>pdb|6HCT|E Chain E, Crystal structure of Archeoglobus fulgidus L7Ae bound to its cognate UTR k-turn
GCCGATGAATG
>pdb|6DSY|P Chain P, Bst DNA polymerase I post-chemistry (n+1) structure
GCGATCACGTA
>pdb|6DSX|P Chain P, Bst DNA polymerase I post-chemistry (n+1 with dATP soak) structure
GCGATCACGTA
>pdb|6DSV|P Chain P, Bst DNA polymerase I post-chemistry (n+2) structure
GCGATCACGTA
>pdb|6DSU|T Chain T, Bst DNA polymerase I pre-insertion complex structure
NCGTGATCGCA
>pdb|6BDA|C Chain C, Wild-type I-OnuI bound to A3G substrate (post-cleavage complex)
NACCTTTTACC
>pdb|6BCH|P Chain P, I-LtrI E29D bound to cognate substrate (nicked complex)
TAGGAGCATTT
>pdb|6BCH|K Chain K, I-LtrI E29D bound to cognate substrate (nicked complex)
TAGGAGCATTT
>pdb|6BCH|G Chain G, I-LtrI E29D bound to cognate substrate (nicked complex)
TAGGAGCATTT
>pdb|6BCH|X Chain X, I-LtrI E29D bound to cognate substrate (nicked complex)
TAGGAGCATTT
>pdb|6A8R|F Chain F, Crystal structure of DUX4 HD2 domain associated with ERG DNA binding site
TAATCTCATCA
>pdb|6A8R|E Chain E, Crystal structure of DUX4 HD2 domain associated with ERG DNA binding site
NGATGAGATTA
>pdb|6CG8|F Chain F, Structure of C. crescentus GapR-DNA
TTTAATTTTAA
>pdb|6CG8|C Chain C, Structure of C. crescentus GapR-DNA
TTAAAATTAAA
>pdb|6M7U|T Chain T, Human DNA polymerase eta in a non-productive ternary complex with Mg2+ and dTMPNPP oppositing cdA
ATNCTCACACT
>pdb|6M7T|T Chain T, Human DNA polymerase eta in a non-productive ternary complex with Ca2+ and dTTP oppositing cdA
ATNCTCACACT
>pdb|6M7O|T Chain T, Human DNA polymerase eta ternary complex with Mn2+ and dTMPNPP oppositing cdA
ATNCTCACACT
>pdb|6DKL|C Chain C, Crystal Structure of a Rationally Designed Six-Fold Symmetric DNA Scaffold
NGTGCTGTGCT
>pdb|6GDR|D Chain D, DNA binding with a minimal scaffold: Structure-function analysis of Lig E DNA ligases
NACTATCGGAA
>pdb|6BKG|P Chain P, Human LigIV catalytic domain with bound DNA-adenylate intermediate in closed conformation
GCTGATGCGTC
>pdb|6BKF|P Chain P, Lysyl-adenylate form of human LigIV catalytic domain with bound DNA substrate in open conformation
GCTGATGCGTC
>pdb|6FPX|F Chain F, Structure of S. pombe Mmi1 in complex with 11-mer RNA
CTTTAAACCTA
>pdb|6FPX|D Chain D, Structure of S. pombe Mmi1 in complex with 11-mer RNA
CTTTAAACCTA
>pdb|6FPX|B Chain B, Structure of S. pombe Mmi1 in complex with 11-mer RNA
CTTTAAACCTA
>pdb|6CBD|C Chain C, Crystal Structure of Human Argonaute2 Bound to Three Tryptophans
CAATGTGAAAA
>pdb|5YIW|E Chain E, Caulobacter crescentus GcrA DNA-binding domain (DBD) in complex with methylated dsDNA (crystal form 2)
CGCGNATCAGG
>pdb|5YIW|D Chain D, Caulobacter crescentus GcrA DNA-binding domain (DBD) in complex with methylated dsDNA (crystal form 2)
CCCTGNTTCGC
>pdb|6F57|H Chain H, Crystal structure of DNMT3A-DNMT3L in complex with single CpG-containing DNA
CATGNGCTCTC
>pdb|6F57|F Chain F, Crystal structure of DNMT3A-DNMT3L in complex with single CpG-containing DNA
CATGNGCTCTC
>pdb|5Z7I|D Chain D, Caulobacter crescentus GcrA DNA-binding domain(DBD)in complex with unmethylated dsDNA
CCCTGATTCGC
>pdb|6AS7|B Chain B, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF HUMAN DNA POLYMERASE ALPHA IN TERNARY COMPLEX WITH AN DNA-PRIMED DNA TEMPLATE AND DCTP
GCCTGGAGCGC
>pdb|6CA0|J Chain J, Cryo-EM structure of E. coli RNAP sigma70 open complex
NCCGCGTCAGA
>pdb|6CA0|I Chain I, Cryo-EM structure of E. coli RNAP sigma70 open complex
NCTGACGCGGC
>pdb|5WN5|C Chain C, APE1 exonuclease substrate complex with a C/T mismatch and Mn2+
NCGACGGATCC
>pdb|5WN4|C Chain C, APE1 exonuclease substrate complex with a C/T mismatch
NCGACGGATCC
>pdb|5WN3|C Chain C, APE1 F266A exonuclease substrate complex with a C/T mismatch
NCGACGGATCC
>pdb|5WN2|C Chain C, APE1 exonuclease substrate complex with phosphoglycolate
NCGACGGATCC
>pdb|5WN1|C Chain C, APE1 exonuclease product complex
NCGACGGATCC
>pdb|5NWA|C Chain C, Crystal structure of the complex of Tdp1 with duplex DNA
NATGCGCATTA
>pdb|6AR3|E Chain E, Structure of a Thermostable Group II Intron Reverse Transcriptase with Template-Primer and Its Functional and Evolutionary Implications (RT/Duplex (Se-Met))
CTCCAGGCAAC
>pdb|6AR3|B Chain B, Structure of a Thermostable Group II Intron Reverse Transcriptase with Template-Primer and Its Functional and Evolutionary Implications (RT/Duplex (Se-Met))
CTCCAGGCAAC
>pdb|6AR1|E Chain E, Structure of a Thermostable Group II Intron Reverse Transcriptase with Template-Primer and Its Functional and Evolutionary Implications (RT/Duplex (Nat))
CTCCAGGCAAC
>pdb|6AR1|B Chain B, Structure of a Thermostable Group II Intron Reverse Transcriptase with Template-Primer and Its Functional and Evolutionary Implications (RT/Duplex (Nat))
CTCCAGGCAAC
>pdb|5OT2|P Chain P, RNA polymerase II elongation complex in the presence of 3d-Napht-A
TTCGAGGAGGG
>pdb|5VI0|F Chain F, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an abasic site analog
TGTCCANGTCT
>pdb|5VI0|E Chain E, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an abasic site analog
AAGACTTGGAC
>pdb|5VI0|D Chain D, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an abasic site analog
AAGACTTGGAC
>pdb|5VI0|C Chain C, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an abasic site analog
TGTCCANGTCT
>pdb|5VHV|F Chain F, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an oxocarbenium-intermediate analog
AAGACTTGGAC
>pdb|5VHV|E Chain E, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an oxocarbenium-intermediate analog
TGTCCANGTCT
>pdb|5VHV|D Chain D, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an oxocarbenium-intermediate analog
AAGACTTGGAC
>pdb|5VHV|C Chain C, Pseudomonas fluorescens alkylpurine DNA glycosylase AlkC bound to DNA containing an oxocarbenium-intermediate analog
TGTCCANGTCT
>pdb|5OR0|B Chain B, NMR derived model of the 5'-splice site of SMN2 in complex with the 5'-end of U1 snRNA
NGAGTAAGTCT
>pdb|5OR0|A Chain A, NMR derived model of the 5'-splice site of SMN2 in complex with the 5'-end of U1 snRNA
NTACNNACCTG
>pdb|5VXQ|B Chain B, X-Ray crystallography structure of the parallel stranded duplex formed by 5-rA5-dA-rA5
AAAAANAAAAA
>pdb|5VXQ|A Chain A, X-Ray crystallography structure of the parallel stranded duplex formed by 5-rA5-dA-rA5
AAAAANAAAAA
>pdb|5EOS|A Chain A, Crystallizing Strained DNA: Self-Assembly of 3D Crystals Containing a Torsionally-Stressed Component
NAGCAGCTGTG
>pdb|5VZJ|M Chain M, STRUCTURE OF A TWELVE COMPONENT MPP6-NUCLEAR RNA EXOSOME COMPLEX BOUND TO RNA
TTATTTTAAAA
>pdb|5VVL|H Chain H, Cas1-Cas2 bound to full-site mimic with Ni
GACCACCAGTG
>pdb|5VVL|G Chain G, Cas1-Cas2 bound to full-site mimic with Ni
GCCCCAGTAGC
>pdb|5VVK|H Chain H, Cas1-Cas2 bound to full-site mimic
GACCACCAGTG
>pdb|5VVK|G Chain G, Cas1-Cas2 bound to full-site mimic
GCCCCAGTAGC
>pdb|5UGO|P Chain P, DNA polymerase beta nick complex with imidodiphosphate
GCTGATGCGCC
>pdb|5UGN|P Chain P, DNA polymerase beta imidodiphosphate reactant complex
GCTGATGCGCC
>pdb|5NIP|B Chain B, An i-motif containing the neutral cytidine protonated analogue pseudoisocytidine
TNCGTTTCNGT
>pdb|5NIP|A Chain A, An i-motif containing the neutral cytidine protonated analogue pseudoisocytidine
TNCGTTTCNGT
>pdb|5K97|E Chain E, Flap endonuclease 1 (FEN1) D233N with cleaved product fragment and Sm3+
NGAGGCAGAGT
>pdb|5K5L|D Chain D, Homo sapiens CCCTC-binding factor (CTCF) ZnF6-8 and H19 sequence DNA complex structure
CACGCGGCAAC
>pdb|5K5L|C Chain C, Homo sapiens CCCTC-binding factor (CTCF) ZnF6-8 and H19 sequence DNA complex structure
GTTGCCGCGTG
>pdb|5K5L|B Chain B, Homo sapiens CCCTC-binding factor (CTCF) ZnF6-8 and H19 sequence DNA complex structure
CACGCGGCAAC
>pdb|5K5L|A Chain A, Homo sapiens CCCTC-binding factor (CTCF) ZnF6-8 and H19 sequence DNA complex structure
GTTGCCGCGTG
>pdb|5V1R|P Chain P, DNA polymerase beta reactant complex with 8-oxoG:C at the primer terminus and incoming dCTP
GCTGATGCGNC
>pdb|5V1O|P Chain P, DNA polymerase beta product complex with 8-oxoG:A and inserted dCTP
GCTGATGCGNC
>pdb|5V1J|P Chain P, DNA polymerase beta open product complex with 8-oxoG:C and inserted dCTP
GCTGATGCGNC
>pdb|5V1I|P Chain P, DNA polymerase beta ternary product complex with 8-oxoG:C and inserted dCTP
GCTGATGCGNC
>pdb|5ULX|T Chain T, Structure of human DNA polymerase iota bound to template 1-methyl-deoxyadenosine crystallized in the presence of dCTP
TCTNGGGTCCT
>pdb|5ULW|T Chain T, Structure of human DNA polymerase iota bound to template 1-methyl-deoxyadenosine
TCTNGGGTCCT
>pdb|5M1W|A Chain A, Structure of a stable G-hairpin
GTGTGGGTGTG
>pdb|5U9H|P Chain P, DNA polymerase beta product complex with inserted Sp-isomer of dCTP-alpha-S
GCTGATGCGCN
>pdb|5KL7|C Chain C, Wilms Tumor Protein (WT1) ZnF2-4Q369R in complex with carboxylated DNA
TANGCCCACGC
>pdb|5KL7|B Chain B, Wilms Tumor Protein (WT1) ZnF2-4Q369R in complex with carboxylated DNA
AGCGTGGGNGT
>pdb|5KL6|C Chain C, Wilms Tumor Protein (WT1) Q369R ZnF2-4 in complex with DNA
TACCCCCACGC
>pdb|5KL6|B Chain B, Wilms Tumor Protein (WT1) Q369R ZnF2-4 in complex with DNA
AGCGTGGGGGT
>pdb|5KL5|C Chain C, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with carboxylated DNA
TANGCCCACGC
>pdb|5KL5|B Chain B, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with carboxylated DNA
AGCGTGGGNGT
>pdb|5KL4|F Chain F, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA
TANGCCCACGC
>pdb|5KL4|E Chain E, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA
AGCGTGGGNGT
>pdb|5KL4|C Chain C, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA
TANGCCCACGC
>pdb|5KL4|B Chain B, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA
AGCGTGGGNGT
>pdb|5KL3|C Chain C, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with DNA
TACTCCCACGC
>pdb|5KL3|B Chain B, Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with DNA
AGCGTGGGAGT
>pdb|5KL2|C Chain C, Wilms Tumor Protein (WT1) ZnF2-4 in complex with DNA
TACTCCCACGC
>pdb|5KL2|B Chain B, Wilms Tumor Protein (WT1) ZnF2-4 in complex with DNA
AGCGTGGGAGT
>pdb|5HQQ|B Chain B, DNA duplex containing a ribonolactone lesion
GCNTGGGAGCG
>pdb|5HQQ|A Chain A, DNA duplex containing a ribonolactone lesion
CGCTCNCACGC
>pdb|5HQF|B Chain B, DNA duplex containing a ribonolactone lesion
GCGTGGGANCG
>pdb|5HQF|A Chain A, DNA duplex containing a ribonolactone lesion
CGCTCNCACGC
>pdb|4Z53|H Chain H, Quinolone(Trovafloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NACTATGCACG
>pdb|4Z53|F Chain F, Quinolone(Trovafloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NGTCATTCATG
>pdb|4Z4Q|H Chain H, Quinazolinedione(PD 0305970)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NGTTATCCACA
>pdb|4Z4Q|F Chain F, Quinazolinedione(PD 0305970)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NACCGTATTAC
>pdb|4Z3O|H Chain H, Quinolone(Moxifloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NACTATGCACG
>pdb|4Z3O|F Chain F, Quinolone(Moxifloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniae
NGTCATTCATG
>pdb|5IIM|T Chain T, Crystal structure of the pre-catalytic ternary extension complex of DNA polymerase lambda with an 8-oxo-dG:dA base-pair
CGGCANTACTG
>pdb|5DEV|A Chain A, High resolution structure of CCG DNA repeats at 1.71 angstrom resolution
TCCGCCGCCGA
>pdb|5IIO|N Chain N, Crystal structure of the DNA polymerase lambda binary complex
CGGCNGTACTG
>pdb|5IIO|J Chain J, Crystal structure of the DNA polymerase lambda binary complex
CGGCNGTACTG
>pdb|5IIO|F Chain F, Crystal structure of the DNA polymerase lambda binary complex
CGGCNGTACTG
>pdb|5IIO|B Chain B, Crystal structure of the DNA polymerase lambda binary complex
CGGCNGTACTG
>pdb|5IIN|T Chain T, Crystal structure of the pre-catalytic ternary extension complex of DNA polymerase lambda with an 8-oxo-dG:dC base-pair
CGGCANTACTG
>pdb|5IIL|T Chain T, Crystal structure of the post-catalytic nick complex of DNA polymerase lambda with a templating 8-oxo-dG and incorporated dA
CGGCANTACTG
>pdb|5IIK|T Chain T, Crystal structure of the post-catalytic nick complex of DNA polymerase lambda with a templating 8-oxo-dG and incorporated dC
CGGCANTACTG
>pdb|5IIJ|T Chain T, Crystal structure of the pre-catalytic ternary complex of DNA polymerase lambda with a templating 8-oxo-dG and an incoming dCTP
CGGCNGTACTG
>pdb|5III|T Chain T, Crystal structure of the pre-catalytic ternary complex of DNA polymerase lambda with a templating 8-oxo-dG and an incoming dATP
CGGCNGTACTG
>pdb|5HNH|L Chain L, Crystal structure of pyrene- and phenanthrene-modified DNA in complex with the BpuJ1 endonuclease binding domain
GNACCCGTGGA
>pdb|5HNF|M Chain M, Crystal structure of pyrene- and phenanthrene-modified DNA in complex with the BpuJ1 endonuclease binding domain
TCCACGGGTNC
>pdb|5HNF|L Chain L, Crystal structure of pyrene- and phenanthrene-modified DNA in complex with the BpuJ1 endonuclease binding domain
GNACCCGTGGA
>pdb|5K7E|B Chain B, The structure of pistol ribozyme, soaked with Mn2+
NTCAGNTGCAA
>pdb|5K7D|B Chain B, The structure of native pistol ribozyme, bound to Iridium
NTCAGNTGCAA
>pdb|5K7C|B Chain B, The native structure of native pistol ribozyme
NTCAGNTGCAA
>pdb|4YFT|D Chain D, HUab-20bp
NACACACAGAC
>pdb|4YFH|C Chain C, HU38-20bp
NCCTTTTCCCC
>pdb|4YF0|C Chain C, HU38-19bp
NCCTTTTCCCC
>pdb|4YEW|D Chain D, HUab-19bp
NACACACAGAC
>pdb|5JCF|Y Chain Y, Crystal structure of chicken MDA5 with 5'p 10-mer dsRNA and ADP-Mg2+ at 2.6 A resolution (orthorhombic form).
AGGTACGTACC
>pdb|5JB2|X Chain X, Crystal structure of chicken LGP2 with 5'ppp 10-mer dsRNA and ADP-AlF4-Mg2+ at 2.2 A resolution.
NGTACGTACCC
>pdb|5JAJ|X Chain X, Structure of chicken LGP2 witha 5'p 10-mer dsRNA and ADP-AlF4-Mg.
NGTACGTACCC
>pdb|5A0M|K Chain K, THE CRYSTAL STRUCTURE OF I-SCEI IN COMPLEX WITH ITS TARGET DNA IN THE PRESENCE OF MN
NAGGGTAATAC
>pdb|5A0M|J Chain J, THE CRYSTAL STRUCTURE OF I-SCEI IN COMPLEX WITH ITS TARGET DNA IN THE PRESENCE OF MN
NAGGGTAATAC
>pdb|5DKW|F Chain F, Ternary crystal structure of polymerase lambda with a GA mispair at the primer terminus with Ca2+ in the active
CGGCGGTACTG
>pdb|5DKW|T Chain T, Ternary crystal structure of polymerase lambda with a GA mispair at the primer terminus with Ca2+ in the active
CGGCGGTACTG
>pdb|5CWR|F Chain F, Crystal Structure of human DNA polymerase lambda L431A mutant in complex with a one nucleotide DNA gap and dCTP
CGGCGGTACTG
>pdb|5CWR|T Chain T, Crystal Structure of human DNA polymerase lambda L431A mutant in complex with a one nucleotide DNA gap and dCTP
CGGCGGTACTG
>pdb|4XA5|T Chain T, Crystal structure of the pre-catalytic ternary complex of DNA polymerase lambda with a templating A and an incoming 8-oxo-dGTP
CGGCAGTACTG
>pdb|4XUS|T Chain T, Crystal structure of the pre-catalytic ternary complex of DNA polymerase lambda with a templating A and an incoming dTTP
CGGCAGTACTG
>pdb|5E63|C Chain C, K262A mutant of I-SmaMI
NGGAGGATACC
>pdb|4ZYM|D Chain D, Structural implications of homo-pyrimidine base pairs on the parallel-stranded d(GAY) motif.
ACTCGGACGAT
>pdb|4ZYM|C Chain C, Structural implications of homo-pyrimidine base pairs on the parallel-stranded d(GAY) motif.
ACTCGGACGAT
>pdb|4ZYM|B Chain B, Structural implications of homo-pyrimidine base pairs on the parallel-stranded d(GAY) motif.
ACTCGGACGAT
>pdb|4ZYM|A Chain A, Structural implications of homo-pyrimidine base pairs on the parallel-stranded d(GAY) motif.
ACTCGGACGAT
>pdb|5DEU|C Chain C, Crystal structure of TET2-5hmC complex
NCACNGGTGGT
>pdb|4X5V|T Chain T, Crystal structure of the post-catalytic nick complex of DNA polymerase lambda with a templating A and incorporated 8-oxo-dGMP
CGGCAGTACTG
>pdb|5DFH|D Chain D, Human APE1 mismatch product complex
NCGACGGATCC
>pdb|5DFF|D Chain D, Human APE1 product complex
NCGACGGATCC
>pdb|4Z4I|D Chain D, Human Argonaute2 A481T Mutant Bound to t1-G Target RNA
CAATGTGAGAA
>pdb|4Z4H|D Chain D, Human Argonaute2 A481T Mutant Bound to t1-A Target RNA
CAATGTGAAAA
>pdb|4Z4G|D Chain D, Human Argonaute2 Bound to t1-Inosine Target RNA
CAATGTGANAA
>pdb|4Z4F|D Chain D, Human Argonaute2 Bound to t1-DAP Target RNA
CAATGTGANAA
>pdb|4Z4E|D Chain D, Human Argonaute2 Bound to t1-U Target RNA
CAATGTGATAA
>pdb|4Z4D|D Chain D, Human Argonaute2 Bound to t1-G Target RNA
CAATGTGAGAA
>pdb|4Z4C|D Chain D, Human Argonaute2 Bound to t1-C Target RNA
CAATGTGACAA
>pdb|5AKM|M Chain M, The Crystal Structure Of I-dmoi G20s In Complex With Its Target Dna In The Presence Of 2mm Mg
NTTCCGGCGCG
>pdb|5AKM|H Chain H, The Crystal Structure Of I-dmoi G20s In Complex With Its Target Dna In The Presence Of 2mm Mg
NTTCCGGCGCG
>pdb|5AKM|C Chain C, The Crystal Structure Of I-dmoi G20s In Complex With Its Target Dna In The Presence Of 2mm Mg
NTTCCGGCGCG
>pdb|5AKF|K Chain K, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna Nicked In The Coding Strand A And In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|5AKF|G Chain G, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna Nicked In The Coding Strand A And In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|5AKF|C Chain C, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna Nicked In The Coding Strand A And In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|5AK9|L Chain L, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|5AK9|G Chain G, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|5AK9|C Chain C, The Crystal Structure Of I-dmoi Q42ak120m In Complex With Its Target Dna In The Presence Of 2mm Mn
NTTCCGGCGCG
>pdb|4YPR|F Chain F, Crystal Structure of D144N MutY bound to its anti-substrate
AAGACNTGGAC
>pdb|4YPR|E Chain E, Crystal Structure of D144N MutY bound to its anti-substrate
TGTCCACGTCT
>pdb|4YPR|D Chain D, Crystal Structure of D144N MutY bound to its anti-substrate
AAGACNTGGAC
>pdb|4YPR|C Chain C, Crystal Structure of D144N MutY bound to its anti-substrate
TGTCCACGTCT
>pdb|4YPH|C Chain C, Crystal Structure of MutY bound to its anti-substrate with the disulfide cross-linker reduced
TGTCCACGTCT
>pdb|4YPH|B Chain B, Crystal Structure of MutY bound to its anti-substrate with the disulfide cross-linker reduced
AAGACNTGGAC
>pdb|4YOQ|C Chain C, Crystal Structure of MutY bound to its anti-substrate
TGTCCACGTCT
>pdb|4YOQ|B Chain B, Crystal Structure of MutY bound to its anti-substrate
AAGACNTGGAC
>pdb|4X9J|C Chain C, EGR-1 with Doubly Methylated DNA
TANGCCCANGC
>pdb|4X9J|B Chain B, EGR-1 with Doubly Methylated DNA
AGNGTGGGNGT
>pdb|4WUH|H Chain H, Crystal structure of E. faecalis DNA binding domain LiaR wild type complexed with 22bp DNA
NTCTTAAGTCC
>pdb|4PH5|P Chain P, Structure of human DNA polymerase beta complexed with a nicked DNA containing a AC at N-1 position and GC at N position
GCTGATGCGCC
>pdb|2MXJ|A Chain A, Structural features of a 3' splice site influenza A: 11-nt hairpin
CCAGAAACGGA
>pdb|4RQ8|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine(8-oxoG) and dATP soaked with MnCl2 for 35 s
GCTGATGCGCA
>pdb|4RQ7|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG)and dATP soaked with MgCl2 for 1hr
GCTGATGCGCA
>pdb|4RQ6|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine(8-oxoG) and dATP soaked with MgCl2 for 80 s
GCTGATGCGCA
>pdb|4RQ5|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG)and dATP soaked with MgCl2 for 60 s
GCTGATGCGCA
>pdb|4RQ4|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine(8-oxoG) and dATP soaked with MgCl2 for 30 s
GCTGATGCGCA
>pdb|4RQ2|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG)and dCTP soaked with MnCl2 for 35 s
GCTGATGCGCC
>pdb|4RQ1|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine(8-oxoG) and dCTP soaked with MgCl2 for 1hr
GCTGATGCGCC
>pdb|4RQ0|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG)and dCTP soaked with MgCl2 for 80 s
GCTGATGCGCC
>pdb|4RPZ|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG)and dCTP soaked with MgCl2 for 60 s
GCTGATGCGCC
>pdb|4RPY|P Chain P, Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine(8-oxoG) and dCTP soaked with MgCl2 for 30 s
GCTGATGCGCC
>pdb|4XVI|T Chain T, Binary complex of human polymerase nu and DNA with the finger domain ajar
CCTAGCGTCAG
>pdb|4RIP|A Chain A, BromoUracil substituted structure of intercalation-locked DNA tetraplex
ACNCGGANGAT
>pdb|4RIM|A Chain A, Native structure of intercalation-locked DNA tetraplex
ACTCGGATGAT
>pdb|4PZQ|A Chain A, Crystal Structure of CCG DNA repeats
TCCGCCGCCGA
>pdb|4WAN|H Chain H, Crystal structure of Msl5 protein in complex with RNA at 1.8 A
TATACTAACAA
>pdb|4WAN|F Chain F, Crystal structure of Msl5 protein in complex with RNA at 1.8 A
TATACTAACAA
>pdb|4WAN|D Chain D, Crystal structure of Msl5 protein in complex with RNA at 1.8 A
TATACTAACAA
>pdb|4WAN|B Chain B, Crystal structure of Msl5 protein in complex with RNA at 1.8 A
TATACTAACAA
>pdb|4WAL|B Chain B, Crystal structure of selenomethionine Msl5 protein in complex with RNA at 2.2 A
TATACTAACAA
>pdb|4D6N|M Chain M, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mg (state 7)
NTTCCGGCGCG
>pdb|4D6N|H Chain H, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mg (state 7)
NTTCCGGCGCG
>pdb|4D6N|C Chain C, The Crystal Structure Of I-dmoi In Complex With Its Target Dna At 10 Days Incubation In 5mm Mg (state 7)
NTTCCGGCGCG
>pdb|4RI9|W Chain W, FAN1 Nuclease bound to 5' phosphorylated p(dT)/3'(dT-dT-dT-dT-dT-dT-dT-dT) double flap DNA
NAGCCACGCCT
>pdb|4RI9|S Chain S, FAN1 Nuclease bound to 5' phosphorylated p(dT)/3'(dT-dT-dT-dT-dT-dT-dT-dT) double flap DNA
NAGCCACGCCT
>pdb|4QCL|B Chain B, Crystal structure of the catalytic core of human DNA polymerase alpha in ternary complex with an RNA-primed DNA template and dCTP
GCCTGGAGCGN
>pdb|4Q5V|F Chain F, Crystal structure of the catalytic core of human DNA polymerase alpha in ternary complex with an RNA-primed DNA template and aphidicolin
GCCTGGAGCGN
>pdb|4Q5V|B Chain B, Crystal structure of the catalytic core of human DNA polymerase alpha in ternary complex with an RNA-primed DNA template and aphidicolin
GCCTGGAGCGN
>pdb|4KPF|H Chain H, Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate
NACTATGCACG
>pdb|4KPF|F Chain F, Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate
NGTCATTCATG
>pdb|4KPE|H Chain H, Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate
NACTATGCACG
>pdb|4KPE|F Chain F, Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate
NGTCATTCATG
>pdb|4KOE|H Chain H, Quinolone(Trovafloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NACTATGCACG
>pdb|4KOE|F Chain F, Quinolone(Trovafloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae
NGTCATTCATG
>pdb|2MKO|A Chain A, G-triplex structure and formation propensity
GGTTGGTGTGG
>pdb|2MKM|A Chain A, G-triplex structure and formation propensity
GGTTGGTGTGG
>pdb|4W5T|D Chain D, The Crystal Structure of Human Argonaute2 Bound to a Guide and Target RNA Containing Seed Pairing from 2-7
ACATGTGAAAA
>pdb|4W5Q|D Chain D, The Crystal Structure of Human Argonaute2 Bound to a Guide and Target RNA Containing Seed Pairing from 2-8
AAATGTGAAAA
>pdb|4W5O|D Chain D, The Crystal Structure of Human Argonaute2 Bound to a Guide and Target RNA Containing Seed Pairing from 2-9
CAATGTGAAAA
>pdb|4UBB|P Chain P, DNA polymerase beta reactant complex with a templating cytosine and incoming 8-oxodGTP, 40 s
GCTGATGCGCN
>pdb|4UB3|P Chain P, DNA polymerase beta closed product complex with a templating cytosine and 8-oxodGMP, 60 s
GCTGATGCGCN
>pdb|4UB2|P Chain P, DNA polymerase beta product complex with a templating cytosine and 8-oxodGMP, 120 s
GCTGATGCGCN
>pdb|4UB1|P Chain P, DNA polymerase beta product complex with a templating adenine and 8-oxodGMP, 90 s
GCTGATGCGCN
>pdb|4UAZ|P Chain P, DNA polymerase beta reactant complex with a templating adenine and incoming 8-oxodGTP, 20 s
GCTGATGCGCN
>pdb|4UAY|P Chain P, DNA polymerase beta product complex with a templating adenine and inserted 8-oxodGMP, 40 s
GCTGATGCGCN
>pdb|4MCF|H Chain H, Crystal structure of the Gas5 GRE Mimic
AAGACTGCCTG
>pdb|4MCF|F Chain F, Crystal structure of the Gas5 GRE Mimic
AAGACTGCCTG
>pdb|4MCF|B Chain B, Crystal structure of the Gas5 GRE Mimic
AAGACTGCCTG
>pdb|4MCF|D Chain D, Crystal structure of the Gas5 GRE Mimic
AAGACTGCCTG
>pdb|4R2S|C Chain C, Wilms Tumor Protein (WT1) Q369P zinc fingers in complex with methylated DNA
TANGCCCACGC
>pdb|4R2S|B Chain B, Wilms Tumor Protein (WT1) Q369P zinc fingers in complex with methylated DNA
AGCGTGGGNGT
>pdb|4R2R|C Chain C, Wilms Tumor Protein (WT1) zinc fingers in complex with carboxylated DNA
TANGCCCACGC
